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The intestinal tract of virtually any metazoan, including mammals, is colonized
with a complex microbial community to which we refer as intestinal or gut microbiota.
One of the roles of the healthy intestinal microbiota is to protect the host against gut
colonization  with  pathogenic  bacteria  through  a  phenomenon  known as  colonization
resistance (CR). Dysbiosis of the intestinal microbiota, usually as a result of an antibiotic
treatment,  may  lead  to  the  disruption  of  the  CR,  and  subsequent  colonization  with
bacterial pathogens. Interestingly, CR is affected differently by antibiotics of different
spectrum,  suggesting  that  some  members  of  the  microbiota  participate  in  CR  while
others are dispensable. Moreover, once established in the intestine, bacterial pathogens
may  reach  high  levels  and  disseminate  into  the  bloodstream  of  the  host  provoking
infection. However, and despite the importance, the role of the microbiota dysbiosis on
the  gut  colonization  by  many  bacterial  pathogens,  such  as  multidrug  resistant
Enterobacteriaceae, has not been elucidated: the members of the microbiota that confer
CR and factors that promote colonization remain mostly unknown.
The general aim of this thesis has been to improve the understanding of the role
of the microbiota dysbiosis in gut colonization by bacterial pathogens. For this purpose,
3 projects have been established. In the first project we tried to elucidate the role of the
microbiota dysbiosis on colonization by multidrug resistant Enterobacteriaceae (MRE) in
mice. MRE, such as Escherichia coli and Klebsiella pneumoniae, are among the leading
causes of morbidity and mortality worldwide. Infections with MRE usually begin by the
colonization  of  the  intestinal  tract.  However,  little  is  known  about  clinical  factors
associated  with  MRE  colonization  or  which  members  of  microbiota  could  prevent
colonization and subsequent infection with MRE. In order to elucidate the role of the
microbiota  dysbiosis  on  mice  colonization  with  MRE,  we  treated  mice  with  several
antibiotics  and  infected  them  with  a  multidrug  resistant  strain  of  K.  pneumoniae
(MRKP). Our  results  indicate  that  persistent  microbiota  dysbiosis,  as  a  result  of
antibiotic treatment,  promotes MRKP intestinal colonization in mice.  Importantly, we
were  able  to  demonstrate  that  the  restoration  of  the  levels  of  2  bacterial  genera
(Lactobacillus and Barnesiella), depleted by antibiotic therapy, significantly diminish the
ability of MRKP to colonize the intestinal tract.
In  the  second  project  we  investigated  the  risk  factors  and  members  of  the
microbiota  associated  with  the  MRE  colonization  in  hospitalized  patients.  MRE
infections represent a great threat for hospitalized patients. Specifically, acute leukemia
patients are often colonized with MRE, probably due to the impaired CR as a result of
intensive antibiotic treatments these patients receive. Notably, we did not identify any
antibiotic  that  enhance  intestinal  colonization  by  MRE.  In  contrast,  we  identified
systematic administration of beta-lactams, when the patient is colonized with MRE strain
sensitive to beta-lactams, as one of the factors associated with the reduction in MRE
colonization levels. On the other hand, administration of beta-lactams when the patient is
colonized  with  MRE  beta-lactam-resistant  strain  does  not  enhance  MRE  intestinal
colonization. Among commensal bacteria associated with changes in MRE colonization
levels,  we  identified  higher  abundance  of  the  genus  Coprobacillus,  1  operational
taxonomical  unit  (OTU)  of  the  genus  Lactobacillus and  2  Bacteroides OTUs  to  be
associated with a decrease of MRE fecal levels in acute leukemia patients, suggesting
that these commensal bacteria may have a protective role against MRE.
In  the  third  project  we  studied  the  role  of  the  microbiota  dysbiosis  on  the
development of Epizootic Rabbit Enteropathy (ERE). ERE is a severe gastrointestinal
disease with a  high percentage of  mortality  that  occurs  in  young rabbits  during first
weeks post-weaning. ERE rabbits have been shown to suffer microbiota dysbiosis during
the development of the disease. Moreover, the disease could be reproduced by contact
between healthy and sick animals and by administration of cecal contents from ERE
rabbits to healthy rabbits, suggesting that a pathogenic agent may be involved in the
development of this intestinal pathology, although no causative agent has been identified
until now. Here, we demonstrated that the major changes in the microbiota composition
observed after the initiation of ERE cannot be detected in rabbits that will develop ERE
before the disease onset. Moreover, the only change that could be detected before the
development  of  ERE  was  the  higher  presence  of  a  novel  species  within  the  genus
Clostridium in  rabbits  that  will  develop  ERE on the  very  day of  the  disease  onset,
suggesting that this bacterium could have a major role in the initiation of ERE.
Resumen
El  tracto  intestinal  de  prácticamente  cualquier  metazoo,  incluidos  los
mamíferos,  está  colonizado  por  una  compleja  comunidad  microbiana  a  la  que  nos
referimos como microbiota intestinal. Uno de los papeles de la microbiota intestinal es
proteger al huésped contra la colonización intestinal con bacterias patógenas a través de
un  fenómeno  conocido  como  resistencia  a  la  colonización  (RC).  La  disbiosis  de  la
microbiota  intestinal,  a  menudo como resultado de  un  tratamiento  antibiótico,  puede
conducir a la alteración de la RC y posterior colonización por patógenos bacterianos.
Curiosamente, RC es afectada de manera distinta por antibióticos de espectro diferente,
lo que sugiere que algunos miembros de la microbiota participan en RC, mientras que
otros  son  dispensables.  Además,  una  vez  establecidos  en  el  intestino,  los  patógenos
bacterianos  pueden alcanzar  niveles  altos  y diseminarse en el  torrente  sanguíneo del
huésped provocando infección. Sin embargo, y pese a su importancia,  el  papel de la
disbiosis  de  la  microbiota  en  la  colonización  intestinal  por  muchos  patógenos
bacterianos,  como son las  Enterobacterias  multirresistentes,  no se ha  esclarecido:  los
miembros  de  la  microbiota  que  confieren  RC  y  los  factores  que  promueven  la
colonización siguen siendo desconocidos.
El objetivo general de esta tesis ha sido mejorar la comprensión del papel de
disbiosis de la microbiota en la colonización intestinal por patógenos bacterianos. Para
ello se han establecido tres proyectos. En el primer proyecto investigamos el papel de
disbiosis  de  la  microbiota  intestinal  en  la  colonización  por  Enterobacterias
multiresistentes  (MRE)  en  ratones.  MRE,  como  Escherichia  coli y  Klebsiella
pneumoniae, están entre las principales causas de morbilidad y mortalidad en todo el
mundo. Las infecciones con MRE generalmente comienzan por la colonización del tracto
intestinal.  Sin  embargo,  se  sabe  poco  sobre  los  factores  clínicos  asociados  con  la
colonización de MRE o que miembros de la microbiota podrían prevenir la colonización
y la consecuente infección con MRE. Con el fin de esclarecer el papel de la disbiosis de
la microbiota intestinal en la colonización con MRE en ratones, se trataron ratones con
varios  antibióticos  y  se  infectaron  con  una  cepa  multiresistente  de  K.  pneumoniae
(MRKP). Nuestros resultados indican que la persistente disbiosis microbiana, resultante
del tratamiento antibiótico, promueve la colonización intestinal con MRKP en ratones.
Es importante destacar que hemos podido demostrar que la restauración de niveles de 2
géneros  bacterianos  (Lactobacillus y  Barnesiella),  afectados  por  el  tratamiento  con
antibióticos,  disminuye  significativamente  la  capacidad  de  MRKP para  colonizar  el
tracto intestinal de ratones.
En el segundo proyecto investigamos los factores de riesgo y los miembros de
la microbiota asociados con la colonización por MRE en pacientes hospitalizados. Las
infecciones por MRE representan una gran amenaza para los pacientes hospitalizados.
Específicamente,  MRE  a  menudo  colonizan  los  pacientes  con  leucemia  aguda,
probablemente  debido  a  que  la  RC  está  alterada  como  resultado  de  tratamientos
antibióticos intensivos recibidos por estos pacientes. Cabe destacar que no identificamos
ningún  antibiótico  que  promueva  la  colonización  intestinal  por  MRE.  Al  contrario,
hemos identificado la administración sistemática de beta-lactámicos, cuando el paciente
se  coloniza  con la  cepa  MRE sensible  a  beta-lactámicos,  como uno  de  los  factores
asociados con la reducción de los niveles de colonización intestinal por MRE. Por otro
lado, la administración de beta- lactámicos cuando el paciente está colonizado con una
cepa resistente a beta-lactámicos no aumenta los niveles intestinales de MRE. Entre las
bacterias comensales asociadas con cambios en los niveles de colonización por MRE,
identificamos  el  género  Coprobacillus,  una  unidad  taxonómica  operativa  (OTU)  del
género  Lactobacillus y  dos  OTUs  del  género  Bacteroides estar  asociadas  con  una
disminución de los niveles fecales de MRE en pacientes con leucemia aguda, lo que
sugiere que estas bacterias comensales pueden tener un papel protector contra el MRE.
En  el  tercer  proyecto  investigamos  el  papel  de  la  disbiosis  microbiana  en
desarollo  de  Enteropatía  Epizoótica  de  Conejo  (ERE).  ERE  es  una  enfermedad
gastrointestinal  severa  con  un  alto  porcentaje  de  mortalidad  que  ocurre  en  conejos
jóvenes durante las primeras semanas después del destete.  Se ha demostrado que los
conejos  con  ERE  sufren  disbiosis  microbiana  después  del  inicio  de  la  enfermedad,
aunque no está claro el papel de la disbiosis en el desarollo de la enfermedad. Además, la
enfermedad puede ser reproducida por contacto entre animales sanos y enfermos y por la
administración del contenido cecal de conejos con ERE a conejos sanos, lo que sugiere
que  un  agente  patógeno  podría  estar  implicado  en  el  desarrollo  de  esta  patología
intestinal, aunque hasta ahora no se ha logrado identificar ningún agente causal. Aquí,
hemos  demostrado  que  los  principales  cambios  en  la  composición  de  la  microbiota
observada después de la iniciación de ERE no se puede detectar en los conejos antes de
la aparición de la enfermedad. Por otra parte, el único cambio que se pudo detectar antes
de desarollo de la enfermedad fue la mayor presencia de una especie nueva dentro del
género Clostridium en conejos que desarrollaran ERE el mismo día de la aparición de la
enfermedad, lo que sugiere que esta bacteria podría tener un papel importante en el inicio
de ERE.
Resum
El tracte intestinal de pràcticament qualsevol metazoo, inclosos els mamífers,
està  colonitzat  per  una  complexa  comunitat  microbiana  a  la  qual  ens  referim  com
microbiota  intestinal.  Un dels  papers  de la  microbiota  intestinal  és  protegir  a  l'hoste
contra la colonització intestinal amb bacteris patògens a través d'un fenomen conegut
com  a  resistència  a  la  colonització  (RC).  La  disbiosis  de  la  microbiota  intestinal,
frecuentment com a resultat d'un tractament antibiòtic, pot conduir a l'alteració de la RC i
posterior colonització per patògens bacterians. Curiosament, RC és afectada de manera
diferent pels antibiòtics d'espectre diferent, la qual cosa suggereix que alguns membres
de la microbiota participen en RC, mentre que uns altres són dispensables. A més, una
vegada  establerts  en  l'intestí,  els  patògens  bacterians  poden  aconseguir  nivells  alts  i
disseminar-se en el torrent sanguini de l'hoste provocant la infecció. No obstant això, i
malgrat la seva importància, el paper de la disbiosis de la microbiota en la colonització
intestinal per molts patògens bacterians, com són les Enterobacteries multirresistentes, no
s'ha  esclarit:  els  membres  de  la  microbiota  que  confereixen  RC  i  els  factors  que
promouen la colonització segueixen sent desconeguts.
L'objectiu general d'aquesta tesi ha estat millorar la comprensió del paper de la
disbiosis de la microbiota en la colonització intestinal per patògens bacterians. Per a això
s'han establert tres projectes. En el primer projecte vam investigar el paper de la disbiosis
de la microbiota intestinal en la colonització per Enterobacteries multiresistentes (MRE)
en  ratolins.  MRE,  com  Escherichia  coli i  Klebsiella  pneumoniae,  estan  entre  les
principals  causes  de  morbiditat  i  mortalitat  a  tot  el  món.  Les  infeccions  amb MRE
generalment comencen per la colonització del tracte intestinal. No obstant això, se sap
poc sobre els factors clínics associats amb la colonització de MRE o que membres de la
microbiota podrien previndre la colonització i la subsegüent infecció amb MRE. Amb la
finalitat d'esclarir el paper de la disbiosis de la microbiota intestinal en la colonització
amb MRE en ratolins, vam tractar ratolins amb diversos antibiòtics i els vam infectar
amb un cep multiresistente de  K. pneumoniae (MRKP). Els nostres resultats indiquen
que la persistent disbiosis microbiana, com a resultat del tractament antibiòtic, promou la
colonització  intestinal  amb MRKP en ratolins.  És  important  destacar  que  hem pogut
demostrar  que  la  restauració  de  nivells  de  2  gèneres  bacterians  (Lactobacillus i
Barnesiella),  afectats  pel  tractament  amb antibiòtics,  disminueix  significativament  la
capacitat de MRKP per colonitzar el tracte intestinal de ratolins.
En  el  segon  projecte,  investiguem  els  factors  de  risc  i  els  membres  de  la
microbiota  associats  amb  la  colonització  per  MRE  en  pacients  hospitalitzats.  Les
infeccions  per  MRE  representen  una  gran  amenaça  per  als  pacients  hospitalitzats.
Específicament, MRE sovint colonitza els pacients amb leucèmia aguda, probablement a
causa de que la RC està alterada com a resultat de tractaments antibiòtics intensius rebuts
per aquests pacients. Cal destacar que no vam identificar cap antibiòtic que promogui la
colonització intestinal per MRE. Al contrari, hem identificat l'administració sistemàtica
de  beta-lactamics,  quan  el  pacient  es  colonitza  amb  un  cep  MRE  sensible  a  beta-
lactamics,  com un dels factors  associats  amb la reducció dels  nivells  de colonització
intestinal per MRE. D'altra banda, l'administració de beta-lactamics quan el pacient està
colonitzat amb un cep resistent a beta-lactámics no augmenta els nivells intestinals de
MRE. Entre les bacteries comensals associades amb canvis en els nivells de colonització
per  MRE,  hem identificat  el  gènere  Coprobacillus,  una  unitat  taxonómica  operativa
(OTU) del gènere Lactobacillus i dos OTUs del gènere Bacteroides estar associades amb
una disminució dels nivells fecals de MRE en pacients amb leucèmia aguda, la qual cosa
suggereix que aquests bacteries comensals poden tenir un paper protector contra el MRE.
En el  tercer  projecte,  vam investigar  el  paper  de la  disbiosis  microbiana en
desenvolupament  de  l’Enteropatía  Epizoótica  de  Conill  (ERE).  ERE és  una  malaltia
gastrointestinal severa amb un alt percentatge de mortalitat que ocorre en conills joves
durant les primeres setmanes després del deslleti.  S'ha demostrat que els conills amb
ERE sofreixen disbiosis microbiana després de l'inici de la malaltia, encara que no és clar
el paper de la disbiosis en el desenvolupament de la malaltia. A més, la malaltia pot ser
reproduïda per contacte entre animals sans i malalts i per l'administració del contingut
cecal de conills amb ERE a conills sans, la qual cosa suggereix que un agent patogen
podria estar implicat en el desenvolupament d'aquesta patologia intestinal, encara que
fins ara no s'ha aconseguit identificar cap agent causal.  Aquí, hem demostrat que els
principals canvis en la composició de la microbiota observada després de la iniciació de
ERE no es poden detectar en els conills abans de l'aparició de la malaltia. D'altra banda,
l'únic canvi que es va poder detectar abans del desenvolupament de la malaltia va ser la
major  presència  d'una  espècie  nova  dins  del  gènere  Clostridium en  conills  que  van
desenvolupar ERE, el mateix dia de l'aparició de la malaltia, la qual cosa suggereix que
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 1.1 The intestinal microbiota
 1.1.1 Definition and composition
The intestinal tract of virtually any metazoan, including mammals, is colonized
with a complex microbial community to which we refer as intestinal or gut microbiota
(1,2). This ecosystem is comprised of members of all 3 domains of life: bacteria, archea,
eukarya (fungi, yeasts and protozoa) and their viruses (3). However, due to the objectives
and tasks performed during this thesis, we will focus on the bacterial components of this
ecosystem. Bacteria represent the most numerous and the most studied microorganisms
that colonize the intestinal tract  (4,5). They can reach concentrations of 1011  bacterial
cells per gram of fecal content in the colon (4,6). The majority of intestinal bacteria are
strict  anaerobes,  which  dominate  facultative  anaerobes  and  aerobes.  Although  it  is
suggested that there are around 50 bacterial phyla described to date, the gut microbiota of
mammals is dominated by only 2 of them: Bacteroidetes and Firmicutes  (1,7,8). Other
bacterial  phyla,  such  as  Proteobacteria,  Verrucomicrobia,  Actinobacteria  and
Fusobacteria are present in minor proportions. Although number of estimated bacterial
species  that  inhabit  intestinal  tract  (further  called  intestinal  microbiota)  vary  among
studies, it is generally accepted that it contains between 500 and 1,000 species (8,9).
It is important to note that the composition of the intestinal microbiota is not
homogeneous  and  varies  highly  during  the  lifetime,  along  the  intestinal  tract  of  the
animal  and even among different  hosts  (1,6).  Besides  this  natural  variability, a  wide
range of external factors such as diet, geography, hygiene and antibiotic treatment can
cause shifts in the microbiota composition. Some of these changes, termed dysbiosis, are
associated  with  harmful  effects  for  the  host’s  health  and  may  have  long-term
consequences  leading  to  disease.  In  order  to  talk  about  dysbiotic  state,  we  have  to
understand first variability that occurs naturally.
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 1.1.1.1 Temporal variability of the intestinal microbiota
Colonization of the intestinal tract was thought to begin immediately after birth,
although  recent  studies  in  which  authors  analyzed  human  placental  microbiome
(bacterial species and genes they encode) challenge this assumption  (10,11) In a study
from 2016 Collado  et  al.  (11) confirmed the presence of bacteria in placenta and in
meconium (the newborn’s first  intestinal discharge).  The authors suggested that there
could  be  intrauterine  colonization  of  the  infant’s  gut  with  bacteria  from  mother’s
intestinal tract. These results concord with those obtained in another study published by
Gosalbes et al. (12).
Following  birth,  intestinal  microbiota  is  characterized  by  low  diversity  and
changes in composition until it  reaches a stable, adult-like state  (13). During the first
weeks  infant’s gut  is  colonized  with  facultative  anaerobes  including  Staphylococcus,
Streptococcus,  and  members  of  the  family  Enterobacteriaceae  (14).  These  microbes
consume the available oxygen and create an environment in which obligate anaerobes
can grow. Various studies have shown that the initial composition of the microbiota could
be affected by the mode of delivery  (15,16). While the intestinal microbiota of infants
delivered  vaginally  shows  similarities  with  mother’s  vaginal  microbiota,  infants
delivered through cesarean section have a microbial composition more similar to the skin
microbiota  of  their  mothers  (17).  These  results  suggest  that  the  microbiota  of  the
environment (vaginal or skin) to which offspring is being exposed during birth could
represent  the  seed  for  the  future  complex  community  that  will  be  inhabiting  their
intestinal tract. It has been suggested that the mode of delivery, besides having an effect
on microbiota composition, could be associated with celiac disease, obesity and asthma
(17).
As  mentioned  before,  first  colonizers  consume  oxygen  and  produce  new
metabolites allowing succession of the primary microbial community with another one,
comprised  of  strictly  anaerobic  bacteria  such  as  bifidobacteria,  Clostridium and
Bacteroides (13,15).  This change in composition could be due to the introduction of




The second diet-related change in microbiota composition of a mammal occurs
after  weaning  or  transition  to  a  solid  food.  Study performed  on 605 infants  from 5
European countries (Sweden, Scotland, Germany, Italy and Spain) showed that weaning
was  accompanied  with  a  significant  decrease  in  proportions  of  bifidobacteria,
lactobacteria  and  enterobacteria,  whereas  some  species  within  Firmicutes  phylum
increased (18).
Results  from  a  study  performed  by  Bergstrom  et  al. (13) suggest  that  the
changes  in  the  intestinal  microbiota  composition  continue  up  to  36  months  of  age.
During this period, the microbiota is converging towards adult-like state characterized by
high  levels  of  Firmicutes  and  Bacteroidetes  and  smaller  fractions  of  Actinobacteria,
Proteobacteria, and Verrucomicrobia.
A final  set  of  age-related  shifts  in  the  composition  and function  of  the  gut
microbiota occurs during old age. Age-related differences reported in a study performed
by Odamaki et al. (19) include marked decrease in bifidobacteria in subjects older than
70 years.
 1.1.1.2 Spatial variability of the intestinal microbiota
Besides variability in microbiota composition during the lifetime of an animal,
there  is  also  variability  between  different  compartments  of  the  gastrointestinal  tract
(GIT).  Host  physiology  and  intestinal  microbiota  are  intimately  connected.  This  is
evident from the fact that each distinct anatomical region along the GIT is characterized
by  its  own  physiochemical  conditions,  and  that  these  changing  conditions  exert  a
selective pressure on the microbiota (20,21).
There is very limited insight in the composition of the human microbiota that
resides in the small intestine due to the difficulty of sampling. In a study performed in
2011, Frank et al. (22) suggested that the wall of the distal small intestine is colonized by
microbial populations that are not radically different from those of the large intestine,
although  some  differences  could  be  observed.  Both  environments  are  dominated  by
bacteria of the phyla Bacteroidetes and Firmicutes but differ in the relative proportions.
Members of the class Bacilli (predominantly the Lactobacillales clade) were significantly
more abundant in the small intestine than in the colon. In contrast, a variety of members
3
Role of intestinal dysbiosis on gut colonization by bacterial pathogens
of the Bacteroidetes and the family Lachnospiraceae were less abundant in the small
intestine.
In another study performed on mucosal tissue collected along the colon and
fecal samples collected from 3 healthy individuals Eckburg et al. (8) detected differences
between the  microbiota  composition  of  feces  and the  one  from the  colonic  mucosa.
Eckburg  et  al.  postulated  that  the fecal  microbiota  represents  a  combination  of  shed
mucosal bacteria and a separate non-adherent luminal population.  Indeed, Swidinski  et
al.  (21) demonstrated  that  the  microbiota  present  in  the  intestinal  lumen  differs
significantly from the microbiota attached and embedded in the mucus layer as well as
the microbiota present in the immediate proximity to the epithelium (Figure I1).
Figure I1. Spatial and temporal variability of intestinal microbiota composition. (A)  Variations in
microbial numbers and composition across the length of the GIT. (B) Transversal variations in microbial
composition in the intestine. (C) Temporal aspects of microbiota establishment and maintenance. Adapted
from Sekirov et al., Physiological Reviews, 2010.
For convenience, the majority of the studies whose objective is the assessment
of the microbiota composition have been performed on fecal samples. Related with the
thesis  proposal,  the fecal microbiota composition has been useful to identify specific
changes  in  the  microbiota  that  promote  colonization  by  pathogens  including
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vancomycin-resistant  Enterococcus (VRE)  (23) or  Clostridium difficile  (24), indicating
that fecal samples can provide relevant information about changes in the microbiota that
contribute to intestinal pathogen colonization.
 1.1.1.3 Microbiota variability among different host species
Co-evolution is believed to occur in animal species whose parental care enables
vertical  transmission  of  whole  gut  communities,  and  where  the  properties  of  the
microbial community confer a fitness advantage to the host (25). This co-evolution has
been conferred from observations of bacterial host specificity.
Rawls et al. (26) performed a study in 2006 in which they showed differences in
the microbiota composition between zebrafish and mice. Their results indicate that the
intestinal microbiota of zebrafish and mice share 6 bacterial phyla, 5 of which are shared
with  the  human microbiota.  However, members  of  zebrafish microbiota  within these
shared phyla are distinct from those in mice and humans at more deeper phylogenetic
resolution. Interestingly, the authors of this study isolated gut microbiota from zebrafish
and mouse hosts and performed reciprocal transplantations of these consortia into germ-
free mice and zebrafish, respectively. Rawls et al. (26) demonstrated that vertebrate host
can  be  colonized by the microbiota  of  another  vertebrate  species,  but  the ratios  and
proportions of the shared bacterial divisions will reflect the balance of the phyla natural
to the host in which the microbiota is residing. They concluded that the gut environment
of  a  particular  host  species  “selects”  which  portions  of  an  introduced  microbial
population will dominate and persist.
In a study performed in 2008, Ley et al.  (25) analyzed the composition of the
intestinal  microbiota  of  106  individual  mammals  representing  60  species  from  13
taxonomic orders, including 17 non-human primates. The majority of detected bacteria in
all  mammals  belonged  to  2  phyla:  Bacteroidetes  and  Firmicutes.  However,  each
mammalian host harbored species not observed in any other. Overall, the fecal microbial
communities of the same species hosts were more similar to each other than to those of
different  host  species.  The  impact  of  host  species  on  microbiota  composition  was
evident,  taking  into  account  that  some  members  of  the  same  species  analyzed,  that
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contain  similar  microbiota,  were  living  separately,  therefore  removing  possible
confounding effect of co-housing.
Studies performed in different animals, such as mice, rabbits or human, point to
the variability in the microbiota composition as a result of co-evolution between host and
its  microbiota.  However,  and  despite  the  differences,  mice  are  commonly  used  as  a
model in order to clarify unknown aspects of the human microbiota. For example, related
to the thesis, Buffie  et al. (27) identified a protective role of the commensal bacterium
Clostridium  scindens against  infections  produced  by  C.  difficile both  in  mice  and
humans, indicating that some results obtained from mice studies can be extrapolated to
humans.
 1.1.1.4 External factors that affect composition of the intestinal microbiota
As  explained  in  previous  sections,  microbiota  composition  varies  among
different host species, along the GIT and during the lifetime. In addition, some external
factors such as use of antibiotics or diet  can also produce changes in the microbiota
composition (28).
Although diet is known to be a driving force for the maturation of the intestinal
microbiota (i.e. introduction of breast or formula feeding and solid food in infancy) and
for  the  species  specialization  (animal  species  with  similar  diet  have  more  similar
microbiota compositions), it can also produce changes in the composition of the healthy,
adult  microbiota.  In  a  study published in  2011,  Wu  et  al.  (29) demonstrated  a  high
correlation between enterotypes (variants of the microbiota identified in humans) and
long-term  diet  differences.  The  Bacteroides enterotype  was  associated  with  meat
consumption, a feature characteristic of the Western diet, while the Prevotella enterotype
was associated with a carbohydrate-based diet typical of agrarian societies. In another
study, David et al. (30) demonstrated that the short-term consumption of diet composed
entirely of animal or plant products alters the intestinal microbial community structure.
The  animal-based  diet  increases  the  abundance  of  bile-tolerant  microorganisms
(Alistipes,  Bilophila,  and  Bacteroides)  and  decreases  the  levels  of  Firmicutes  that
metabolize  dietary  plant  polysaccharides  (Roseburia,  Eubacterium  rectale,  and
Ruminococcus  bromii).  Besides,  it  has  been  shown  that  tea  phenolics  and  their
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derivatives repressed the growth of certain pathogenic bacteria such as C. perfringens, C.
difficile, and Bacteroides spp., while they less severely affect commensal anaerobes (31).
Dietary iron mostly from red meat and fortified cereals, or iron from cigarette smoking,
can  also  change  the  gut  bacteria  composition  (32).  Elevated  iron  availability  may
increase the proliferation and virulence of gut bacteria and increase the permeability of
the gut barrier. Fasting could also produce changes in microbiota composition. A recent
study compared the responses of the gut microbiota to fasting across several vertebrate
hosts (33). Interestingly, besides species-specific changes in microbiota composition as a
result of food deprivation, authors observed other changes that were widespread among
tested species. Specifically, tetrapods (toads, geckos, quail, mice) exhibited decrease in
the abundances of Coprobacillus and Ruminococcus in the colon as a result of fasting.
Antibiotics  represent  another  external  factor  that  affects  microbiota
composition.  Antibiotics  are  widely  used  as  antimicrobial  agents  to  treat  infections
caused by pathogenic bacteria.  However, they do not  only affect  pathogens,  but  also
commensal  intestinal  microbial  communities.  Effects  of  antibiotic  treatments  on  the
composition of the intestinal microbiota and the consequences that they have on health
will be discussed in detail later in the section 1.2.2.3.
In order to understand how shifts in composition of the intestinal microbiota
could lead to disease, it  is important to understand the roles of the healthy intestinal
microbiota, which will be explained in the following section.
 1.1.2 Roles of the intestinal microbiota
Millions of years of mammalian-microbial co-evolution have led not only to
tolerance of intestinal microbiota by the host but to interdependency among them. As a
result, the intestinal microbiota plays a role in metabolic, nutritional, physiological and
immunological processes in the host’s body  (20). In addition, the intestinal microbiota
participates  in  the defense against  pathogens,  a  phenomenon known as  “colonization
resistance”. In the recent years, there has been an increase in the number of publications
addressing the roles of the intestinal microbiota. These studies have allowed us to realize
about the link that exists between the intestinal microbiota and health. Some of the roles
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of the intestinal microbiota in establishment and preservation of the healthy state of the
host will be explained in the following sections.
 1.1.2.1 Effect of the intestinal microbiota on the host metabolism
Various  studies  have  shown that  the  intestinal  microbiota  maximizes  caloric
availability of nutrients ingested by the host (6). Mechanisms by which this occurs fall
into  2  groups:  extraction  of  additional  calories  from  otherwise  indigestible
polysaccharides and promotion of nutrient uptake and utilization by modulation of the
absorptive capacity of the intestinal epithelium.
Between  10%  and  20%  of  ingested  dietary  carbohydrates  are  resistant  to
digestion  in  the  small  intestine.  These  non-digestible  dietary  carbohydrates  enter  the
colon where one part is fermented by colonic bacteria to lactate, gases and short-chain
fatty acids (SCFAs),  including acetate,  propionate and butyrate  (34,35).  In mammals,
butyrate  serves  as  a  predominant  energy  substrate  for  colonocytes  and  enterocytes.
Propionate  is  primarily  absorbed  by  the  liver,  where  hepatocytes  use  it  for
gluconeogenesis,  while  acetate  is  released  into  peripheral  tissues  (Figure I2).  In  the
human  gut,  members  of  Bacteroidetes  phylum  secrete  high  levels  of  acetate  and
propionate whereas those of the Firmicutes phylum generate large amounts of butyrate.
In  addition  to  being  able  to  break  down  indigestible  polysaccharides  to
absorbable  monosaccharides  or  SCFAs,  the  intestinal  microbiota  also  modulates  the
uptake and deposition of dietary lipids. Bile acids (or bile salts) are steroid acids that are
produced in  the  liver  from cholesterol  and secreted  in  bile  where  they  facilitate  the
metabolism of  dietary  fat  and the  absorption  of  fat  soluble  vitamins  and cholesterol
(Figure I2) (36). Bile acids are secreted in form of bile salts conjugated with glycine and
taurine. Members of genera Bacteroides, Eubacterium, and Clostridium have the ability
to deconjugate bile salts and perform partial dehydroxylation producing secondary bile
acids.  This transformation is necessary not only for re-absorption of bile acids but also
for performing their metabolic functions. Indeed, the gut microbiota, through effects on




Besides facilitating access to nutrients, intestinal microbiota produce vitamins
(B9, B12, vitamin K) and metabolizes xenobiotics (compounds of non-host origin that
enter the gut with the diet), such as isoflavones, oxalates and choline (28,36,37).
Figure  I2.  The  gut  microbiota  is  involved  in  host  metabolism  processes  such  as  anaerobic
fermentation, vitamin biosynthesis, and bile acid metabolism.  The polysaccharides, that form part of
the dietary fibers, can be degraded by the gut microbiota via anaerobic fermentation. The main products
are short-chain fatty acids: acetate, propionate, and butyrate. These metabolites can be absorbed by the gut
epithelial  cells  and  then  transferred  to  other  tissue  cells,  including  adipocytes  and  hepatocytes.  The
microbial  cells  can  also  synthesize  amino acids  and  vitamins  (mainly B  and K).  On the  other  hand,
conjugated  bile  acids  are  synthesized  in  the  liver  and  secreted  into  the  intestinal  tract  through  the
duodenum. Most of these primary bile acids can be deconjugated by the gut microbiota in the intestine and
be  reabsorbed  by  the  liver  (38).  Adapted  by  permission  from Macmillan  Publishers  Ltd:  Nature [Ji,
Nielsen. 2016], copyright (2016).
These  studies  show the  importance  of  the  intestinal  microbiota  for  the  host
physiology and metabolism. Consequently, changes in microbiota composition that affect
metabolism could lead to health problems of the host. Some of the diseases that have
been associated with alteration in metabolism (Inflammatory Bowel Disease, etc.) will be
discussed in later sections.
9
Role of intestinal dysbiosis on gut colonization by bacterial pathogens
 1.1.2.2 Intestinal microbiota-brain axis
Recently, there has been an increasing interest  in studying the effects  of the
intestinal microbiota on the brain’s physiological,  behavioral and cognitive functions.
Although  the  exact  mechanism  of  gut  microbiota-brain  axis  has  not  yet  been  fully
understood and clarified, the evidence from animals and human studies has shown that
the  gut  microbiota  can  play  an  important  role  in  brain  behavior  and  cognitive
development by producing hormones, immune factors, and metabolites (39).
A study published in 2011 by Diaz Heijtz et al. (40) showed that germ-free (GF)
mice have increased motor activity and less anxiety-like behavior compared to specific
pathogen-free  mice  (SPF).  When  adult  GF  mice  were  incorporated  into  the  SPF
environment, its reduced anxiety-like behavior did not change, but its offspring's anxiety
behavior returned to the normal state, indicating that there was a critical time window for
the influence of gut microbiota on behavior development.
The gut microbiota is also linked to the control of the levels of several signaling
molecules such as brain derived neurorotrophic factor, norepinephrine, and tryptophan in
different  areas  of  the  central  nervous  system.  These  observations  prompted  to
hypothesize on the role of the microbiota in the regulation of mood and behavior, and its
contribution to the pathophysiology of mood disorders (41).
As described in previous sections, some members of the intestinal microbiota
have the ability to produce SCFAs. Besides being a nutrient source for colonocytes and
enterocytes,  SCFAs  (mainly  butyrate  and  propionate)  act  as  histone  deacetylase
inhibitors that epigenetically regulate gene expression  (41). Recent findings implicate
epigenetic modifications in the etiology of mood disorders via chromatin remodeling and
changes in histone acetylation. Additionally, results from another study demonstrated that
colonic  acetate  crosses  the  blood–brain  barrier  and  is  taken  up  by  the  brain  (42).
Moreover, the authors of this study showed that acetate administration is associated with
activation of acetyl-coenzyme A carboxylase and changes in the expression profiles of
regulatory neuropeptides that favor appetite suppression, suggesting that acetate has a
direct role in central appetite regulation.
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Accordingly, alterations in the intestinal microbiota composition are associated
with  numerous  neurological  and  psychiatric  disorders  such  as  Multiple  Sclerosis,
Parkinson’s disease, Alzheimer’s disease, major depressive disorder and autism (43).
 1.1.2.3 Effect of the intestinal microbiota on maturation of the immune system
The role of the intestinal microbiota in maturation of the immune system is
expected,  taking into account  that  the intestinal  mucosa is  in direct  contact  with the
members of the microbiota, exposing the host to a high concentration of antigens. The
first  comparisons  of  GF rodents  with  “microbiota-colonized  animals”  resulted  in  the
observation that there were gross physiological differences between GF and the SPF state
(44). Importantly, the absence of commensals has profound effects on the structural and
functional development of the immune system, including but not limited to defects in
lymphoid tissue development within the spleen, thymus, and lymph nodes.
The  effect  that  the  intestinal  microbiota  can  have  on  the  maturation  of  the
immune system has been shown in several studies that compared innate lymphoid cells
(ILCs) composition and characteristics between GF and SPF mice (45,46). For example,
in a study published in 2009, Sanos et al. (46) showed that signals from the commensal
microbiota contribute to the differentiation of a subgroup of ILCs. Besides, GF mice
were shown to have a decreased number of CD4+ and CD8+ intestinal T cell subsets
(47), indicating that the intestinal microbiota has a role in development of the adaptive
immune system as well.
Although these are only few examples demonstrating the role of the intestinal
microbiota in the host immune system development, there are many more described (48).
Collectively, these studies demonstrate that the microbiota participates in the maturation
of the immune system and suggests that specific events in association with the process of
microbial colonization may be important in the development of a normal immune system
in  a  healthy  individual.  Besides  its  role  in  the  maturation  of  the  immune  system,
microbiota has the capability to induce the immune system in order to protect the host
against pathogens, which will be explained in more detail in the following section.
11
Role of intestinal dysbiosis on gut colonization by bacterial pathogens
 1.1.2.4 Protection against pathogens
The intestinal microbiota can provide protection against pathogens, also known
as colonization resistance (CR), indirectly, through induction of the immune system (49).
Besides this indirect mechanism of protection, intestinal microbiota can provide direct
protection  by  competing  for  space  and  nutrients  with  intruders  and  by  secreting
inhibitory molecules (Figure I3).
Figure  I3. The intestinal  commensal  microbiota  provides  colonization  resistance  against  a  wide
range of pathogens by indirect and direct mechanisms.  Commensal bacteria activate innate immune
defenses  in  the  mucosa  (e.g.  defensins  with  bactericidal  activity),  produce  or  modify  host-derived
metabolites  with  inhibitory  capacities  (e.g.  SCFA),  deplete  nutrients,  or  produce  substances  that  are
directly  toxic  to  competing  bacteria  (e.g.  bacteriocins)  (49).  Adapted  from  Pamer  E.,  Science.  2016.
Reprinted with permission from AAAS.
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Microbiota mediated protection against colonization with pathogens, especially
against  multidrug resistant  Enterobacteriaceae,  will  be investigated  in  this  thesis  and
thus, mechanisms that confer CR will be explained in detail in the following sections.
 1.1.2.4.1 Protection mediated through microbiota induction of the immune system
The  intestinal  microbiota  not  only  helps  in  the  maturation  of  the  immune
system,  it  also  induces  innate  and  adaptive  immune  responses  in  the  presence  of
pathogens and also promotes the maintenance of the intestinal barrier, allowing better
protection against infection.
One mechanism by which commensals enhance the host immune response to
pathogens is by triggering the secretion of host antimicrobial peptides. Indeed, GF mice
exhibit diminished Paneth cell’s expression of antimicrobial peptides RegIIIγ, RegIIIβ
and  defensin  Defcr-rs-10  (50).  Besides,  it  was  shown  that  the  microbiota  plays  an
important role in the induction of alpha-defensin secretion by Paneth cells, which in turn
controls pathogen growth and restrains commensals within the intestine (44). Moreover,
in a study published in 2012, Hasegawa  et al.  (51) demonstrated that translocation of
commensal bacteria was essential to promote the secretion of the cytokine IL-1β and
subsequent protection against C. difficile intestinal colonization. This result indicates that
stimulation  of  pro-inflammatory  responses  by  commensal  organisms  can  have  a
protective function. Besides, production of IL-22 by a subgroup of innate lymphoid cells
(ILC3)  is  dependent  on  the  presence  of  commensal  Lactobacillus  reuteri (52). A
metabolic product of this bacterium is a ligand for a receptor present on membrane of
ILC3 and activates the production of IL-22, providing CR against the fungus  Candida
albicans.
Besides stimulating innate immunity, intestinal microbiota can also induce the
activation of the adaptive immunity. Studies  using GF mice colonized with different
commensal microbes have demonstrated that certain intestinal bacterial species play a
major role in the differentiation of T cells into different subsets, including T helper cells
and  T  regulatory  cells  (Tregs)  (50).  For  example,  segmented  filamentous  bacterium
promotes the development of Th17 cells, which confer protection against  Citrobacter
rodentium infection (53). On the other hand, several studies have demonstrated that the
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intestinal microbiota influences B-cell development and antibody production. Kim et al.
(54) demonstrated that SCFA, derived from microbiota metabolism, directly affect the
differentiation of B cells into IgA-producing plasma cells. Consequently, mice receiving
a diet with high levels of fiber (a major source of microbial production of SCFA) had
higher  numbers  of  intestinal  IgA+ B cells  and were  more  resistant  to  C.  rodentium
intestinal colonization than those animals fed with a low-fiber diet.
 1.1.2.4.2 Direct protection against pathogens conferred by the intestinal microbiota
As mentioned before, microbiota provides direct protection against pathogens
through secretion of inhibitory molecules, and by competing with them for space and
nutrients. Besides, commensal bacteria produce secondary metabolites that could exert a
negative effect on pathogen’s growth. In a recent study, Buffie et al.  (27) demonstrated
that secondary bile acids, produced by dehydroxylation of primary bile acids as a result
of  C. scindens  metabolism, confer protection against  C. difficile in a mouse model of
infection by directly inhibiting the growth of the pathogen.  In addition, some microbes
produce  antimicrobial  proteins  that  can  target  pathogens.  Some  commensal
Enterobacteriaceae,  including  the  probiotic  Escherichia  coli Nissle,  secrete  small
antimicrobial peptides called microcins (bacteriocins of less than 10kDa) (55). In a study
published in 2016, Sassone-Corsi et al. (56) demonstrated that the probiotic strain E. coli
Nissle 1917 limits the growth of invasive E. coli strain through production of microcins.
Besides,  the  intestinal  microbiota  could  confer  protection  through  the  production  of
SCFA. Indeed,  in vitro, SCFA markedly suppress the growth of the pathogenic  E. coli
strain O157:H7  (50). SCFA can also influence the expression of virulence factors. For
example,  butyrate  and  propionate,  both  present  in  high  concentrations  in  the  large
intestine,  downregulate  the  expression  of  genes  encoded  in Salmonella  typhimurium
pathogenicity  island  1  (SP1),  required  by  this  pathogen  for  invasion  of  intestinal
epithelial cells.
Another  group of  mechanisms by which  commensal  bacteria  provide  CR to
pathogens include direct interaction by competing for the same niche (Figure I3)  (57).
Some beneficial microbes acquire similar nutrients as pathogens, often more efficiently,
thus  hindering  the  replication  and colonization  of  the  infectious  agent.  For  instance,
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commensal E. coli strain HS and the probiotic strain E. coli Nissle 1917 occupy a unique
nutritional niche in the mouse gut (58). E. coli HS consumes 6 sugars and E. coli Nissle
1917 uses a complementary yet divergent set of 7 sugars to colonize, thus establishing a
nutritional  basis  to  occupy  distinct  niches  in  the  mouse  intestine.  Together  these  2
commensals  use  the  5  sugars  previously  determined  to  be  the  most  important  for
colonization of pathogenic E. coli strain, thereby impeding its successful colonization of
the gut.
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 1.2 Dysbiosis of the intestinal microbiota
 1.2.1 Definition of the dysbiosis
Dysbiosis is a term that explains imbalance in the composition of the resident
commensal communities relative to the community found in healthy individuals (59). It
is  characterized  by  loss  of  beneficial  microbial  organisms,  expansion  of  pathobionts
(members of microbiota with potential to contribute to the disease development) or other
harmful  microorganisms,  and  loss  of  overall  microbial  diversity.  Factors  that  could
promote alteration of the structure of the intestinal microbiota include diet, infection, or
medical interventions (such as antibiotics), and are explained in detail in the following
section.
 1.2.2 Factors that promote microbiota dysbiosis
 1.2.2.1 Diet as a promoter of microbiota dysbiosis
Association between the diet and the intestinal microbiota dysbiosis has been
investigated  in  various  studies.  In  a  study  published  in  2016,  Desai  et  al.
(60) demonstrated  that  dietary-fiber  deprivation  results  in  clear  shift  in  microbiota
composition  reflected  in  the  decreased  abundances  of  fiber-degrading  bacteria.
Importantly, during fiber deficiency, the gut microbiota resorts to host-secreted mucus
glycoproteins as a nutrient source, leading to erosion of the colonic mucus barrier and
high-levels of colonization with the pathogen C. rodentium. In another study, Agus et al.
(61) showed  that  Western  diet  (high-fat,  high-sugar  diet)  produced  dysbiosis  of  the
intestinal  microbiota  towards  higher  abundances  of  the  Proteobacteria  phylum  and
decrease  in  the  Firmicutes  phylum.  Moreover,  the  Western  diet  microbiota  favored
colonization  of  adherent-invasive  E.  coli  strain,  especially  in  the  mucus  layer.  The
authors also observed that mice fed on Western diet become more susceptible to induced
colitis, probably through decrease in abundances of protective SCFA producing bacteria,
suggesting that Western diet could aggravate the inflammatory process.
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 1.2.2.2 Inflammation as a promoter of microbiota dysbiosis
In  a  study published  in  2007,  Lupp  et  al. (62) demonstrated  that  the  host-
derived inflammation results in dysbiosis of the colonic microbial community. Infection
of mice with C. rodentium produced inflammation, which resulted in clear reduction of
the  total  numbers  of  commensal  bacteria.  In  contrast,  colonization  with  an  enteric
pathogen that does not induce inflammation (Campylobacter jejuni) failed to produce
similar  changes.  Moreover, the authors  demonstrated that  inflammation produced the
bloom of Enterobacteriaceae family. Interestingly, some pathogens, such as  Salmonella
enterica serovar Typhimurium have the ability to exploit host’s inflammatory immune
responses  for  its  own  benefit.  In  a  study  published  by  Stecher  et  al. (63), authors
demonstrated  that  S.  typhimurium overcomes  CR  by  inducing  inflammation  and
subsequent dysbiosis of the intestinal microbiota. On the other hand, a non-virulent strain
of  S.  typhimurium was  not  able  to  produce  inflammation  and  colonize  the  murine
intestine.  Importantly,  colonization  of  mice  with  virulent  S.  typhimurium resulted  in
domination of Proteobacteria, among which E. coli reached high levels, suggesting that
other bacterial species closely related to S. typhimurium may also be able to benefit from
the S. typhimurium–triggered inflammation.
 1.2.2.3 Antibiotic treatment as a promoter of microbiota dysbiosis
Antibiotics are widely used as antimicrobial agents to treat bacterial infections
caused  by  pathogenic  microorganisms.  However,  antibiotics  (even  narrow-spectrum
ones)  do  not  only  affect  pathogens,  but  also  commensal  intestinal  microbial
communities. In a study published recently, Panda et al. (64) investigated the short-term
effects  of  fluoroquinolones  and beta-lactams on the  microbiota  composition.  Authors
shown  that  both  antibiotic  treatments  significantly  decreased  microbial  diversity.
Moreover, fluoroquinolones,  as well as beta-lactams, caused a decrease of Firmicutes
phylum and an increase of  the Bacteroidetes  phylum.  In another  study published by
Ubeda et al. (65), authors described microbiota dysbiosis in mice as a result of treatment
with ampicillin or vancomycin. All mice receiving ampicillin had increased abundances
of Streptococcaceae family, and decreased levels of other bacterial families present in
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untreated animals. Moreover, mice treated with ampicillin had reduced bacterial density
both  in  ileum and cecum.  On the  other  hand,  vancomycin  treatment  resulted  in  the
expansion  of  Enterobacteriaceae  family  in  4  out  of  6  mice.  Besides,  treatment  with
vancomycin, an antibiotic that selectively targets Gram-positive bacteria, eliminated the
Gram-negative  phylum  Bacteroidetes  from  the  cecum.  These  results  were  later
confirmed in a  study published by Isaac  et  al.  (66).  Authors found that  vancomycin
treatment  greatly  reduced  the  levels  of  the  Bacteroidetes  phylum,  while  the
Proteobacteria and Fusobacteria phyla underwent a drastic expansion. Moreover, Isaac et
al. demonstrated that the changes in the microbiota composition as a consequence of
vancomycin treatment persisted several months after the cessation of the treatment. Other
authors also pointed to the long-term effects of antibiotic treatment on the microbiota
composition. In a study published in 2015, Rashid et al. (67) demonstrated the long-term
effects of ciprofloxacin and clindamycin on the microbiota composition. Authors shown
that exposure to ciprofloxacin or clindamycin had a strong effect on the diversity of the
microbiome. The interval needed for the microbiota to be normalized after ciprofloxacin
or clindamycin treatment was different for various bacterial species. Overall, changes in
the microbiota composition could be observed up to 2 months post-treatment, although
alterations in abundances of few members of the intestinal microbiota could be detected
up to 4 months after the treatment for both antibiotics.
Recently, there has been an increasing interest in analyzing not only the effects
of  different  antibiotic  treatments  on  microbiota  composition,  but  also  it’s  effects  on
functional  diversity  of  the  microbiota.  Perez-Cobas  et  al.  (68) conducted  the  first
comparative  omic  (word  that  implies  set  of  metabolomics,  metagenomics,
metatranscriptomics and metaproteomics) investigation of gut microbial communities in
fecal  samples  taken  from  a  patient  subjected  to  beta-lactam  therapy.  Authors
demonstrated  that  beta-lactam treatment  produces  alteration  of  metabolic  and protein
profiles, besides changes in the microbiota composition.
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 1.2.3 The effect of the dysbiosis on the host’s health
 1.2.3.1 Dysbiosis and non-infectious diseases
The adverse effects  of dysbiosis  on host  health  have long been appreciated.
Increasing  clinical  evidence  links  dysbiosis  with  various  immune,  metabolic  and
neurological  disorders  in  both  intestinal  and extra-intestinal  sites.  Intensively  studied
examples for which dysbiosis of the intestinal microbiota has been described include
Inflammatory Bowel Disease (IBD)  (69), diabetes  (70), asthma  (71), and even autism
(72).
IBD is a  collective name for  chronic inflammatory disorders  of  the GIT, of
which Crohn’s disease (CD) and ulcerative colitis (UC) are the most prevalent forms
(28).  In a study published in 2011, Joossens  et al.  (73) found that 5 bacterial species
defined the dysbiosis observed in CD patients.  Moreover, higher levels of one of these
species (Faecalibacter prausnitzii) have been associated with lower disease remission in
CD  patients  after  treatment.  Interestingly,  a  recent  study  observed  a  reduction  of
Roseburia hominis and F. prausnitzii  in fecal samples of UC patients, and both species
showed an inverse correlation with disease activity (69).
Necrotizing enterocolitis is a diseases characterized by gut inflammation that is
most frequent in premature newborns  (74). It affects up to 10% of infants with a birth
weight below 1500g. Mortality can be as high as 30%. The gut microbiota dysbiosis has
been  associated  with  the  onset  of  the  necrotizing  enterocolitis,  since  a  rise  in
Proteobacteria and a concomitant fall of Firmicutes levels has been found to precede the
onset of the disease.
A growing body of evidence has indicated that alterations of the gut microbiome
may affect central nervous system (CNS). In a study published by Lyte et al. (75) authors
have shown that infection with pathogen  C. rodentium  significantly increased anxiety-
like behavior in mice.
Besides the role of the microbiota dysbiosis in non-infectious diseases, recent
studies have shown an association between microbiota dysbiosis and infections produced
by antibiotic resistant pathogens, such as VRE (76) or C. difficile (24). The role of the
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microbiota  dysbiosis  in  colonization  of  the  intestinal  tract  with  pathogens  will  be
described in detail in following section.
 1.2.3.2 Dysbiosis and colonization of the intestinal tract by pathogens
As discussed in previous sections, the intestinal microbiota has a crucial role in
the protection against pathogens. Thus, it is not surprising that altered representation of
the microbiota members, especially as a result of the antibiotic treatment, is associated
with the loss of CR and, consequently, intestinal tract colonization by pathogens (Figure
I4).
Figure  I4.  The  effect  of  the  antibiotic  treatment  on  microbiota  composition  and  colonization
resistance against pathogens.  Antibiotics can decrease overall  bacterial  diversity which may promote
intestinal colonization by multidrug resistant pathogens (black circles).
Early studies by Freter, Bohnhoff, and their colleagues  (23) roughly 50 years
ago demonstrated that antibiotic administration enhanced infection with Vibrio cholerae
or S. typhimurium by eliminating obligate anaerobic bacteria. Recently, clindamycin has
been shown to have  a  large  negative impact  on the intestinal  microbiota  as  seen by
reduced  resistance  to  colonization  by  pathogens,  leading  to  a  high  risk  for
pseudomembranous colitis  due  to  C. difficile overgrowth in  humans  (77).  In  another
study, Buffie et al. (24) demonstrated that inoculation of clindamycin-treated mice with
C. difficile spores results in rapid development of diarrhea and colitis, with a 4- to 5-day
period of profound weight loss and associated 40 to 50% mortality rate. In contrast, mice
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that  did  not  receive  the  antibiotic  were  resistant  to  intestinal  colonization  by  this
pathogen.
It  is important to point out that in order to colonize the intestine during the
antibiotic treatment, the pathogenic bacteria have to be resistant to the antibiotic. For this
reason,  besides  C.  difficile,  another  pathogen  that  frequently  colonizes  the
gastrointestinal  tract  during  antibiotic  therapy  is  VRE,  which  is  multidrug  resistant.
Indeed, it has been shown that the loss of CR during the vancomycin treatment allows
colonization  of  the  intestinal  tract  of  mice  with  VRE  (65). Members  of  the  family
Enterobacteriaceae  represent  another  group  of  pathogens  with  resistances  to  many
antibiotics,  and that  often  colonize  the  human gut  as  a  result  of  loss  of  CR due to
antibiotic  treatment  (78).  The  association  between  microbiota  dysbiosis  and  the
colonization of the intestine by these pathogens, as well as the factors that promote their
colonization, are the object of investigation in this thesis and are explained in more detail
in the following section.
 1.2.3.2.1 Gut colonization by multidrug resistant Enterobacteriaceae (MRE)
The  members  of  family  Enterobacteriaceae,  such  as  E.  coli and  Klebsiella
pneumoniae, are among the leading causes of morbidity and mortality worldwide (56). In
the past decades, Enterobacteriaceae have acquired multiple antibiotic resistances  (79).
Increasing number  of  antibiotics  to  which isolated Enterobacteriaceae  strains  express
resistance led to the definition of multidrug resistant Enterobacteriaceae (MRE).  MRE
are defined by Magiorakos et al.  (80) as those Enterobacteriaceae non-susceptible to at
least  1  agent  in  3  or  more  antimicrobial  categories,  not  taking  into  account  those
antibiotics for which there is an intrinsic resistance (Table I1).
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Table I1. Antimicrobial categories and agents used to define MRE. Reprinted from Multidrug-resistant,
extensively  drug-resistant  and  pandrug-resistant  bacteria:  An  international  expert  proposal  for  interim
standard definitions for acquired resistance, Magiorakos AP. et al.,  Clinical Microbiology and Infection,
268–281, Copyright (2011), with permission from Elsevier.
Antimicrobial 
categorya
Antimicrobial agent Species with intrinsic resistance
Aminoglycosides Gentamicin Providencia rettgeri (P. rettgeri), 
Providencia stuartii (P. stuartii)
Tobramycin P. rettgeri, P. stuartii
Amikacin














cephalosporins; 1st and 
2nd generation 
cephalosporins
Cefazolin Citrobacter freundii (C. freundii), 
Enterobacter aerogenes (E. 
aerogenes), Enterobacter cloacae 
(E. cloacae), Hafnia alvei (H. 
alvei), Morganella morganii (M. 
morganii), Proteus penneri (P. 
penneri), Proteus vulgaris (P. 
vulgaris), P. rettgeri, P. stuartii, 
Serratia marcescens (S. 
marcescens)
Cefuroxime M. morganii, P. penneri, P. vulgaris,
S. marcescens
Extended-spectrum 







Cephamycins Cefoxitin C. freundii, E. aerogenes, E. 
cloacae, H. alvei












Glycylcyclines Tigecycline M. morganii, Proteus mirabilis (P. 
mirabilis), P. penneri, P. vulgaris, P.
rettgeri, P. stuartii
Monobactams Aztreonam
Penicillins Ampicillin Citrobacter koseri (C. koseri), C. 
freundii, E. aerogenes, E. cloacae, 
E. hermanii, H. alvei, Klebsiella 
spp., M. morganii, P. penneri, P. 






C. freundii, E. aerogenes, E. 
cloacae, H. alvei, M. morganii, P. 
rettgeri, P. stuartii, S. marcescens
Ampicillin-sulbactam C. freundii, C. koseri, E. aerogenes,




Polymyxins Colistin M. morganii, P. mirabilis, P. 
penneri, P. vulgaris, P. rettgeri, P. 
stuartii, S. marcescens
Tetracyclines Tetracycline M. morganii, P. mirabilis, P. 
penneri, P. vulgaris, P. rettgeri, P. 
stuartii
Doxycycline M. morganii, P. penneri, P. vulgaris,
P. rettgeri, P. stuartii
Minocycline M. morganii, P. penneri, P. vulgaris,
P. rettgeri, P. stuartii
a  When a species has intrinsic resistance to an antimicrobial agent or to the whole category, that agent or
category should not be counted when calculating the number of agents or categories to which the bacterial
isolate is non-susceptible.
Nosocomial  infections  caused  by MRE represent  a  major  threat  world-wide
(81). Indeed, the last report of the European Center for Disease Prevention and Control
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from 2015 revealed that during one year 21,871 strains of  K. pneumoniae displaying
combined  resistance  to  third-generation  cephalosporins,  fluoroquinolones  and
aminoglycosides  were  isolated  in  hospitals  in  the  European Union (Figure I5)  (82).
Moreover,  the  percentage  of  strains  with  combined  resistance  increased  significantly
from 17.7% in 2012 to 18.6% in 2015. The last resort antibiotics, mostly prescribed off-
label, are 2 revived antimicrobials of the 1970s to 1980s, colistin and fosfomycin, as well
as  tigecycline,  which  in  combination  with an  aminoglycoside have  shown promising
efficacy  both  in  vitro and in  vivo in  the  critically  ill  host.  Nevertheless,
Enterobacteriaceae strains resistant to these antibiotics have already been found.
Figure  I5. Percentage  (%)  of  invasive  isolates  of  K.  pneumoniae with  combined  resistance  to
fluoroquinolones, third-generation cephalosporins and aminoglycosides, by country in 2015. Adapted
from European Center for Disease Prevention and Control, 2017.
Infections with MRE usually begin by the colonization of the intestinal tract.
Moreover,  once  established, MRE  can  reach  high  numbers  in  the  intestine,  which
promotes their dissemination into the bloodstream where they can be a real threat for
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patient’s life (83). Importantly, in a study published recently, Woerther et al. (83) showed
that  carriers  with  the  highest  level  of  extended  spectrum  beta-lactamase  (ESBL)
producing  Enterobacteriaceae  were  also  those  with  the  highest  risk  of  bacteremia
produced by these pathogens. Besides, high levels of colonization promote transmission
of the pathogen among patients  (84). Despite the importance, to this date, there is no
study  investigating  the  risk  factors  that  could  be  associated  with  MRE  levels  of
colonization in hospitalized patients.
Importantly, a healthy intact microbiota provides CR against colonization with
MRE. For example, mice are protected against intestinal colonization by MRE unless
their microbiota is altered with antibiotics  (85). Several studies have tried to identify
factors associated with fecal colonization with antibiotic-resistant Enterobacteriaceae in
humans  (presence  of  the  strain  in  feces,  no  matter  the  level  of  colonization).  For
example, in a study published in 2015, Torres-Gonzalez et al. (86) identified hematologic
malignancy as one of the risk factors for carbapenem-resistant Enterobacteriaceae (CRE)
fecal carriage. The authors point to the fact that hematologic patients are subjected to
constant  readmission  to  health  care  facilities,  and  administration  of  broad-spectrum
antibiotics  and chemotherapy agents  that  may disrupt  the gastrointestinal  microbiota,
thus rendering them prone to colonization by CRE. In the same study, authors reported
carbapenem treatment as one of the risk factors for CRE fecal carriage. In another study,
Mittal  et al.  (78) identified the use of aminoglycosides as clinical variable associated
with CRE colonization. These results corroborate those obtained in studies performed in
mice. Caballero  et al. (85) demonstrated that ampicillin treatment renders mice highly
susceptible  to  colonization  with  K.  pneumoniae. In  another  study,  Hoyen  et  al.
(87) studied  the  effect  of  different  antibiotic  treatments  on  colonization  by  ESBL-
producing K.  pneumoniae  in  mice.  The  authors  found  that  antibiotics  with  minimal
activity against intestinal anaerobes (i.e., cefepime, aztreonam, and levofloxacin) did not
promote  colonization  by  ESBL-producing  K. pneumoniae,  whereas  an  anti-anaerobic
agent (i.e., clindamycin) promoted high-density colonization. These results support the
hypothesis that the indigenous anaerobic microbiota inhibit colonization with antibiotic-
resistant  Enterobacteriaceae,  such  as  ESBL-producing  K.  pneumoniae, although  the
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bacterial species that provide CR against members of Enterobacteriaceae family remain
unknown.
Despite the importance of MRE, little is known about clinical factors associated
with  MRE  colonization  levels  or  which  members  of  the  microbiota  could  prevent
colonization and subsequent infection with MRE. One of the objectives of this thesis is
to respond to these questions.
 1.2.3.2.2 Dysbiosis as a consequence of colonization with intestinal pathogens
The  protective  capacity  of  the  gut  microbiota  against  pathogen  intestinal
colonization is well documented and explained in previous sections. As indicated above,
bacterial pathogens such as MRE do not successfully colonize the intestinal tract unless
the microbiota is altered, mainly by administration of antibiotics. Nevertheless, there are
some exceptions to this. For example, S. typhimurium is able to colonize the murine gut
without  previous  exposure  to  antibiotics  (88).  After  initial  colonization  of  the  gut,
Salmonella induces inflammation, which alters the microbiota composition and prevents
suppression of Salmonella by the microbiota. Thus in this case, external factors such as
antibiotics  are  not  required  for  altering  the  microbiota  in  order  for  the  pathogen  to
colonize  the  intestine,  but  rather  the  dysbiosis  is  induced  by  the  pathogen,  and
subsequently  enhances  pathogen  intestinal  colonization  (63).  Importantly,  Salmonella
induced dysbiosis promotes the bloom of members of family Enterobacteriaceae (e.g. E.
coli), suggesting that conditions created as a result of infections with some pathogens
could favor the expansion of other putative pathogenic bacteria.
Thus,  in  some cases dysbiosis  of the intestinal microbiota  opens the way to
colonization by pathogens such as MRE. Yet, in case of some other pathogens, dysbiosis
occurs  after  the  initial  pathogen  colonization.  Although  the  role  of  the  microbiota
dysbiosis  is  clear for some diseases,  for others  it  remains unknown. Epizootic  rabbit
enteropathy is one of the diseases for which the role of the microbiota dysbiosis remains
unclear, and will be explained in detail in the following section.
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 1.2.3.3 Epizootic rabbit enteropathy
Epizootic rabbit enteropathy (ERE) is a severe gastrointestinal disease with 30–
80% of mortality, and with a particular incidence in the post-weaning period (89). Since
it  was first identified ERE has become a serious concern for rabbit  breeders in most
European countries, and causes significant economic losses in rabbit farms. Moreover,
there have been reports of ERE cases in South America and Turkey recently (90,91). This
pathology is characterized by a decrease in food intake followed by distended abdomen,
emission of small quantities of watery diarrhea, appearance of the mucus in feces, and
decrease in daily weight gain  (92). Pathological changes at the intestinal level include
distension of the stomach and/or duodenum, presence of liquid and gaseous content in
the intestine and impaction, especially in cecum. All these changes are consistent with a
prolonged paresis  of the intestinal transport.  Indeed, some authors have reported that
intestinal  ligation  reproduces  ERE  symptoms  (89). Disease  could  be  reproduced  by
contact between healthy and sick animals or healthy animals and contaminated breeding
material, which is why it is suspected that ERE is a contagious disease and therefore that
a pathogenic agent is involved in the development of this intestinal pathology. However,
no causative agent has been identified for the moment.
In  2005  Licois  et  al.  (92) reproduced  the  disease  in  healthy  animals  by
administrating an inoculum obtained from rabbits affected by ERE. This inoculum was
obtained by mixing contents of the small intestine, cecum and colon of sick animals, and
was named TEC. Thus, at least part of the Koch’s postulate was respected, although the
authors were not able to isolate and identify the causative agent of the disease.
In  another  study published  in  2007,  Szalo  et  al.  (93) fractioned one  of  the
reference TEC inoculums on a discontinuous sucrose gradient. Different fractions were
used for  infection  of  healthy  rabbits.  Fractionation  of  the  inoculum has  allowed  the
separation of microorganisms according to type, size, morphology and density. In such
conditions, small entities, such as viruses and toxins, are isolated in the upper fraction,
large entities, such as parasites, are isolated in the pellet and lower fraction, and bacteria
were isolated in the middle fraction. The authors demonstrated that the etiological agent
of ERE was present in the middle fraction, suggesting that the ERE etiological agent may
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be of bacterial origin, although authors were not able to identify which specific species is
the cause of the disease.
Various authors have pointed to the possible  role of  C. perfringens  in  ERE.
Marlier and coworkers (94) detected high fecal counts of C. perfringens in the digestive
contents of 80% of the ERE field cases. On the other hand, Romero et al. (95) showed
that high counts of C. perfringens in the hindgut are associated with clinical symptoms of
ERE and mortality. Nevertheless, both authors point to the fact that these associations
could be the consequence of the disease rather than the cause. In fact, no experimental
reproduction of ERE has been obtained after inoculation of rabbits with strains of  C.
perfringens.  Still, the observed expansion of  C. perfringens could play a role, if not in
the initiation of the disease, in the subsequent exacerbation of the symptomatology and
mortality rate. Moreover, Romero et al. (95) showed that conditions that were associated
with  a  decrease  in  C.  perfringens fecal  counts  (delayed  weaning  and/or  diet  with
increased fiber content) were also associated with a decrease in mortality rate due to
ERE.
As  mentioned  before,  ERE has  been  associated  with  intestinal  dysbiosis.  A
recent study published by Bauerl et al. (89) described remarkable dysbiosis and reduced
taxonomic  diversity  in  the  cecal  microbiota  of  animals  with  ERE.  Quantitative  and
qualitative  differences  between  healthy  and  ERE  rabbits,  such  as  the  abundance  of
Verrucomicrobiae,  particularly  the  genus  Akkermansia,  were  described.  Akkermansia
muciniphila is  a  typical  intestinal  anaerobe  frequently  associated  to  human  healthy
mucosa.  Its  high  prevalence  in  ERE cecal  samples  could  be  related  to  their  mucin
scavenger character since, as indicated above, one of the ERE symptoms is the intestinal
mucus secretion. On the other hand,  Ruminococcus is the most relevant genus of the
Firmicutes phylum dominant in healthy individuals, that notably decreases in ERE. In
addition,  a  number  of  opportunistic  pathogens  were  found  to  increase  in  samples
obtained  from  ERE  rabbits,  including  members  of  family  Enterobacteriaceae.
Nevertheless, the authors pointed out that it is unclear whether the microbiota changes
observed in ERE rabbits were the cause or the consequence of the disease, a key point
that, as indicated in the objectives of the thesis, we will try to elucidate by studying gut
microbiota  dynamics before and after  the initiation of  ERE. In relation to this,  ERE
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occurs in young rabbits during first weeks after the weaning (89), a period during which
changes in microbiota structure are known to occur. The role of these changes in ERE
development is unknown and will also be studied in this thesis.
 1.2.4 Restoration of the intestinal microbiota
As mentioned in previous sections, microbiota dysbiosis can be crucial for the
colonization  of  the  intestine  by  pathogens.  Accordingly,  restoration  of  the  intestinal
microbiota could provide protection against colonization by pathogens and could also
eliminate  pathogens  in  cases  colonization  have  already  occurred.  The  increasing
knowledge about the importance of the intestinal microbiota in maintenance of CR and
mechanisms  that  underlie  this  phenomenon  are  opening  a  new  field  for  possible
therapeutic  approaches (Figure I6).  Microbiota  interventions  as  therapeutic  strategies
include  fecal  microbiota  transplant  (FMT),  which  implies  transplant  of  complete
microbial community from a healthy donor to a recipient, or administration of probiotics
(microbial species that, upon administration confer a benefit to the host) (49).
Figure I6. Restoration of the colonization resistance after the antibiotic treatment by administration
of commensal bacterial species. Antibiotic-induced microbiota defects and the resulting loss of CR can be
corrected by administration of commensal bacterial species. From Pamer E., Science. 2016. Reprinted with
permission from AAAS.
Reconstitution of the commensal flora by adoptively transferring live bacterial
populations has a long history. In China,  administration of ‘yellow soup’, which is a
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dilute solution of human feces, was used to treat patients with intestinal infections for
hundreds of years  (96).  Recently, fecal transplantation was used to treat recurrent  C.
difficile infections (CDI). As previously mentioned, antibiotic administration alters the
microbiota  and  renders  the  host  more  susceptible  to  infection  with  C.  difficile (77).
Transplant of fresh or frozen feces to individuals with recurrent CDI resulted in infection
resolution for approximately 90% of patients  (97). More importantly, authors reported
that  relapses  and  deaths  after  FMT were  uncommon.  Recently, the  first  prospective
randomized controlled trial  evaluating duodenal infusion of donor fecal material  was
completed  (98).  The  trial  reported  high  success  rates  that  greatly  exceeded  standard
treatment with vancomycin (one of the antibiotic therapies used for CDI). Resolution of
C.  difficile–associated  diarrhea  after  the  first  infusion  of  a  solution  of  donor  feces
through  a  nasoduodenal  tube  occurred  in  81% of  patients,  compared to  31% of  the
patients  that  received  vancomycin  treatment.  Moreover,  patients  receiving  fecal
microbiota transplantation were reconstituted with a broad range of intestinal microbial
taxa,  spanning  the  Bacteroidetes  and  Firmicutes  phyla.  However,  despite  the  high
percentage of resolved infections,  much is still  unknown about why in some patients
with recurrent  C. difficile infection FMT fails. Importantly, the practice of adoptively
transferring  commensal  bacteria  to  reconstitute  a  health-associated  microbiota  in
individuals  with disease carries risks as well  as promise.  Microbiota  transplants may
contain bacteria or virus that have uncharacterized infectious and pathological properties,
and  the  overall  effect  of  transplantation  on  the  native  intestinal  community  can  be
dynamic and unpredictable (96). Besides, it is even possible that a bacterium completely
changes its behavior after transplantation into a new environment because of the host
genotype, its diet, or the residual microbiota, turning form a beneficial bacterium into a
pro-inflammatory pathobiont. Therefore, many efforts are underway to identify a mixture
of beneficial bacteria, which can help to fight against enteric infections by administering
small consortia of cultivable bacteria rather to transfer the whole microbiota (79).
In a study published in 2013 Petrof et al. (99) showed that a set of 33 bacteria
isolated from a healthy donor was able to clear recurrent CDI. Another study identified a
minimal consortium of 6 taxonomically diverse bacterial species that cleared C. difficile
infection in a mouse model (100). In these experiments, transfer of the 6 bacterial species
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resulted  in  marked  increase  in  overall  microbiota  diversity,  which  suggests  that  the
transferred bacterial population facilitated intestinal repopulation with a diverse range of
bacterial taxa. As previously mentioned, Buffie et al. (27) showed that administration of
C. scindens, a commensal bacterium, is associated with resistance to CDI in patients and
suppress  C. difficile colonization in a mouse model of infection. Interestingly, several
companies already have started clinical trials with “semi-standardized” donor material to
treat recurrent CDI (79). Rebiotix is a company that is now planning a clinical trial for
microbiota restoration therapy to prevent CDI. Moreover, they have provided evidence
that administration of their product promotes clearance of VRE (79).
Importantly,  the  first  step  towards  the  development  of  probiotics  is  the
identification  of  bacteria  that  provide  CR  against  pathogens.  Although  for  some
pathogens, such as  C. difficile, some of the key bacterial species that provide CR have
been  already  identified,  for  others,  such  as  MRE,  it  is  unclear  which  members  of
microbiota provide protection against colonization. Identification of bacterial species that




The  general  objective  of  this  thesis  is  to  study  the  role  of  the  microbiota
dysbiosis  on the colonization of intestine by bacterial  pathogens.  For this  purpose,  3
major projects with their own specific objectives were designed:
Project  1.  Microbiota  dysbiosis  and  multidrug  resistant  Enterobacteriaceae
(MRE) colonization and persistence in mice.
In order to study the role of microbiota dysbiosis on MRE colonization and
persistence in mice, the following specific objectives were proposed:
 1.1 To investigate changes in the microbiota, induced by antibiotic treatments,
that promote MRE intestinal colonization and persistence.
 1.2  To test if an altered microbiota can be restored to prevent MRE intestinal
colonization.
 1.3  To identify the specific commensal bacteria that confer protection against
MRE intestinal colonization in mice.
Project 2. Microbiota dysbiosis and MRE colonization in hospitalized patients.
In order to study the role of the microbiota dysbiosis on MRE colonization in
hospitalized patients, the following specific objectives were proposed:
 2.1  To investigate  the prevalence of MRE intestinal  colonization in  acute
leukemia patients.
 2.2  To  characterize  MRE  strains  isolated  from  feces  of  acute  leukemia
patients.
 2.3  To identify clinical variables that promote intestinal colonization by MRE
in acute leukemia patients.
 2.4  To  identify  specific  commensal  bacteria  that  are  associated  with
protection against MRE intestinal colonization in acute leukemia patients.
Project  3.  Microbiota  dysbiosis  and  development  of  Epizootic  Rabbit
Enteropathy (ERE)
In order to study the role of microbiota dysbiosis and development of ERE, the
following specific objectives were proposed:
 3.1  To define intestinal microbiota changes in rabbits suffering ERE.
 3.2  To define intestinal microbiota dynamics in rabbits after weaning.
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 3.3  To define specific changes in the intestinal microbiota after weaning that
could lead to ERE development.




 3 Material and Methods
 3.1 Experiments setup
 3.1.1 Mouse experimental model
In order to determine the association between the microbiota composition and
intestinal  colonization with  MRE  various  experiments  using  mice  as  a  model  were
performed. These experiments included the treatment with different antibiotics, challenge
with multidrug resistant  K. pneumoniae (MRKP), a MRE that frequently colonized the
intestinal tract of patients, and attempts to restore microbiota CR against MRKP. All
experiments were approved by University of Valencia Animal Care Committee, protocol
number  2015/VSC/PEA/00082,  and  carried  out  in  accordance  with  the  approved
guidelines. Mice used in experiments performed as part of this thesis were 6 weeks old
C57BL/6J  mice  obtained  from Charles  River,  France.  They  were  reared  under  SPF
conditions within the animal facility at the University of Valencia. Mice had ad libitum
access  to  food and  water  during  the  course  of  all  experiments.  Fecal  samples  were
collected at  various time points,  as it  will  be indicated in the following sections.  As
previously  mentioned  in  the  Introduction,  fecal  samples  have  been  used  in  various
studies for assessing the intestinal microbiota composition. Fecal microbiota composition
has been useful to identify specific changes in the microbiota that promote colonization
by pathogens, including VRE (23) or C. difficile (24), indicating that fecal samples can
provide relevant information about changes in the microbiota that contribute to intestinal
pathogen  colonization,  which  is  why  we  decided  to  collect  this  type  of  samples.
Immediately after collection, fecal samples were kept on ice until further processing. One
part of the sample was used to assess the levels of colonization with MRKP by plate
counting technique, which will be described in section 3.3.1. The other part of the sample
was used for determination of microbiota composition (sections 3.4 and 3.6).
 3.1.1.1 Treatment of mice with antibiotics
For assessing the effect of antibiotics on microbiota composition and MRKP
colonization, mice were administered 1 of 3 different antibiotics, including ampicillin,
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vancomycin  and  neomycin,  and  a  combination  of  these  3.  All  antibiotics  were
administered  in  the  mouse  drinking  water  for  1  week at  following  concentrations:
ampicillin 0.5 g/l; vancomycin 0.5 g/l; neomycin 1 g/l. Treatment with combination of
these 3 antibiotics was prepared by combining them at the same concentrations as used
when administrating them individually. During the treatment, antibiotics were changed
once, at 3rd/4th day since the beginning of the treatment. This change was performed since
we noticed that some antibiotics (i.e. ampicillin) lost part of its bactericidal activity after
4  days  at  room  temperature.  Mice  were  housed  separately  (1  mouse  per  cage) in
experiments in which they were treated with different antibiotics to determine treatment
effect on microbiota and capability of MRKP to colonize the intestine. In the second set
of  experiments  in  which  the  goal  was  to  restore  the  intestinal  microbiota  by
administration of  fecal  transplant  or specific  isolated commensal  bacteria,  mice were
reared in groups of 5 per cage during the antibiotic treatment. Upon the cessation of the
treatment, animals were separated and housed 1 mouse per cage.
To analyze the effect of antibiotics on the mouse intestinal microbiota, fecal
samples were collected from mice treated with antibiotics on the day before the cessation
of the treatment. The capability of microbiota recovery after the antibiotic treatment was
assessed by collecting fecal samples 2 weeks and 4  weeks after treatment withdrawal.
Mice that had not received antibiotic treatment were used as controls.
 3.1.1.2 MRKP challenge in mice
Multidrug  resistant  K.  pneumoniae was  obtained  from  the  Clinical
Microbiology  Laboratory  at  Memorial  Sloan-Kettering  Cancer  Center  where  it  was
isolated from a blood sample of a hospitalized patient (85). MRKP was grown at 37°C in
Luria-Bertani (LB) agar over night. The next morning it was resuspended in phosphate
buffer saline (PBS). For infection experiments, 106 colony-forming units (CFUs) of  K.
pneumoniae were administered to each mouse by oral gavage in a 200μl volume. In
experiments in which the capability of colonization with MRKP after different antibiotic
treatments was tested, mice were infected the day before cessation of the treatment. In
experiments  in  which  mice  were  left  to  recover  after  antibiotic  treatment  or  fecal
transplant and specific isolated commensal bacteria were administered, infection with
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MRKP was performed 2 weeks or 4  weeks after  the antibiotic  treatment  withdrawal
(Figure M1). Fecal samples were collected before the infection and 1 day post-infection
in order to determine the levels of colonization with MRKP.
Figure  M1.  Schematic  representation  of  the  experiments  performed  with  the  mouse  model  of
infection  with  MRKP. (A)  In  experiments  in  which  the  capability  of  colonization  with MRKP after
different antibiotic treatments was tested, mice were infected the day before cessation of the treatment, and
fecal samples were collected on following weeks in order to assess the MRKP colonization levels. (B) In
experiments in which the ability of the microbiota recovery after the antibiotic withdrawal was tested, mice
were challenged with MRKP 2 or 4 weeks after the end of the antibiotic treatment, and the next day a fecal
sample was collected in order to assess the MRKP colonization levels.  (C) In experiments in which an
attempt to restore the intestinal microbiota and CR was performed, fecal suspension or bacterial culture
was administered to mice during 3 consecutive days after the antibiotic withdrawal. After 11 more days (2
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weeks in total after the end of the antibiotic treatment) mice were challenged with MRKP, and on the first
day post-infection a fecal sample was collected in order to assess the MRKP colonization levels.
 3.1.1.3 Fecal transplant and administration of specific commensal bacteria to mice
In  order  to  determine  if  CR  could  be  restored  after  perturbation  of  the
microbiota with antibiotic treatment, fecal content collected from untreated, healthy mice
or a mix of different bacterial strains isolated from the intestine of untreated mice was
administered  to  antibiotic-treated  mice.  For  fecal  transplant,  fecal  pellets  from  3
untreated  mice  were  collected  and  resuspended  in  1ml  of  PBS  just  before  it’s
administration. To each mouse 100μl of the fecal suspension was administered by oral
gavage during 3 consecutive days starting on the first  day after  the cessation of  the
antibiotic  treatment  (Figure  M1).  The  isolated  commensal  bacterial  strains  were
prepared in the laboratory (explained in detail later), and transported on dry ice to the
animal husbandry. To each mouse 200μl of commensal bacterial  mix suspension was
administered by oral gavage during 3 consecutive days starting on the first day after the
cessation of the antibiotic treatment.
The administration of commensal  bacterial  mix for microbiota recovery was
performed  in  2  sets  of  experiments:  in  one  of  them,  commensal  bacterial  mix  was
obtained by cultivation of a fecal sample from untreated mice in different cultivation
media in anaerobic conditions, while in the other type of experiments, it was obtained by
isolation of desired bacterial strains from fecal samples of untreated mice.
 3.1.1.3.1 Preparation of commensal bacterial mix obtained by cultivation of fecal
samples from untreated mice in different cultivation media
Once confirmed it was possible to restore CR and decrease MRKP levels using
a fecal transplant, experiments were performed in order to identify those bacteria that are
necessary  for  maintenance  of  CR.  For  this  purpose,  various  microbiota  anaerobic
cultures were administered to mice. These cultures were obtained by cultivation of feces
from untreated mice in selective media. Since the selective media provide nutrients for
the growth of particular groups of bacteria present in feces, it was possible that a culture
obtained from the growth of fecal samples in particular media could support the growth
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of specific bacteria necessary for CR. Later, therefore, it would be possible to grow these
anaerobic cultures again in their corresponding media, and isolate those bacteria that are
responsible for CR.
To  obtain  the  desired  microbiota  cultures,  fecal  content  was  collected  from
untreated mice and resuspended in autoclave-sterilized PBS 15% glycerol, frozen in dry
ice/ethanol bath and stored at -80ºC. Different cultivation media including, Schaedler,
Gut  modified  media,  and  Sellers  were  prepared  according  to  the  manufacturer’s
instructions. Plates containing the different media were left over night in an anaerobic
chamber in order to ensure anaerobic conditions for the cultivation of bacteria present in
the fecal sample (most intestinal bacteria are strict anaerobs). High purity H2 is used for
purging the  anaerobic  chamber  initially  and the  working anaerobic  gas  mixture  was
N2:H2:CO2 proportioned at 80:10:10. Fecal sample suspension was thawed and different
dilutions were plated on each cultivation media in the anaerobic chamber. Plates were
incubated  at  37ºC  in  anaerobic  conditions  for  1  week.  Subsequently,  bacteria  were
collected with the help of a swab from those dilutions in which individual colonies could
be observed (approximately 5,000 CFUs per plate, 20 plates). Bacteria were resuspended
in 2ml of PBS 15% glycerol 0.1% cysteine and aliquoted in 4 tubes, which were then
frozen using a dry ice/ethanol bath. One tube was thaw in the anaerobic chamber and
plated into the corresponding cultivation media (e.g. bacteria that was collected from
Schaedler agar, was plated on Schaedler agar). The goal of this second subculture was to
ensure that  the  bacteria  that  mice were going to  receive by oral  gavage were really
capable of growing in the specific media, since subsequently we were planning to isolate
individual bacteria from cultures conferring resistance against MRE. We did this second
subculture because we noticed that some bacterial strains where indeed not able to grow
in this second subculture although they were actually able to produce a bacterial colony
the first time we grew the feces in agar media. After 1 week of growth of this second
culture in the anaerobic chamber at 37ºC, bacteria were collected and resuspended as
described above. Three aliquotes of commensal bacterial mix suspension were made, 1
for each day of administration to mice.
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 3.1.1.3.2 Preparation of commensal bacterial mix obtained by isolation of different
bacterial strains isolated from fecal samples of untreated mice
Another  strategy  for  restoration  of  CR  consisted  on  the  administration  of
commensal  bacterial  strains,  which  were  identified,  through  a  series  of  analysis  as
explained in Results section, as potentially protective commensal bacteria against MRKP
colonization. Isolation of these strains is explained in detail in section 3.2.1.
For the preparation of the bacterial mix, each bacterial strain was cultivated in
the  corresponding  media  in  an  anaerobic  chamber  at  37ºC.  Strains  belonging  to
Bacteroides and Lactobacillus were grown on Schaedler plates, while strains that belong
to Barnesiella, Alistipes and Mucispirillum were grown on Brucella plates. As described
in the previous section, all necessary material was left in the anaerobic chamber for 24 h
prior to its use in order to ensure  anaerobic conditions. Bacteria were collected from
plates and resuspended in PBS 15% glycerol 0.1% cysteine,  until  reaching the same
absorbance (optic density-OD600 of 0.1) for all  the strains.  Equal volume was taken
from each strain suspension in order to produce a mix of commensal bacteria that was
subsequently administered to antibiotic-treated mice. As in the previous case, 3 aliquots
of bacterial mix suspension were made, 1 for each day of administration.
 3.1.2 Fecal sample collection and MRE levels analysis in hospitalized patients
In order to determine if similar bacterial species could confer protection against
MRE colonization in humans and if similar mechanisms could provide CR, fecal samples
from patients with acute leukemia that were hospitalized in the Hospital La Fe (Valencia)
were  collected.  As  mentioned  in  the  introduction,  due  to  their  immune  system
deficiencies, combined with low CR because of severe antibiotic therapy, these patients
are  often  colonized  with  MRE,  which  makes  them  suitable  for  analysis.  Signed
permission was obtained from each patient before including them in the study. Samples
were collected from December of 2013 until  May of 2015.  Sampling was performed
weekly during all the hospitalization period that each patient underwent (patients can be
hospitalized  several  times  because  they  undergo  several  rounds  of  chemotherapy,
subsequently some of them receive a transplant or can be admitted into the hospital due
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to associated diseases such as graft versus host disease). Thus from each patient, several
samples from different time points were collected. In total,  we analyzed 817 samples
collected from 140 patients. Samples were kept at 4ºC for less than 24 h until shipment
to the laboratory. Once received, samples were aliquoted in 5 tubes and weighted. Three
aliquots were resuspended in autoclave-sterilized PBS 15% glycerol in order to preserve
viability of bacteria upon freezing. One of these aliquots was used for platting the fecal
sample in MRE selective media in order to confirm that the patient was colonized with
MRE strain, as well as to identify the levels of intestinal colonization. No differences in
the intestinal MRE levels were observed if fecal samples were directly plated or plated
after being frozen at  -80ºC (N= 30 number of samples tested).  The other 2 glycerol
aliquots were kept for the isolation of commensal bacterial strains or the MRE identified
in case it was required. Aliquots that were not resuspended in PBS 15% glycerol served
for the extraction of the DNA in order to determine the microbiota composition, and for
the identification of metabolic and proteomic profile of each sample (tasks that are being
developed by other research groups but whose results are no available yet and therefore
have  not  been  shown  in  the  thesis).  All  aliquots  were  kept  at  -80º  C  until  further
processing.  In  order  to  determine  the  effect  of  different  factors  on  MRE  intestinal
colonization, clinically relevant data, such as immune status of the patient, antibiotics
received, underlying diseases, etc. were also obtained for each patient.
 3.1.3 Experiments in rabbits for elucidating the role of dysbiosis in ERE
In order to elucidate the association between microbiota and ERE, experiments
were performed on New Zeland rabbits from a strain raised at the Polytechnic University
of Valencia (89). All studies were performed in compliance with Polytechnic University
guidelines. The experimental protocol was approved by the Committee of Ethics and
Animal  Welfare  of  the  Polytechnic  University  of  Valencia  and followed the  Spanish
Royal Decree 53/2013 on protection of animals used for scientific purposes. Animals
were weaned at 30 days of age and housed in separate individual cages where they had
ad libitum access to food and water. The food used in the diet was standard, antibiotic-
free  and  coccidiostatic-free  (Cunicebal  Retirada,  Nanta,  Spain).  In  order  to  assess
microbiota composition of rabbits, caecotrophs were collected the day of weaning, the
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day after weaning and then every other day during the next 20 days. Caecotrophs are soft
feces  excreted  by  rabbits  that  have  a  more  similar  chemical  and  microbiological
composition  to  that  of  the  cecal  contents,  where  major  physiological  changes  occur
during ERE (101). Caecotroph samples were collected using neck collars to prevent their
ingestion by rabbits. Samples were kept at 4°C during approximately 3 hours and stored
at -80ºC afterwards. Samples from mothers were also collected the day of weaning and 7
days afterwards.
A sharp decrease in food consumption is considered the first sign that can be
detected in rabbits that develop ERE. For this  reason, food consumption was measured
daily in order to detect the onset of the disease. The day of disease onset was considered
to be that one in which a rabbit diminishes food consumption >50% compared to the
previous day. The threshold of 50% was chosen since a few healthy rabbits diminished
food consumption on specific days (up to 46% of reduction) without developing any
other ERE signs. For ethical reasons, rabbits developing ERE were sacrificed when they
ate during 2 consecutive days less than 10g of food. Healthy rabbits were followed for an
additional week before euthanasia (total of 3 weeks after weaning) to ensure that they did
not  develop  any  ERE  compatible  signs.  All  rabbits  were  sacrificed  by  injecting
pentobarbital. To confirm ERE development, a necropsy was performed in all rabbits,
and gross lesions were annotated.
 3.1.3.1 Food deprivation experiment
In  order  to  determine  the  effect  of  decreasing  food  consumption  on  ERE
development and ERE associated dysbiosis, rabbits were subjected to food deprivation.
Rabbits were weaned and housed in separated cages (1 rabbit per cage, N= 28). Rabbits
were  divided  in  4  groups  with  7  rabbits  in  each:  first  group was  subjected  to  food
deprivation that started on day 7 post-weaning and lasted for 2 days, the second group
was subjected to food deprivation that started on day 14 post-weaning and lasted for 2
days  also;  third  and  fourth  groups  were  control  for  the  previous  ones.  In  order  to
determine the effect of exclusively food restriction on microbiota composition changes ,
all  rabbits  that  developed  ERE were  excluded  from analysis.  Food  deprivation  was
performed on first and second week after weaning since it is when the majority of rabbits
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develop ERE. We perform food deprivation only for 2 days for ethical reasons and since
we already observed major signs of the diseases and changes in the composition of the
microbiota after rabbits have reduced their food consumption during 2 consecutive days.
On  the  8th and  14th day  post-weaning  30g  of  food  were  left  in  each  feeder  in  the
corresponding  food  deprivation  group.  This  amount  of  food  represents  >50%  of
reduction compared to the food consumption measured on the day before.  The same
amount was left on the following day too. Since it was impossible to obtain caecotrophs,
probably because of the reduction in food intake, and in order to determine microbiota
composition from rabbits in groups subjected to food deprivation, the third day after the
initiation of the experiment all rabbits were sacrificed as previously described and the
cecal content was collected. In addition, a necropsy was performed in order to detect any
lesions compatible with ERE.
 3.1.3.2 Infection of healthy rabbits with the putative infectious agent isolated from
ERE rabbits
Operational  Taxonomic  Unit  31  (OTU-  corresponds  approximately  to  the
phylogenetic level of species using a sequencing approach for taxonomic classification),
classified as Clostridium, was identified as a putative infectious agent in ERE. In order to
test its capacity of promoting ERE, healthy rabbits were exposed to this bacterial strain.
Experiment was performed on SPF New Zealand White rabbits in the animal facility
located at Principe Felipe Research Center (Valencia). Animals had ad libitum access to
food and water. Food consumption and weight gain were measured daily.  Clostridium
strain was grown in TSA blood agar plates in anaerobic conditions at 37ºC. Bacteria were
collected with a swab and resuspended in PBS 0.1% cysteine on the day of infection.
Aliquots of 1.2ml were made for each rabbit (108 CFUs/ml). All aliquots were introduced
in  anaerobic  atmosphere  generation  bags  and transported  on  ice  to  the  husbandry  at
Principe  Felipe  Research  Center.  To  each  rabbit  1ml  of  suspension  containing  the
putative infectious strain classified as Clostridium was administered orally with the help
of a nasogastric tube (total of 10 animals). PBS was administered to another group of 10
animals  as  control.  A third group of  10 rabbits  received 1ml  of  cecal  contents  from
rabbits that developed ERE. This last group of rabbits was considered to be a positive
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control,  since  a  previous  study  was  able  to  reproduce  the  disease  symptoms
administering cecal contents of ERE rabbits to SPF rabbits (92).
 3.2 Isolation and characterization of intestinal bacteria from mice and rabbits
Isolation  of  bacterial  strains  associated  with  ERE,  as  well  as  isolation  of
bacterial strains that were identified as potentially protective against MRKP colonization
in mice was performed following the same protocol, which is explained in detail below.
 3.2.1 Cultivation and isolation of the intestinal bacteria
In order to isolate intestinal bacteria that was associated with protection against
MRKP colonization in  mice or  with ERE onset  in  rabbits,  fecal  samples from these
animals were collected. Murine fecal samples were resuspended in PBS 15% glycerol,
frozen in a dry ice/ethanol bath and stored at -80ºC until its subsequent cultivation in
anaerobic conditions. For isolation of the Clostridium strain associated with ERE onset, a
fecal sample from a rabbit suffering ERE and with the highest abundance of the OTU
identified  as  a  putative  infectious  ERE  agent,  was  thaw  in  an  anaerobic  chamber,
resuspended in PBS and cultivated in TSA blood agar plates.
Mouse and rabbit  fecal  samples  were cultivated in  different  cultivation agar
media, such as BHI, Brucella, GUT, Schaedler, TSA blood agar, Columbia blood agar,
etc. at various dilutions, ensuring the growth of individual colonies. Both for rabbit and
murine fecal  samples,  bacteria  were grown in anaerobic conditions at  37ºC during 1
week. Every day, colonies that had grown enough to be visible were isolated, allowing
isolation of both fast and slow growing ones. At least 5 colonies of every morphology
were picked with a pipet tip and resuspended in 20μl of PBS. One part of the volume
(2μl) of the suspension were grown again on the corresponding media plate (what was
collected from TSA blood agar, was grown on TSA blood agar). The rest of the volume
was kept at 4ºC and used for further analysis, which included taxonomic identification of
the colony. Taxonomic identification was performed by 16S rRNA gene sequencing. For
this purpose, polymerase-chain reaction (PCR) and Sanger were performed as described
below. Commensal bacterial strains of interest, as identified by 16S rRNA sequencing,
were subsequently resuspended in PBS 15% glycerol and stored at -80C. 
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 3.2.2 16S rRNA gene PCR of isolated intestinal bacteria
In order to isolate murine commensal bacteria associated with resistance against
MRKP and putative etiological agent of ERE from rabbits’ fecal samples amplification of
the bacterial 16S rRNA gene of each colony was performed. Briefly, for each sample,
25µl reaction was prepared containing 1μl of 1 bacterial colony resuspended in PBS,
2.5µl  10x  Standard  Taq  Reaction  Buffer  (New  England  BioLabs),  0.25  mM  of
deoxynucleoside triphosphates (dNTPs), 2.5 U of Taq DNA Polymerase (New England
BioLabs) and 0.2 mM of primers. The volume was completed with water. The list of
primers used in the PCR is shown in  Table M1. Cycling conditions were 94ºC for 5
minutes, and 35 cycles of 94ºC for 30 seconds, 56ºC for 30 seconds and 68ºC for 30
seconds,  and a  final  elongation  cycle  at  68ºC for  5  minutes.  The  amplification  was
confirmed through electrophoresis by loading 4μl of the PCR reaction on a 1.6% agarose
gel. The rest of the volume was purified on ExcelaPureTM 96-Well PCR Purification
Plates (Edge Bio). In order to obtain the sequence of the amplified products, a Sanger
reaction was performed, as described in the next section, using as substrates the obtained
amplicons.
In order to isolate the Clostridium strain associated with ERE, colonies obtained
by cultivation of rabbit fecal samples were amplified using primers (Table M1) that were
specific of the 16S rRNA sequence of the Clostridium OTU identified to be associated
with ERE development (see Results section 4.3.4). Specific primers were designed using
the  Primrose  program.  Briefly,  FASTA  file  with  16S  rDNA  sequences  that  are
representative for every OTU detected in the fecal sample used for isolation were used to
construct a database, which is used for the design of primers. OTUs sequences from the
particular fecal sample were obtained through 16S rRNA high-throughput sequencing, as
described in section 3.6. This approach allowed to select primers specific for the 16S
rRNA sequence of the desired OTU, and that will not amplify any other OTUs present in
the  sample  used  for  isolation.  The  maximum  length  of  the  primers  was  set  to  20
nucleotides, while no ambiguous nucleotides were accepted. The PCR conditions utilized
were the same as  described above.  The obtained PCR products  were also confirmed
through  electrophoresis  by  loading 4μl  of  the  PCR reaction  on  a  1.6% agarose  gel.
Colonies that gave rise to an amplified product using the specific primers and whose
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PCR product was of the expected size when separated by electrophoresis on an agarose
gel, were considered of interest. Since the length of the PCR product did not cover whole
16S rRNA gene, PCR reaction was repeated for colonies of interest with universal 16S
rRNA primers (Table M1) covering the entire 16S rRNA sequence in order to obtain
further sequencing information from the particular OTU.
All PCR products obtained by amplification of the 16S rRNA gene with universal
primers  of  colonies  isolated  both  from  rabbits  and  from  mice  were  subjected  to
electrophoresis  on  a  1.6% agarose  gel  in  order  to  confirm  the  success  of  the  PCR
reactions.  PCR  products  were  purified  on  ExcelaPureTM  96-Well  PCR  Purification
Plates.  Purified  16S  amplicons  were  used  as  substrate  for  the  Sanger  sequencing
reaction.
 3.2.3 Obtaining the 16S rRNA gene sequence of the gut isolated bacteria using the
Sanger reaction approach
For Sanger sequencing, Big Dye Terminator v.3.1 Cycle Sequencing Kit was
used (Thermofisher). Briefly, the reaction mix contained 1.6μl of buffer; 0.4μl of Big
Dye  Terminator;  1μl  of  forward  16S  rRNA  gene  primer  (Table  M1)  at  final
concentration of 0.625μM and 1μl of the purified 16S rRNA PCR product. The total
volume of  the  reaction  was  8μl.  The  Sanger  reaction  was  incubated  at  94ºC for  10
seconds, 50ºC for 5 seconds and 60ºC for 4 minutes. For each reaction 99 cycles of the 3
incubation steps were performed. Subsequently, samples were sent to the Central Service
for Experimental Research at University of Valencia for determining the 16S rRNA gene
sequence.  Briefly,  DNA  fragments  were  separated  by  length  using  capillary
electrophoresis  and  detection  of  dye  fluorescence  in  every  nucleotide  position.  The
output data was formatted as fluorescent peak trace chromatograms.
 3.2.4 Taxonomic identification of isolated bacteria using the 16S rRNA sequence
obtained with the Sanger reaction
16S rRNA gene sequence  chromatograms were  processed  with  the  program
Trev. Low quality peaks at the beginning and end of the chromatograms were manually
removed. The final sequence was used for taxonomic identification of the bacteria. In the
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case of bacterial strains isolated from murine fecal samples, 16S rRNA gene sequences
were aligned against the Silva database by using Silva Incremental Aligner (SINA) in
RDP and default parameters. In the case of bacteria isolated from rabbit fecal samples,
Blast was run against a representative 16S rRNA gene sequence of the OTU31, which
was associated with ERE devlopment and was identified through 16S high-throughput
sequencing as described in the Results section 4.3.4 and Methods section 3.6. Only 100%
similarity and coverage was considered as a good hit.
 3.3 Detection, isolation and characterization of antibiotic resistant pathogens
 3.3.1 Detection of the levels of colonization with MRKP in mice
In order to determine the levels of colonization with MRKP in mice before and
after the MRKP challenge, fecal samples were collected on the day of infection and 1
day  post-infection.  Briefly, the  fecal  sample  was  weighted,  resuspended in  PBS and
grown on  LB agar supplemented with ampicillin (100μg/ml), vancomycin (100μg/ml)
and neomycin (50μg/ml). MRKP colonies were counted and normalized by the factor of
dilution and the fecal weight.
 3.3.2 Detection of MRE fecal levels in patients
The  levels  of  colonization  with  MRE in  patients  with  acute  leukemia  were
measured by growing fecal samples on specific cultivation agar media. A patient was
considered colonized if at least 1 MRE colony was detected in the fecal sample collected
from that patient. In order to detect and measure levels of colonization with MRE we
plated fecal samples on ESBL Brilliance Agar (Oxoid), since the most frequent MRE
isolated from acute leukemia patients in Hospital La Fe are ESBL+ Enterobacteriaceae.
ESBL agar contains Cefpodoxime, in combination with additional antibacterial agents, to
inhibit  non-ESBL  Enterobacteriaceae.  Differentiation  of  the  most  prevalent  ESBL-
producing organisms is achieved through the inclusion of 2 chromogens. For example, E.
coli grown on ESBL agar forms pink colonies, while K. pneumoniae forms green ones.
Therefore,  in  order  to  quantify  the  level  of  MRE colonization,  all  colonies  that  by
morphology  and  color  corresponded  to  ESBL Enterobacteriaceae  were  counted.  The
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limit of detection of ESBL Enterobacteriaceae was 1 colony in 50mg of feces. As in case
of MRKP, the number of colonies was normalized by dilution and fecal weight. Besides
ESBL-producing Enterobacteriaceae, in these plates could grow other bacteria that are
not MRE (e.g. Pseudomonas). For this reason, 5 colonies from each MRE positive plate
were  subjected  to  taxonomic  identification,  as  explained  in  detail  in  the  following
sections,in order to corroborate that they indeed belong to the Enterobacteriaceae family.
In addition, the complete antibiotic resistance pattern of the 5 selected MRE colonies per
plate was also obtained, as we will explain in detail in the next sections.
 3.3.3 Characterization of MRE strains from patients’ fecal samples
From each MRE positive sample, 5 colonies were picked with a pipet tip and
resuspended  in  PBS  15% glycerol.  These  colonies were  kept  at  -80ºC  until  further
processing, which included their taxonomic confirmation and determination of antibiotic
resistance pattern.
 3.3.3.1 Taxonomic confirmation of MRE strains by Maldi-TOF MS
All bacteria isolated from MRE positive plates and kept at -80C were thawed
and subsequently grown over night at 37ºC in LB agar. Subsequently, grown bacteria
were picked with a sterile loop and directly spotted onto a MALDI sample plate and
allowed to air dry. The matrix solution (1μl) was layered onto each bacterial spot and
allowed to air dry afterwards. Subsequently, the sample plate was introduced into the
Maldi-TOF MS. The laser  excites bacterial  molecules in  the zone where colony was
spotted, which produces ions that can be registered as different spectra. The obtained
spectra  of  each  analyzed  isolate  are  compared  to  a  spectra  database,  allowing  the
taxonomic identification of the isolate.
 3.3.3.2 Determination of antibiotic resistance patterns of MRE strains using the
Vitek 2 System
Besides taxonomic confirmation, the 5 colonies isolated from the MRE positive
plates were subjected to determination of their susceptibility to different antibiotics. Over
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night cultures of the bacterial isolates, grown on LB agar, were collected with a sterile
loop and resuspended in 3ml of sterile saline solution to reach the absorbance of 0.5. The
bacterial  solution  was  incubated  with  commercial  antimicrobial  susceptibility  testing
(AST)  cards  for  Enterobacteriaceae  in  the  Vitek  2  System.  The antimicrobial  agents
tested  were  amikacin,  amoxicillin-clavulanic  acid,  ampicillin,  cefepime,  cefotaxime,
cefoxitin,  ceftazidime,  cefuroxime,  ciprofloxacin,  gentamicin,  imipenem,  ertapenem,
nalidixic acid, piperacillin-tazobactam, tigecycline, and trimethoprim-sulfamethoxazole
(the  most  frequent  antibiotics  for  which  resistance  has  been  observed  in
Enterobacteriaceae). Briefly, suspension of the over night culture was loaded into each
card, with wells for cultivation media containing each of the antimicrobials to be tested.
Cards  were  incubated  for  several  hours  (2-7h  depending  on  the  growth  rate  of  the
isolate), and growth of bacteria in each of the wells was assessed. The susceptibility was
determined  according  to  Clinical  and  Laboratory  Standard  Institute  (CLSI)
recommendations from 2012.
In  order  to  confirm  antibiotic  resistance  pattern  identified  through  Vitek2
System,  1  of  the  5  tested  colonies  from each  MRE positive  plate  was  subjected  to
identification of the antibiotic susceptibility pattern through Kirby–Bauer disk diffusion
method. Briefly, an over night culture was resuspended in PBS until reaching absorbance
of 0.5. One part of the volume (200μl) of the suspension was pipetted over Mueller-
Hinton agar and evenly distributed with the help of glass beads. When dried, antibiotic
discs were applied and pressed down to ensure complete contact with agar surface. The
following antibiotic disks were used, ampicillin (10 μg), piperacillin-tazobactam (100/10
μg),  amoxicillin/clavulanic  acid  (20/10  μg),  cefoxitin  (30  μg),  ceftazidime  (30  μg),
ceftriaxone (30 μg), ertapenem (10 μg), imipenem (10 μg), amikacin (30 μg), gentamicin
(10 μg), ciprofloxacin (5 μg), trimethoprim-sulfamethoxazole (1.25/23.75 μg), colistin
(10 μg), tobramycin (10 μg), tigecycline (15 μg) and cefuroxime (30 μg). Plates were
incubated  at  37ºC.  Diameter  of  zone  of  inhibitions  were  measured  and  recorded  in
millimeters.  Depending  on  the  diameter  of  inhibition,  organisms  were  labeled  as
sensitive, resistant, or intermediate, according to CLSI standards from 2012.
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 3.4 DNA extraction from collected fecal samples
DNA isolation was performed using the QIAamp ® DNA Stool Mini kit in the
case of rabbits’ fecal samples and QIAamp ® Fast DNA Stool Mini kit in the case of
mice and patients’ fecal  samples.  Extractions  were  performed following the  protocol
provided by the manufacturer. Fecal sample was weighted before the DNA extraction
was performed. For more efficient extraction of DNA from hard to lyse bacteria, the
initial step was modified, as previously described (102). The modification consisted on
adding 500μl of glass beads, diameter 150μm, to the sample, after addition of the lysis
buffer,  and  vortexing  for  5  minutes  at  maximum  speed  (Vortex-Genie®).  This  step
allows the mechanical disruption of the bacterial cell wall. Subsequent steps of the DNA
extraction followed the QIAamp kit protocol. Finally, DNA was eluted in 50μl (rabbits’
and mice samples) or 100μl (patients’ samples) of the elution buffer. A part of the volume
(4μl) was separated by electrophoresis on 0.8% of agarose gel in order to check the DNA
integrity.  DNA  concentration  was  determined  with  QubitTM  fluorometer  using  the
manufacturer’s protocol. The rest of the DNA was stored at -20ºC until it was used in
subsequent analysis (quantitative PCR or sequencing).
 3.5 Quantitative PCR (qPCR)
In order to determine the total bacterial load in the samples, qPCR of 16S rRNA
gene was performed. For this purpose, the KAPA SYBR ® FAST qPCR Kit was used.
Briefly, for each sample, 20µl PCR duplicates were prepared with each containing 2μl of
the  DNA  (see  previous  section)  used  as  template,  10µl  of  mix  provided  by  the
manufacturer, and 0.4μl of forward and reverse primers at the final concentration of 0.2
mM (Table M1). In order to complete the volume of the reaction, 7.2μl of water was
added.
A PCR product of the 16S rRNA gene from Enterococcus faecium C68 strain
was used for obtaining a standard curve. This E. faecium 16S rRNA PCR was performed
as previously described in  section  3.2.2.  ENDMEMO program was used in  order  to
determine the number of 16S rDNA molecules in the PCR product of  E. faecium C68
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based on sequence of 16S rRNA gene and concentration of the PCR product. A standard
curve was obtained by making 5-fold dilutions of the PCR product.
Cycling conditions of the qPCR were 94ºC for 5 minutes, and 45 cycles of 94ºC
for 30 seconds, 56ºC for 30 seconds and 68ºC for 30 seconds, and a final elongation
cycle at  68ºC for 5 minutes.  By extrapolation of results  with the ones obtained with
standard curve, the number of 16S rRNA genes was determined for each sample. The
final number of 16S rRNA genes per gram of fecal sample was calculated by using the
following formula: 
Number of 16S rDNA molecules/1g of feces = E*N/2*F
where E represents the volume of the buffer used for elution of DNA after extraction
(section 3.4), N represents number of 16S rDNA molecules obtained by qPCR, 2 stands
for the volume of DNA used for the qPCR reaction,  and F represents the weight (in
grams) of the fecal pellet from which DNA was extracted.
 3.6 High-throughput sequencing of the 16S rRNA gene
In order to study the composition of the intestinal microbiota, high-throughput
sequencing  of  the  16S  rRNA  gene  was  performed.  Samples  obtained  in  rabbits
experiments were sequenced first using the 454-Roche sequencing platform, and were re-
sequenced  later  with  MiSeq  Illumina  technology.  Samples  collected  from  mice  and
patients  were  sequenced  only  on  the  MiSeq  Illumina  platform.  Sequencing  was
performed at The Foundation for the Promotion of Health and Biomedical Research of
Valencia Region (FISABIO).
 3.6.1 16S rDNA high-throughput sequencing using the 454 platform
In order to amplify the 16S rRNA gene for microbiota analysis using the 454
platform, 25µl PCR duplicates were prepared with each containing 20ng of DNA, 2.5µl
10x PCR buffer, 0.25 mM of dNTPs, 0.6 U of Taq DNA polymerase and 0.2 mM of
primers  designed  to  amplify  the  V1-V3  region:  a  forward  primer  (5'-
CCATCTCATCCCTGCGTGTCTCCGACTCAGNNNNNNNNTCAGAGTTTGATCMT
GGCTCAG-3'), composed of 454 Lib-L primer A (underline), a unique 8-base barcode
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(Ns), linker nucleotides (bold) and the universal bacterial primer 27F primer (italics); and
a  reverse  primer  (5′-
CCTATCCCCTGTGTGCCTTGGCAGTCTCAGGCTTACCGCGGCKGCTGGCAC-3′)
composed of 454 Lib-L primer B (underline), linker nucleotides (bold) and the broad-
range bacterial primer 515R (italics). For each sample sequenced in the same sequencing
run, a primer with a different barcode was used (Table M1). Cycling conditions were
94ºC for 5 minutes, and 22 cycles of 94ºC for 30 seconds, 56ºC for 30 seconds and 68ºC
for 30 seconds, and a final elongation cycle at 68ºC for 5 minutes. PCRs were purified
using QIAquick PCR purification kit (QIAGEN) according the manufacturer’s protocol.
Subsequently,  PCRs  were  quantified  using  QubitTM  fluorometer  as  previously
described. Subsequently, the same amount of each PCR was combined in the same pool,
containing between 15 and 22 samples. Each pool of samples was sequenced using a 454
GS FLX Titanium platform following Roche recommendations.
 3.6.2 MiSeq Illumina sequencing
The V3-V4 region of the 16S rRNA gene was amplified and sequenced using
the MiSeq platform from Illumina, as described in the manual for “16S Metagenomic
Sequencing Library Preparation” of the MiSeq platform (Illumina).
Briefly, for each sample,  a 25µl reaction was prepared containing 12.5ng of
DNA, 12.5µl 2x KAPA HiFi Hot Start Mix, and 0.2 mM of primers (Table M1). Water
was added to complete the volume of the reaction. In case there was not enough amount
of  DNA, the maximum volume (11.5μl  of DNA) was added to the reaction,  but  the
number of amplification cycles was increased from 25 to 30.  Cycling conditions were
95ºC for 3 minutes, and 25 cycles (30 in case of the low DNA amount) of 95ºC for 30
seconds, 55ºC for 30 seconds and 72ºC for 30 seconds, and a final elongation cycle at
72ºC for 5 minutes. The amplification was confirmed through electrophoresis by loading
4μl of the PCR reaction on a 1.6% agarose gel.  Subsequently, the PCR product was
purified with the AMPure XP beads as described in the Illumina protocol.
Next, a limited-cycle PCR reaction was performed to amplify the DNA and add
index sequences on both ends of the DNA, thus enabling dual-indexed sequencing of
pooled libraries.  Index PCR consisted of a 50µl reaction containing 5μl of the DNA
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obtained from the previous  PCR, 25µl of 2x KAPA HiFi  Hot  Start  Mix, and 5μl  of
forward and reverse indexed primers. Temperature conditions were the same as for the
first reaction, but the number of cycles was reduced to 8. The obtained PCR product was
purified  with  the  AMPure XP beads following the  manufacture’s protocol.  An equal
amount of the purified DNA was taken from each sample for pooling.  Each pool of
samples (N= 96) was sequenced following Illumina recommendations.
 3.7 High-throughput 16S rDNA sequencing analysis
 3.7.1 Analysis of sequences obtained using the 454 platform
Sequences were processed using Mothur (103). All sequences were converted to
standard FASTA format. Sequences shorter than 300 bp that contained homopolymers
longer than 8bp or undetermined bases, with no exact match with the forward primer and
barcode or that did not align with the appropriate 16S rRNA variable region were not
included in analysis. Using the 454 base quality scores, which range from 0 to 40 (0
being ambiguous base), sequences were trimmed using a sliding-window technique, such
that the minimum mean quality score over a window of 50 bases never dropped below
25. Sequences were trimmed from the 3' end until this criterion was met. Sequences were
aligned to the 16S rRNA gene using as a template the SILVA reference alignment (104).
Potential  chimeric sequences were removed using Chimera Slayer program (105).  To
minimize the effect of pyrosequencing errors in overestimating microbial diversity (106),
rare abundance sequences that differ in 1 or 2 nucleotides from a high abundant sequence
were  merged  to  the  high  abundant  sequence  using  the  pre.cluster  option  in  mothur.
Sequences with distance-based similarity of 97% or higher were grouped into the same
OTU  (sequencing  approach  to  roughly  determine  the  bacterial  species  present  in  1
sample)  using  the  average-neighbor  algorithm.  A number  is  assigned  to  each  OTU
according to the order in which it appears in analysis (e.g. OTU31 in analysis of samples
obtained from rabbits’ experiments).  Since different number of sequences per sample
could lead to a different diversity (i.e. more OTUs could be obtained in those samples
with higher coverage), in order to compare the diversity of different fecal samples, all
samples were rarefied to the number of sequences obtained in the sample with the lowest
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number of sequences (see Table M2 for each study). OTU-based microbial diversity was
estimated  by  calculating  the  Shannon  diversity  index,  which  takes  into  account  the
number of OTUs and the relative abundance of each OTU. Each sequence was classified
using the Bayesian classifier algorithm with the bootstrap cutoff of 60% (107). In most
cases, classification could be assigned to the genus level. When it was not possible to
classify  a  sequence  to  a  certain  taxonomic  level,  it  was  assigned  as  “Unclassified”
followed by the upper taxonomic level (in case of genus it would be “unclassified” and
name of the family).
 3.7.2 Analysis  of  16S  rRNA  sequences  obtained  using  the  MiSeq  Illumina
sequencing platform
Sequences obtained by Illumina were also processed using Mothur, with some
differences:
a)  Due  to  dual  sequencing  technology  pair-end  reads  are  obtained  for  each
sequence. For this reason initial trimming by quality was performed on paired ends of
sequences before joining them into a single read. Parameters used for trimming are listed
in  Table M2. In case of sequences obtained from rabbits and mice samples, trimming
was performed with Mothur, while  in  the  case  of  sequences  obtained from patients’
samples, trimming was performed with Prinseq Lite package. Criteria for all Illumina
sequence processing steps are listed in Table M2.
b) Chimeric sequences were removed using Uchime algorithm  (108), since it
has better sensitivity compared to previously used ChimeraSlayer (note that when the
analysis of 454 sequences was performed, the Uchime algorithm was still not available in
Mothur).  Besides,  Uchime  algorithm  is  much  faster  which  is  important  taking  into
account the higher number of sequences obtained by Illumina.
c)  Due  to  the  higher  number  of  sequences  obtained  from  Illumina  runs,
clustering of sequences into OTUs was performed differently than in the case of 454
pyrosequencing. Sequences obtained from rabbits and mice samples were grouped with
cluster.split option in Mothur. This command splits sequences at the taxonomic level of
order and performs clustering within each order. In the case of sequences obtained from
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patients’ samples, clustering into OTUs was performed using the VSEARCH abundance-
based greedy clustering (AGC) method (109). This algorithm, published recently allows
the processing of a large number of sequences, which is the case for patients’ data, since
the number of samples sequenced by Illumina for this study was 817.
d) Rare abundant sequences that differ in 1 to 4 nucleotides (see  Table M2)
from  high  abundant  ones,  were  merged  to  the  high  abundant  sequence  using  the
pre.cluster option in Mothur. The number of nucleotides allowed to differ depends on
length of the sequence (1 nucleotide per 100 base pairs).
 3.7.3 Principal Coordinate of Analysis and Hierarchical clustering
In order to compare the overall  microbiota similarity between different fecal
samples, the Yue Clayton distances between the microbiota of pairs  of samples were
calculated using Mothur. These distances compare the number of shared OTUs between
2 pairs of samples. Moreover, the Yue Clayton takes into account the relative abundance
of each OTU. Principal Coordinates of Analysis (PCoA) was performed on the resulting
distance matrices with Mothur.
 3.8 Nextera sequencing of  the genome of the  Clostridium strain identified as a
potential promoter of ERE in rabbits
To determine genes and functions encoded by the bacterial strain associated with
ERE, genomic sequencing was performed. The strain was grown on TSA blood agar in
anaerobic conditions at 37ºC. Colonies were collected and resuspended in 1ml of PBS.
Bacterial  cells  were  centifuged  at  13,000g  during  20  minutes  and  supernatant  was
discarded. DNA was extracted with the QIAamp ® Fast DNA Stool Mini kit as described
previously in the section 3.4.
Genomic DNA was prepared for sequencing by using Nextera XT DNA Sample
Preparation  Kit  as  described  in  the  next  section.  The  Nextera  XT  DNA  Sample
Preparation  Kit  uses  an  engineered  transposome to  simultaneously  fragment  and tag
("tagment")  input  DNA (DNA extracted  from  fecal  sample),  adding  unique  adapter
sequences in the process. A limited-cycle PCR reaction uses these adapter sequences to
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amplify the DNA and add index sequences on both ends of the DNA, thus enabling dual-
indexed sequencing of pooled libraries.
Briefly, 5μl of Amplicon Tagment Mix was added to 10μl of Tagment DNA
Buffer. The amount of DNA added to the mix was 1ng. The mix was incubated at 55ºC
during  5  minutes.  Neutralization  of  the  reaction  was  achieved  by  adding  5μl  of
Neutralize Tagment Buffer. For the step of amplification, 15μl of Nextera PCR Mix were
added. The cycling conditions were 72ºC during 3 minutes, 95ºC 30 seconds followed by
12 cycles of 95ºC during 10 seconds, 55ºC 30 seconds and 72ºC 30 seconds. A final
elongation step was performed at 72ºC during 5 minutes. The obtained PCR product was
purified  with  the  AMPure  XP  Beads  as  described  in  the  manufacturer’s  protocol.
Samples normalization and pooling was performed according to the Nextera protocol.
Sequencing was performed following Illumina recommendations.
 3.9 Processing of the genome of the Clostridium strain associated with ERE
Characterization of the strain of interest included the assembly and annotation
of the data obtained by genome sequencing, evolutionary placement of the strain into the
Clostridiales  order,  identification  of  the  species  to  which  it  belongs,  and  functional
annotation of the identified genes. First, sequences obtained by Illumina were processed
in order to eliminate bad quality sequences. Briefly, adapter sequences were removed
from the raw data using Cutadapt program (110). Quality filtering was performed using
UrQt (111). Only reads with a size of 75 bp or higher were further processed, to avoid
possible  misclassification of short  reads.  Cleaned genomic data was assembled using
SPAdes v. 3.7.1 (112) using the “careful” algorithm to improve the contig reconstruction.
SPAdes  resulted  in  a  draft  genome  assembly  of  160  contigs.  The  average  basepair
coverage was 27.17X. Open-reading frames (ORFs) were identified and annotated using
PROKKA (113). To maximize the annotation, ORFs were translated into amino acids and
queried against 3 independent databases: Pfam v.27.0  (114), EggNOG v.4.5  (115), and
KEGG  (116).  Annotation  was  performed  using  HMMer  v.3.1.2  (E  value  <  0.05,
minimum coverage 0.5) (117).
Predicted genes were aligned using Mafft  (118) against the Multiple Sequence
Alignment  obtained  from GenBank  RefSeq  that  contained  92  genomes  classified  as
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Clostridiales.  Evolutionary  placement  algorithm  was  performed  to  locate  the  most
probable phylogenetic location of the isolated strain. The best phylogenetic location was
considered only when the Maximum Likelihood Weight was higher than 0.95 (which
translates into a probability of misplacement lower than 0.05). 
The process of bacterial diversification and the concept of bacterial species are
highly  dependent  on  the  accumulation  of,  both,  point  mutations  and  horizontally
transferred  genetic  elements  (119).  Accordingly,  the  definition  of  species  has  been
recently  determined by the  average  percentage  of  dissimilarity  between the  different
genomic sequences.  Based on this  idea,  the genome drafts  of isolate  were compared
against the reference sequences of Clostridiales. Two independent implementations were
performed. First, the average nucleotide identity (ANI) was calculated using an in-house
script. The query genome was fragmented in non-overlapping sequences of 1,000 bp and
queried against the reference genome. The percentage of identity was calculated for each
fragment.  The  ANI  was  then  calculated  as  the  mean  identity  of  all  fragments.  We
considered 2 genomic sequences to belong to the same species if the ANI between them
was  higher  than  95.0.  Second,  MinHash  dimensionality  reduction  algorithm  allows
detecting  the  differences  between  2  genomes  by  analyzing  the  patterns  of  k-mer
composition  (120). We computed the k-mer composition for all Clostridiales genomes,
including our isolate, and compared the different k-mer profiles between them using an
approximation of the Jaccard dissimilarity index. Only MASH distances lower than 0.15
were included in the analysis and distances lower than 0.05 classified 2 genomes as from
the same species.
For construction of the phylogenetic tree, the core-genome of the Clostridiaceae
family was constructed first. To build the core-genomes we started by assigning relations
of orthology between pairs of genomes. Orthologs were defined as bidirectional best hits
using end-gap free global alignment (as in Touchon et al. (121)). Hits with less than 40%
similarity in amino acid sequence or more than 20% difference in protein length were
discarded. A total of 229 core-genes were identified for the Clostridiaceae family. Core-
genes were then translated to amino acids.  The Clostridiaceae family phylogeny was
reconstructed with IQ-tree using a concatenate multiple protein sequence alignment of
the core-genes (122). 
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To identify  possible  toxins,  the  exotoxin  database  DBETH was  used  (123).
Isolate-specific  proteins  were  queried  against  DBETH  using  BlastP  v.2.2.26  (E-
value<0.01).
 3.10 Statistical analysis and modeling
 3.10.1 Statistical analysis applied in the mice studies
In order to determine differences in the microbiota composition between groups
of mice treated with a mix of antibiotics and the control group (untreated mice), LEfSe
method was applied (124). LEfSe determines the features (organisms, clades, operational
taxonomic units, genes, or functions) that most likely explain differences between classes
(e.g.  untreated  mice  vs.  treated  mice)  by  coupling  standard  tests  for  statistical
significance with additional tests encoding biological consistency and effect relevance.
Specifically, it uses the non-parametric factorial Kruskal-Wallis sum-rank test to detect
features  with  significant  differential  abundance  with  respect  to  the  class  of  interest.
Biological significance is subsequently investigated using a set of pairwise tests among
subclasses  using  the  Wilcoxon  rank-sum  test.  As  a  last  step,  LEfSe  uses  Linear
Discriminant Analysis (LDA) to estimate the effect size of each differentially abundant
feature.  As  a  result,  LEfSe  suggest  biomarkers  that  explain  most  of  the  differences
between the groups analyzed. Thus, this test was used to identify the commensal bacteria
that most likely protect against MRKP colonization in antibiotic treated mice.
On  the  other  hand,  for  identifying  differences  in  different  taxa  abundances
between distinct groups of mice (e.g. mice treated with individual antibiotics compared
to the untreated mice), the non-parametric Wilcoxon test was applied using wilcox.test
function in the ‘stats’ R package. Taxa and OTUs with less than 10 counts in both groups
were not included in the analysis. To adjust for multiple hypothesis testing, the false
discovery rate (FDR) approach by Benjamini and Hochberg was used (125).
The non-parametric Wilcoxon test or Kruskal-Wallis (when more than 2 groups
were compared) was used to determine if MRKP levels were statistically significantly
different (P<0.05) between different groups of mice that were challenged with MRKP.
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 3.10.2 Statistical analysis applied for identification of clinical factors associated
with MRE colonization levels in patients with leukemia
In  order  to  determine  which  clinical  factors  could  be  associated  with  MRE
colonization levels, samples positive to MRE from each admission of every patient were
analyzed.  Statistical  comparisons  were  conducted  by  using  non-parametric  Wilcoxon
test, Kruskal-Wallis or linear regression, depending on the type of clinical factor. The
following  clinical  variables  were  assessed  as  univariate  predictors  of  MRE  levels:
gender, age, neutropenia (abnormally low number of neutrophils in blood- less than 500
absolute neutrophil counts per 1µl of blood), admission reason (whether the patient was
admitted for receiving chemotherapy or a transplant), type of leukemia (acute myeloid or
acute lymphoblastic), pathogen type (Escherichia, Klebsiella, Citrobacter, Enterobacter,
Morganella,  Proteus  or  Serratia genus),  antifungal  treatment,  antibiotic  treatment,
parenteral  nutrition  (intravenous  nutrition  by  which  normal  process  of  digestion  is
bypassed),  mucositis  (inflammation  of  the  oral  and gastrointestinal  mucosa),  type  of
chemotherapy (intensive or non-intensive), type of transplant (allogeneic or autologous).
All clinical variables could be divided in 2 groups. First group is composed of those
variables that do not vary with time (gender, type of leukemia patient suffered, etc.).
Variables  that  have  temporal  character  are  included  in  the  second  group  of  clinical
factors  (antibiotic  treatment,  antifungal  treatment,  etc.).  These  clinical  variables  are
initiated at  some point  after  patient’s admission to  the hospital  and last  for different
periods of time. Due to the different nature of the clinical variables, analysis of the effect
on MRE colonization levels were performed differently and are explained in more detail
below.
For analysis of the effect of clinical variables such as gender, age of the patient,
type of leukemia that was diagnosed, type of MRE detected, type of admission (if the
sample was collected during admission during which chemotherapy or transplant were
performed), all MRE positive samples (227) were pooled and grouped according to the
variable to study. For example, for gender, MRE levels were grouped in those obtained
from samples collected from males or females. Subsequently, the levels of MRE detected
in each group of patients were statistically compared using Wilcoxon test. If there were
more than 2 groups of samples, such as the case of MRE type that colonized the patient,
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Kruskal-Wallis was applied. In order to test association between the age of the patient at
the moment of sampling and the MRE colonization levels, linear regression was applied.
In order to investigate the effect of temporal variables on MRE colonization
levels, paired analysis were performed. For this, levels of MRE in the sample previous to
the  initiation  of  the  treatment  (i.e.  antibiotic  treatment,  antifungal  treatment)  or
complication (i.e. mucositis, neutropenia, parenteral nutrition) were compared to levels
of  MRE  in  the  following  sample  collected  after  the  initiation,  both  samples  being
collected  during  the  same  admission  period  in  the  hospital. Two-tailed  Wilcoxon
matched-pairs signed rank test was performed in order to determine the effect of each
tested  clinical  variable  on  changes  in  MRE levels,  allowing to  investigate  if  certain
treatment  or  condition  could  be  associated  with  increase  or  decrease  in  MRE
colonization levels once the patient had been colonized. One-tailed Wilcoxon matched-
pairs test was performed in Figure R20A, Figure R20B, Figure R21, Figure R22 and
Figure R23, since trend toward MRE rate change was observed in previous analysis,
allowing us to form a hypothesis that could be tested using one-tailed test.
In order to investigate if antibiotic treatments or underlying diseases previous to
the MRE colonization could promote or decrease colonization levels, the MRE levels in
the first MRE positive sample from each admission were analyzed. In order to ensure
that the patient got colonized in the hospital, samples included in the analysis had to be
preceded with an MRE negative sample. Due to the results obtained from the previous
analysis  (see Results  section 4.2.2.2)  in which administration of antibiotics  to which
MRE strains were sensitive resulted in reduction of colonization levels, all samples that
were susceptible to antibiotics that were given to the patient at the moment of sampling
were discarded from this analysis. Only those clinical variables that had more than 5
samples per group were analyzed. Clinical variables tested by this type of analysis were
neutropenia, parenteral nutrition, mucositis, antifungal and antibiotic treatment. Since it
was possible that the effect of clinical variables depended on time that passed since the
occurrence of the complication or start of the treatment until the moment of sampling,
linear regression was performed on MRE colonization levels depending on the time that
passed between sampling and the clinical variable event.
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For  confirming  the  independent  association  between  MRE  levels  and  the
clinical  variables  under  study, multivariate  regression  analysis  was  performed  on all
variables  whose  effect  on  change  of  MRE  colonization  levels  was  tested.  Lasso
regression  (126) implemented in Matlab with positive penalty term  λ was applied in
order to achieve a sparse solution. This allowed selection of only few variables sufficient
for the formulation of the model that explains the variability in MRE levels.
 3.10.3 Application  of  the  Lotka-Volterra  (LV)  model  for  the  identification  of
commensal bacteria associated with resistance to MRE colonization in hospitalized
patients
In  order  to  determine  which  bacterial  strains  are  associated  with  protection
against intestinal colonization with MRE, Lotka-Volterra (LV) mathematical model was
applied (127). As mentioned in the introduction, this model was successfully applied on
microbiome  data  obtained  from  patients  colonized  with  C.  difficile,  identifying  C.
scindens as  protector  commensal  bacteria  against  infections  produced by  C. difficile.
Moreover, this result was later confirmed in a mouse model of infection with C. diffcile
(27).
LV model  permits  to  analyze  temporal  community  data  accounting  also  for
time-dependent  external  perturbations.  In  other  words,  LV is  an ecological  model  of
microbiota  dynamics  that  considers  both  species  interaction  networks  and  extrinsic
perturbations,  such  as  antibiotic  treatment.  The  modified  LV equation  is  presented
bellow.
Here, the left part of the equation represents change in abundance of species of
interest (xi),  in our case MRE, over time period tk. The right part  of equation has 3
terms.  First  term (μi)  stands  for  the  specific  growth rate  of  MRE.  The second term
explains the sum of all the other bacteria mean abundances (xj) over time period tk and
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their  coefficients  of  interaction  with  MRE  (Mij).  In  particular,  Mij  >  0  stands  for
activation and Mij < 0 for repression. The third term stands for the sum of all time-
dependent perturbations ul (tk) (for instance antibiotic treatment) and susceptibility to
these perturbations (εil). The left part of the equation, the abundance of our bacteria of
interest, is known from plating fecal samples on ESBL Brilliance plates for detection of
MRE  colonization  levels.  The  mean  abundances  of  other  bacteria  present  in  fecal
samples  (xj)  is  obtained  by  sequencing  of  16S  rRNA  gene.  Data  about  the  time-
dependent perturbations is obtained from clinical data collected from each patient. Thus,
the parameters of interest, inferred from these equations, are the growth, interaction and
susceptibility parameters, μi, Mij and εil. The equation is solved by using regularized
linear regression with a suitable regularizer. This approach in combination with a suitable
model evaluation reduces the risk of overfitting by finding the optimal trade-off between
model  complexity  and predictability  on  unseen  data.  For  this  set  of  data  elastic  net
regularization was applied (126), with positive penalty term λ. A standard approach to
choose λ is to apply k-fold cross-validation in which the data is randomly partitioned into
k equally sized subsets: k-1 of these are used to infer the parameters (M, μ, E) for several
combinations of λ. The remaining, unseen subset is used to estimate the corresponding
prediction errors. This is repeated for all k possible partitions into k-1 possible training
sets  and  one  test  set.  To reduce  random fluctuations,  several  rounds  using  different
random partitionings are  performed. Based on the results  of this  procedure,  λ  as the
penalty parameter with the minimal averaged prediction error on unseen data is chosen.
The final model is determined by applying λ to the complete data set.
The rate of change in  MRE levels  between 2 consecutive samples collected
from the same admission was used as response variable for the model. The rate was
calculated as the difference between logarithmic values of MRE levels in the first and
subsequent  samples  divided  by  the  time  that  passed  between  2  samples.  Since  the
absence of MRE in negative samples at the beginning of the hospitalization period could
be explained by resistance to colonization or by absence of exposure to MRE, the rate of
MRE change was calculated only for those pairs of samples in which the first one had
MRE levels.  The  OTUs  counts  or  genus  counts  per  sample  were  used  as  predictor
variables for the model. Briefly, OTUs or genus abundances from each sample (fraction
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ranging from 0 to 1) were normalized by the total load of bacterial DNA recovered from
1g of each fecal sample (inferred from 16S rRNA qPCR). The 25 most abundant genera
(Bacteroides,  Enterococcus,  unclassified  Lachnospiraceae,  Parabacteroides,
Streptococcus,  Escherichia,  unclassified  Ruminococcaceae,  Alistipes,  unclassified
Clostridiales,  Lactobacillus,  Staphylococcus,  Sutterella,  Akkermansia,  unclassified
Bacteroidales,  Subdoligranulum,  Roseburia,  unclassified  Firmicutes,  Blautia,
Paraprevotella,  Oscillibacter,  Coprobacillus,  Klebsiella,  unclassified  Bacteria,
Faecalibacterium) including the group “Other” containing the remaining lower abundant
genera were included in analysis. This number of genera was chosen since introduction
of more than 25 genera would not allow us generation of the reliable model, due to the
high number of variables included into the model. For the OTU modeling, only OTUs
with abundance higher than 0.1% (25 most abundant ones) were considered for analysis,
including  the  group  “Other”  containing  the  remaining  lower  abundance  OTUs.  The
particular grouping was used to reduce sparsity in the data matrix and to avoid spurious,
presumably noise-driven contributions. In case of non-detection of an otherwise present
OTU or genus, a value that corresponds to detection limit was assigned (1 count per
10,000 sequences  or 0.00001,  since it  is  the number of  sequences  obtained for  each
sample by Illumina sequencing- see section 3.7.2). As in case of MRE levels, for the
pairs of samples that were included in the analysis, geometric mean abundance for each
OTU was calculated from logarithmic values of normalized OTU abundances. Besides
abundance  data,  all  clinical  variables  that  were  statistically  significant  in  previous
univariate analysis were included into the model. To each pair of samples that entered the
model a number (0 or 1) was assigned for each clinical variable. For example, in case of
antibiotic treatment, 1 was assigned to the pair of samples for those antibiotics that were
given  to  the  patient  at  moment  of  their  sampling,  and  0  was  assigned  in  case  that
antibiotic was not administered at sampling. In total 132 pairs of samples from a total of
221 samples were included in the model.
Subsequently,  the  inference was  performed  as  described  above  with  k=  5.
Inference  and  prediction  algorithms  were  implemented  in  MATLAB  R2012b
(Mathworks).
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 3.10.4 Statistical analysis applied in the study with rabbits 
In  order  to  determine  statistically  significant  differences  in  the  relative
abundance of different taxa and OTUs between the group of healthy rabbits and those
that  developed ERE, the non-parametric  Wilcoxon test  was applied using wilcox.test
function in the ‘stats’ R package. Taxa and OTUs with less than 10 counts in both groups
were not included in the analysis. To adjust for multiple hypothesis testing, we used the
FDR approach by Benjamini and Hochberg  (125) implemented in fdr.R package. Taxa
with  an  FDR  value  lower  than  0.1  were  considered  significant.  Various  types  of
comparisons  were  performed.  First,  we  investigated  differences  between  samples  of
healthy  rabbits  and  those  that  developed  ERE,  obtained  after  ERE onset.  Since  the
majority of samples from sick rabbits were obtained on day 11 after weaning, samples
from this same day in healthy rabbits were used for comparison. Since a few samples
from sick rabbits  were obtained on day 13 after  weaning, the same test  was applied
comparing with samples of healthy rabbits collected on days 11 and 13 after weaning.
Subsequently, we studied if significant changes in bacterial taxa or OTUs between both
groups of rabbits could be detected before ERE onset. Accordingly, both groups were
compared applying the Wilcoxon test to the relative abundance of bacterial taxa or OTUs
of samples obtained the day of weaning and days 1,3,5,7 and 9 after weaning. In the
comparison of day 9 after weaning, samples from 3 ERE rabbits that were already sick
were not included in the analysis. Besides, samples obtained the day of ERE onset were
compared using the same statistical approach with samples from healthy rabbits obtained
on similar days. The majority of the samples obtained the day of ERE onset (7 out of 8)
were collected between days 7 to 9 after weaning and 1 sample was obtained at day 12
after weaning. For this reason we compare samples obtained the day of ERE onset with
samples from healthy rabbits obtained on day 7 and on day 9 after weaning. We also
performed the same analysis  but removing the outlier  sample obtained from an ERE
rabbit at day 12 after weaning. For determining if the evolution of the rabbits microbiota
since  the  day  of  weaning  until  day  9  post-weaning  is  different  in  healthy  rabbits
compared  to  those  that  will  develop  ERE,  linear  model  regression  analysis  was
performed using the ‘lm’ function implemented in the ‘stats’ R package.
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In  order  to  determine  statistically  significant  differences  in  the  relative
abundance of different taxa and OTUs between groups of rabbits with food deprivation
and control groups, Wilcoxon test with adjustment for the multiple hypothesis testing
was applied.
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a Primers  27F and 803R are universal  primers  for  the 16S rRNA gene that  were used in the PCR of
colonies isolated from fecal samples. 
b Primers Clost.Otu31F and Clost.Otu31R are specific for the OTU31 (Clostridium OTU that is associated
with ERE development). 
c Primers used in quantitative PCR for  determination of total bacterial load in fecal samples were 27F-
qPCR and 338R-qPCR. 
d Primers from 27F-1 to 515R were used for high-throughput sequencing of the 16S rRNA gene using the
454 platform. 
e Primers  for  high-throughput  sequencing  of  the  16S  rRNA  gene  using  the  MiSeq  platform  were
16SIlluminaF and 16SIlluminaR.
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Table M2. Parameters used in processing of the sequences obtained from Illumina.
Parameters Mice Patients Rabbits
Sequence trimming parameters before joining pair end reads







Average  quality  of
bases  in  sliding
window
25 25 25
Sliding window size 50 50 50
Sequence trimming parameters after joining pair end reads
Minimum length 440 440 440





















 4.1 Microbiota dysbiosis and MRE colonization and persistence in mice
 4.1.1 The  effect  of  antibiotic  treatment  on  MRE  intestinal  colonization  and
persistence
The ability of the healthy intestinal microbiota to suppress the colonization by
exogenous bacteria, including MRE, is termed colonization resistance (CR). Antibiotic
treatment  disrupts  the  microbiota  and  can  accidentally  open  the  way  to  MRE
colonization. CR is affected differently by antibiotics of different spectrum, suggesting
that some members of the microbiota participate in CR while others are dispensable
(128).  In  order  to  study  the  effect  of  the  microbiota  dysbiosis  upon  antibiotic
administration on colonization and persistence of MRE, we used a mouse model and an
MRE strain belonging to the species  Klebsiella pneumoniae  (MRKP). This strain was
previously isolated in Memorial Sloan Kettering Cancer Center from the bloodstream of
a hospitalized patient (85). Mice received different antibiotic treatments, as described in
Methods.  Briefly,  animals  were  treated  during  1  week  with  different  antibiotics
frequently  used  in  hospitals  (ampicillin,  vancomycin,  neomycin)  and  infected  with
MRKP the day before the cessation of the treatment. Fecal samples were collected after 1
week of treatment and before infection in order to determine the microbiota composition
and  levels  of  colonization  with  MRKP  in  these  mice.  Yue  &  Clayton  measure  of
microbiota dissimilarity, which takes into account the similarity in the relative abundance
of the identified OTUs, and PCoA were used to compare the microbiota structure of
samples obtained from mice after 1 week of treatment with different antibiotics (Figure
R1). The microbiota composition in samples obtained from mice treated with antibiotics
differed  from that  one  of  the  untreated  group (AMOVA, p<0.01).  Specifically, mice
treated with ampicillin or vancomycin had a more different microbiota compared to the
control (ampicillin p= 0.005; vancomycin p= 0.006) than those treated with neomycin
(p= 0.01).
73
Role of intestinal dysbiosis on gut colonization by bacterial pathogens
Figure  R1.  Effect  of  antibiotic  treatment  on  murine  intestinal  microbiota.  PCoA of the  overall
microbial structure obtained from Yue & Clayton values calculated in samples collected from mice treated
for 1 week with ampicillin, vancomycin and neomycin, and from samples obtained from a control group of
mice  that  did  not  receive  antibiotics.  Each  point  corresponds  to  1  fecal  sample.  Distance  between  2
samples  is  a  measure of  overall  microbial  dissimilarity  between these 2 samples-  the closer  they are
located on the graph, more similar is their microbial composition. The 2 principal coordinates (PC1 and
PC2) that explain most of the variability in the samples are shown. N= 5 mice per group.
These differences can be also observed in  Figure R2, a heatmap representing
the 200 most abundant OTUs identified in these mice. As can be seen in this figure, both
vancomycin and ampicillin depleted most of the OTUs present in untreated mice, while
neomycin treatment induced lower changes.
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Figure R2. The effect of different antibiotic treatments on OTU abundances. While ampicillin and
vancomycin treatment depleted the abundances of a high number of the OTUs present in mice, neomycin
treatment  induced  lower  changes.  Heatmap  representing  percentage  of  the  abundances  of  200  most
abundant OTUs (N= 5 mice per group).
A similar effect of the antibiotics could be observed at the genera level (Figure
R3). The abundances of 31 most abundant genera (with mean abundance >0.01%) did
not  differ  after  neomycin  treatment  (Figure  R3).  In  contrast,  mice  treated  with
vancomycin  had  drastic  changes  at  the  genus  level,  including  lower  abundances  of
genera belonging to the phylum Bacteroidetes and Firmicutes, while genera belonging to
the  phylum  Proteobacteria  underwent  a  drastic  expansion  (i.e.  Parasutterella and
Escherichia). Moreover, as previously described  (65), bacterial genera that represented
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minor populations in untreated mice became dominant in antibiotic-treated mice (e.g.
Akkermansia  expansion upon vancomycin treatment). On the other hand,  mice treated
with ampicillin had significantly higher levels of Proteobacteria, including the expansion
of the genus Parasutterella. In order to have an estimate of the total number of changes
induced by the different antibiotics, the non-parametric Wilcoxon test was applied. To
avoid false positives, the FDR was subsequently applied. This analysis confirmed that
ampicillin  and  vancomycin  treatment  produced  drastic  changes  in  the  microbiota
composition. Specifically, ampicillin treatment affected the abundances of 30 out of the
44  analyzed  genera  (FDR<0.1).  When  using  a  more  stringent  FDR  threshold
(FDR<0.05), the abundance of 29 genera differed between mice treated with ampicillin
and untreated mice. Similarly, vancomycin treatment resulted in altered abundances of
39 genera (FDR<0.1), or 36 when a more stringent threshold was applied (FDR<0.05),
compared to abundances observed in untreated animals. On the other hand, neomycin
treatment resulted in  altered abundances  of only 7 genera (FDR<0.1).  When using a
more  stringent  threshold  (FDR<0.05),  no  differences  at  the  genus  level  were  found
between the microbiota of neomycin treated mice compared to that of untreated animals.
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Figure R3. The effect  of different antibiotic treatments on abundances of the 31 most abundant
genera. Ampicillin and vancomycin treatment produced drastic changes in the microbiota composition (30
and 39 out of 44 analyzed genera were altered, respectively), while neomycin treatment altered abundances
of  only  7  genera  (FDR<0.1).  Each  bar  represents  the  microbiota  of  1  mouse.  The most  predominant
bacterial  taxa  (mean  abundance  >0.01%)  are  shown  and  labeled  with  different  colors  as  indicated.
Bacterial taxa were obtained by classification of 16S rDNA sequences to the genus level using Mothur. In
case a sequence could not be classified to the genus level, the closest level of classification to the genus
level was given, preceded by “unclassified_”. N=5 mice per group.
Importantly, differences in the microbiota  composition as a result  of distinct
antibiotic treatments were reflected in the levels of colonization with MRKP (Figure
R4A). As expected, MRKP was not able to colonize untreated mice. On the other hand,
CR was not impaired in mice treated with neomycin: MRKP was undetectable in 4 out of
5 mice treated with neomycin 2 days post-infection (Figure R4A). These results suggest
that  the  minor  changes  induced  by  neomycin  did  not  impair  the  capacity  of  the
microbiota  to confer  protection against  MRKP. However, ampicillin  and vancomycin
treatment disrupted CR and allowed MRKP to colonize the intestine at high levels.
77
Role of intestinal dysbiosis on gut colonization by bacterial pathogens
Figure R4. MRKP levels of intestinal colonization on days following infection in mice that did not
receive antibiotics (control) or mice treated with different antibiotics. (A) MRKP intestinal levels on
the day 2 post-infection: while neomycin treated mice had intact CR, mice treated with ampicillin and
vancomycin  were  highly  susceptible  to  MRKP  colonization.  (B) Mice  treated  with  ampicillin  and
vancomycin remained  colonized  with MRKP for  1  month after  the infection and antibiotic  cessation,
although a high variability in the intestinal levels of MRKP was observed among different mice. Values are
represented in logarithmic scale and reflect  the number of CFUs identified in 20mg of fecal  material.
Horizontal lines represent the mean and +/- SEM.
In  order  to  study  the  capacity  of  the  murine  microbiota  to  recover  upon
antibiotic  treatment  and  suppress  MRKP  in  those  mice  in  which  MRKP  could
successfully colonize the intestinal tract (i.e. ampicillin and vancomycin treated mice),
both the microbiota composition and the fecal levels of MRKP were analyzed up to 4
weeks  post  MRKP colonization  and  subsequent  antibiotic  withdrawal.  As  shown  in
Figure R5 (OTU level) and  Figure R6  (genus level), mice treated with ampicillin or
vancomycin  did not  completely recover  their  original  microbiota  even 4 weeks after
antibiotic cessation (AMOVA, p= 0.009 and p= 0.007 for ampicillin and vancomycin
recovery respectively compared to untreated mice). Interestingly, the level of recovery at
the OTU level was different depending on the mouse. While some mice recovered the
majority of the baseline most prevalent OTUs (up to 53% of the OTUs present in all
untreated mice- N= 95), in others, only 9% of the prevalent baseline OTUs could be
detected 4 weeks after antibiotic withdrawal.
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Figure R5. The capacity of the OTUs present in the mice intestine to recover upon withdrawal of
antibiotic  treatment.  Mice  treated  with  ampicillin  or  vancomycin  did  not  completely  recover  their
original  microbiota  even  4  weeks  after  antibiotic  cessation.  Heatmap  representing  percentage  of  the
abundances of the 200 most abundant OTUs present in the analyzed mice (N= 5 mice per group).
Accordingly  to  the  incomplete  recovery  of  the  microbiota,  4  weeks  post-
infection,  all  mice  treated  with  ampicillin  or  vancomycin,  were  still  colonized  with
MRKP, although the levels of colonization were lower than those detected 2 days post
infection (Figure R4B). Besides, a high variability in the intestinal levels of MRKP was
observed among the different mice analyzed, probably due to the different microbiota
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recovery observed in these animals. These results suggest that an incomplete recovery of
the microbiota upon ampicillin or vancomycin treatment may allow MRKP persistence in
the intestinal tract of mice, although to a different extent depending on the mouse.
Figure R6. The capacity of the most abundant genera present in the mice intestine to recover upon
antibiotic treatment. The abundances of the most abundant genera remained altered up to 4 weeks after
the cessation of the ampicillin (12 genera) or vancomycin (29 genera) treatment (Wilcoxon test, FDR<0.1).
Each bar represents the microbiota of 1 mouse. The most predominant bacterial taxa are shown and labeled
with different colors as indicated. Bacterial taxa were obtained by classification of 16S rDNA sequences to
the genus level using Mothur. In case a sequence could not be classified to the genus level, the closest level
of classification to the genus level was given, preceded by “unclassified_”. N= 5 mice per group.
Although  the  results  indicate  that  a  single  antibiotic,  such  as  ampicillin  or
vancomycin, is capable of promoting MRKP intestinal colonization, hospitalized patients
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are frequently treated with multiple antibiotics at the same time. To test the effect of a
combination  of  antibiotics  on  CR,  mice  were  treated  with  a  cocktail  of  antibiotics
containing ampicillin, vancomycin and neomycin (AVN). As described previously, mice
were infected with MRKP 1 day before the cessation of the treatment. As expected, mice
treated with AVN were highly susceptible to MRKP intestinal colonization (Figure R7).
Indeed, MRKP intestinal levels 2 days post-infection were slightly higher compared to
mice that received ampicillin or vancomycin alone (mean value of MRKP detected on
day  2  post-infection  in  AVN  treated  mice  was  1.18E+08,  while  in  ampicillin  and
vancomycin treated mice it was 4.22E+07 and 2.48E+07 respectively). Moreover, high
MRKP intestinal levels were maintained in all mice 4 weeks upon antibiotic cessation.
Figure R7. The effect of antibiotic cocktail on MRKP intestinal levels of colonization.  MRKP fecal
levels on different days, following infection of mice previously treated with AVN for 1 week (N= 8 mice
per group). One day after infection AVN treatment was stopped. Values are represented in logarithmic scale
and reflect the number of CFUs identified in 20mg of fecal material. Horizontal lines represent the mean
and +/- SEM.
Consistent with the previous obtained results, regarding the long lasting changes
induced by vancomycin and ampicillin in the microbiota composition, mice treated with
the  combination  of  the  3  antibiotics  and  infected  with  MRKP did  not  recover  their
baseline microbiota even 4 weeks upon antibiotic withdrawal (Figure R8). Specifically,
the abundance of 25 genera and 147 OTUs remained altered even 4 weeks after AVN
cessation (Wilcoxon test, FDR<0.1). Thus, a cocktail of antibiotics promoted drastic and
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long lasting changes in the microbiota composition, and allowed MRKP persistence in
the intestinal tract of mice to a higher extent than therapy with single antibiotics.
Figure R8. The long-lasting effects of an antibiotic cocktail containing ampicillin, vancomycin and
neomycin  on  the  fecal  microbiota  composition  of  mice. Mice  were  treated  with  AVN for  1  week.
Subsequently mice were infected with MRKP and the antibiotic treatment was stopped. Microbiota of fecal
samples was analyzed 4 weeks after antibiotic withdrawal. (A) Heatmap representing the percentage of the
abundances of the 200 most abundant OTUs identified in analyzed mice.  (B) Bargraphs representing the
microbiota composition at the level of genus of the analyzed mice. The most predominant bacterial taxa
are shown and labeled with different colors as indicated. Bacterial taxa were obtained by classification of
16S rDNA sequences to the genus level using Mothur. In case a sequence could not be classified to the
genus level, the closest level of classification to the genus level was given, preceded by “unclassified_”.
N=5 mice per group.
 4.1.2 Long-lasting changes in the microbiota composition as a result of antibiotic
treatment promote MRKP intestinal colonization
The results obtained from previous experiments suggested that the inability of
the microbiota to recover its baseline state upon antibiotic cessation allowed MRKP to
persist in the mouse intestine. However, it  could be possible that MRKP colonization
suppresses microbiota recovery, allowing the pathogen to persist in the intestinal tract. To
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test the capacity of the microbiota to recover upon antibiotic withdrawal, in the absence
of pathogen colonization, mice were treated with AVN and the microbiota was allowed to
recover for 2 or 4 weeks before its analysis by 16S rRNA sequencing (Figure M1). As
shown in  Figure R9A,  the intestinal microbiota was not able to recover even in the
absence of the pathogen (AMOVA, p= 0.004). Importantly, mice that were allowed to
recover for 2 or 4 weeks after antibiotic administration were still highly susceptible to
MRKP  intestinal  colonization  (Figure  R9B).  MRKP  intestinal  levels  in  both  mice
infected 2 or 4 weeks after the antibiotic withdrawal were significantly higher compared
to those observed in untreated mice (Wilcoxon test,  p<0.05). Altogether, these results
suggest  that  AVN  indeed  induces  long-lasting  changes  in  the  composition  of  the
microbiota,  which  impair  CR  and  allow  high  levels  of  intestinal  colonization  and
persistence by MRKP.
Figure  R9.  The  long-lasting  effect  of  antibiotic  treatment  on  the  microbiota  composition  and
colonization resistance against MRKP. (A) Microbiota of untreated mice (Control) and mice that were
treated  with  AVN  for  1  week  and  left  to  recover  for  4  weeks  (AVN_4w).  Each  bar  represents  the
microbiota of 1 mouse. The most predominant bacterial taxa are shown and labeled with different colors as
indicated. Bacterial taxa were obtained by classification of 16S rDNA sequences to the genus level using
Mothur. In case a sequence could not be classified to the genus level, the closest level of classification to
the genus level was given, preceded by “unclassified_”. (B) MRKP levels of colonization on the first day
after  the  infection  in  groups  of  mice  that  were  infected  (i)  the  day  before  the  cessation  of  the AVN
treatment (AVN), (ii) 2 weeks after the end of the treatment (AVN_2w), (iii) 4 weeks after the end of the
treatment (AVN_4w). MRKP intestinal levels in all 3 groups were significantly higher compared to those
observed  in  untreated  mice  (Wilcoxon  test,  **p<0.01,  *p<0.05,  N=  5  mice  per  group).  Values  are
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represented in logarithmic scale and reflect  the number of CFUs identified in 20mg of fecal  material.
Horizontal lines represent the mean and +/- SEM. N= 5 mice per group.
 4.1.3 Restoration of the CR and suppression of MRKP colonization
 4.1.3.1 Restoration of  the microbiota with a fecal  transplant suppresses MRKP
intestinal colonization
It has been shown previously that a fecal transplant can restore the microbiota
composition  upon  antibiotic  treatment,  and  suppress  the  intestinal  colonization  by
pathogens such as VRE or C. difficile (23,129). To fully demonstrate that the incomplete
recovery of the microbiota upon antibiotic cessation was responsible for the intestinal
colonization by MRKP, mice treated with AVN were orally gavaged with feces from
healthy,  untreated  mice  during  3  consecutive  days  after  antibiotic  withdrawal,  as
described in Methods (Figure M1). Mice were left for 11 days (in total 2 weeks after the
end of the treatment) to re-establish the administered microbiota before the infection with
MRKP was performed. Notably, microbiota composition of mice that received a fecal
transplant highly resembled that one from untreated animals (Figure R10A). To test if
restoration of the microbiota after antibiotic treatment restores CR, mice were infected
with MRKP and the levels of colonization were analyzed 1 day after the infection. As
shown  in  Figure  R10B,  the  levels  of  colonization  1  day  after  the  infection  were
significantly lower (Man-Whitney test, p<0.01) in the group of mice that received the
fecal transplant compared to the group of mice that did not received it,  but was also
treated  with  antibiotics.  Indeed,  in  3  out  of  5  mice  to  which  fecal  transplant  was
administered,  MRKP was undetectable.  Moreover, levels of colonization in mice that
received the fecal transplant were not different from the levels of MRKP in mice that
were not treated with AVN, and thus had an intact microbiota. These results confirm that
long-lasting  changes  in  the  microbiota  composition,  promoted  by  the  antibiotic
treatment, are responsible for MRKP intestinal colonization.  In addition, these results
demonstrate that the loss of CR against MRKP upon antibiotic administration can be
restored by oral gavage with feces from untreated mice.
84
Results
Figure  R10.  Restoration  of  the  microbiota  with  a  fecal  transplant  suppresses  MRKP intestinal
colonization. (A) Fecal microbiota, 2 weeks after AVN treatment cessation, of mice that received a fecal
transplant for 3 consecutive days, starting 1 day after antibiotic withdrawal (AVN_F). For comparison, the
fecal microbiota o untreated mice (Control) is shown. Each bar represents the microbiota of 1 mouse. The
most predominant bacterial taxa are shown and labeled with different colors as indicated. Bacterial taxa
were  obtained  by  classification  of  16S  rDNA sequences  to  the  genus  level  using  Mothur.  In  case  a
sequence could not be classified to the genus level, the closest level of classification to the genus level was
given,  preceded by  “unclassified_”.  (B) MRKP levels  of  colonization 1  day  after  the  infection  in  (i)
untreated mice, (ii) mice that were treated with AVN and left to recover during 2 weeks after the end of the
treatment (AVN_2W), and (iii) mice to which, besides treatment and the 2 week recovery period, fecal
transplant  was administered for 3 consecutive days,  starting 1 day after antibiotic cessation (AVN_F).
Man-Whitney  test  was  performed  for  analyzing  differences  in  colonization  levels  between  2  groups
(**p<0.01, ns-not significant). Values are represented in logarithmic scale and reflect the number of CFUs
identified in 20mg of fecal material. Horizontal lines represent the mean and +/- SEM. N= 5 mice per
group.
 4.1.3.2 Effect  of  the  administration  of  fecal  microbiota  anaerobic  cultures  in
restoring CR against MRKP after antibiotic treatment
Previous  studies  have  shown  that  CR  against  VRE,  lost  upon  antibiotic
administration,  could  be  restored  not  only  with  a  fecal  transplant,  but  also  with  the
administration  of  an  anaerobic  culture  of  the  fecal  microbiota  (23).  This  approach
allowed  the  authors  to  identify  commensal  bacteria  that  were  involved  in  resistance
against VRE colonization, and if successful, would be of great help for the development
of  novel  therapeutic  approaches  to  inhibit  MRKP  intestinal  colonization.  For  these
reasons, an experiment was performed in order to test if CR against MRKP could be
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restored by administration of anaerobic microbiota cultures to antibiotic treated mice. For
this purpose, mice treated with AVN were orally gavaged with various anaerobic cultures
of the microbiota, obtained by cultivation of feces from untreated mice in different types
of anaerobic media. As in the experiment explained in the previous section, mice were
treated with AVN during 1 week. After the cessation of the treatment, fecal suspension or
anaerobic cultures were administered during 3 consecutive days. MRKP infection was
performed 2 weeks after antibiotic treatment withdrawal. Media used for cultivation of
bacteria  present  in  feces  were  Schaedler,  Gut  media,  Wilkinson,  and  Sellers.
Unfortunately, none of the cultures administered to mice treated with AVN was able to
consistently  suppress  MRKP  colonization,  while  fecal  transplant  reduced  MRKP
colonization levels significantly (Wilcoxon test, Figure R11).
Figure R11. No anaerobic culture of the fecal microbiota suppresses consistently MRKP colonization.
MRKP fecal levels 1 day after the infection of mice treated with AVN and left to recover during 2 weeks
before the infection. The different groups of mice received after antibiotic withdrawal during 3 consecutive
days: PBS (AVN_2W), feces from untreated mice (AVN_F) or fecal microbiota cultures obtained from the
cultivation of  feces  in Schaedler  (SCH), Gut media (GM), Wilkinson (W),  and Sellers  (S) cultivation
media. Wilcoxon test was applied for analyzing differences in colonization levels between different groups
of  mice  (ns-not  significant,  ***p<0.001).  Values  are  represented  in  logarithmic  scale  and  reflect  the
number of CFUs identified in 20mg of fecal material. Horizontal lines represent the mean and +/- SEM.
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 4.1.3.3 Identification of bacteria that could provide CR against MRKP
Since no anaerobic microbiota culture was able to suppress MRKP colonization,
and in order to identify bacteria that could potentially provide CR against MRKP, an
attempt  to  determine  the  commensal  bacteria  that  were  not  able  to  recover  upon
antibiotic  cessation  was  performed.  For  this,  the  microbiota  of  untreated  mice  was
compared with that one of mice that received AVN and were allowed to recover for 4
weeks. Our hypotheses was that some of the commensal bacteria that were not recovered
in mice susceptible to MRKP colonization could be relevant in conferring CR against
MRKP. For this comparison, LEfSe algorithm for microbiota biomarker discovery was
applied  (124).  LEfSe determines  those  members  of  microbiota  (with  a  highest  LDA
score) that  most  likely  explain  differences  between groups that  are  being  compared,
which is why this algorithm was used for identification of commensal bacteria that could
provide protection against MRKP in antibiotic treated mice.  Analysis of the microbiota
composition revealed profound changes, induced by antibiotics, in mice that were treated
with  AVN and allowed to recover  for  1  month.  Specifically, LEfSe revealed  altered
abundances  of  12  bacterial  genera  between  the  2  groups  under  comparison  (Figure
R12A).  Specifically,  the  genera  Barnesiella,  Alistipes,  Bacteroides,  Lactobacillus,
Mucispirillum,  Prevotella,  Adlerecreutzia, Odoribacter,  Butyricicoccus  and
Subdoligranulum were identified to be more abundant in untreated mice as compared to
mice  that  recovered  from  AVN  treatment  (Figure  R12A).  Therefore,  these  bacteria
represent potential candidates involved in protection against MRKP. On the other hand,
the  genera  Staphylococcus and  Dorea were  represented  in  higher  abundances  in  the
group of treated mice. In addition, 8 more taxa were also differently abundant between
these 2 groups, although it was not possible to classify them to the genus level.
After a major cultivation and taxonomic identification effort (more than 1,500
colonies were screened as described in Methods), we were able to isolate the genera with
the  highest  LDA  score  (Barnesiella,  Alistipes,  Bacteroides,  Lactobacillus  and
Mucispirillum,  Figure  R12B).  As indicated  in  the  next  section,  these  bacteria  were
administered to mice treated with AVN in order to confirm their role in CR.
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Figure R12. Changes in the microbiota composition in mice that were allowed to recover for 1 month
after AVN treatment. (A) Taxa selected by LEfSe as biomarkers of dysbiosis produced by AVN treatment.
In green are indicated those bacteria that were more abundant in untreated mice and in red are indicated
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those bacteria that were more abundant in AVN treated mice. (B) Relative abundances (%) of 5 genera with
the highest LDA score (those that better differentiate the microbiota of both groups of mice) were  higher
in untreated mice. These bacteria were selected for testing their effect on restoration of MRKP colonization
resistance.
 4.1.3.4 A commensal bacterial mix partially restores MRKP colonization resistance
after antibiotic therapy
In order to test the role of the 5 selected bacteria that were most affected by
AVN treatment on MRKP colonization resistance, a mix containing 5 murine commensal
bacterial strains, each belonging to one of the selected genera (Barnesiella, Alistipes,
Bacteroides, Lactobacillus  and Mucispirillum) was prepared as described in Methods.
The  attempt  to  restore  the  intestinal  microbiota  was  performed  as  in  the  previous
experiment,  in  which  the  capacity  of  a  fecal  transplant  for  restoring  CR was tested.
Briefly, mice were treated with AVN during 1 week. Upon the cessation of the treatment,
a mix containing the 5 commensals was administered to mice during 3 consecutive days.
Mice were infected 11 days after the last day of bacterial administration in order to allow
the establishment of the introduced bacterial strains. Importantly, administration of the
mix  containing  Barnesiella,  Alistipes,  Bacteroides,  Lactobacillus  and Mucispirillum
strains  resulted  in  reduction  of  MRKP  colonization  levels  of  almost  4  orders  of
magnitude as compared to mice that did not received the bacterial mix (Figure R13A).
Although suppression of the colonization was not complete, reduction in MRKP levels
on first day post-infection was statistically significant, indicating that the bacteria present
in  the  mix  of  5  commensal  strains  could  partially  restore  resistance  against  MRKP
colonization.
Although  unlikely,  it  was  possible  that  the  same  reduction  in  MRKP
colonization levels could be achieved with other bacterial strains. In order to confirm that
the effect  on CR produced by administration of  the mix of the 5 commensal  strains
(MIX5) was due  to  the  bacteria  present  in  the  mix,  and would not  be  produced by
administering any type of bacteria,  anaerobic culture obtained by cultivation of feces
from untreated mice in Gut media (GM) was administered to another group of mice
treated  with  AVN.  Culture  harvested  from Gut  media  was  chosen  since  in  previous
experiments it  was shown that administration of this  anaerobic culture did not affect
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MRKP colonization levels. As in the previous experiment, mice were administered GM
during 3 consecutive days,  starting 1 day after  antibiotic  cessation.  After  11 days of
recovery, mice were infected with MRKP. As expected, no protection against MRKP was
observed in those mice that received GM (Figure R13B).
It is important to indicate that antibiotic treatment can result in reduction of total
bacterial  density,  which  could  promote  MRKP  intestinal  colonization.  In  order  to
investigate if the effect of the MIX5 on CR was the result of restoration of bacterial
density, 16S rRNA quantitative PCR was performed.  Notably, the intestinal  bacterial
density of mice treated with AVN was lower in those mice that were allowed to recover
for  2  weeks  without  receiving  the  MIX5  (Wilcoxon  test  p<0.01;  Figure  R13C).
Nevertheless, the bacterial load of fecal samples collected from mice to which GM was
administered did not differ from that one of mice that received the MIX5. These results
suggest  that  the  protection  conferred  by  the  mix  containing  Barnesiella,  Alistipes,
Bacteroides, Lactobacillus and Mucispirillum strains is not the result of the recovery of
the  bacterial  density,  but  rather  is  due  to  a  specific  mechanism  that  should  be
investigated.
Figure  R13.  A commensal  bacterial  mix  partially  restores  MRKP colonization  resistance  after
antibiotic therapy. (A) Group of mice that received the bacterial MIX5 containing Barnesiella, Alistipes,
Bacteroides,  Lactobacillus and  Mucispirillum had significantly lower levels  of  MRKP 1 day after  the
infection  (Man-Whitney  test,  ***p= 0.0002,  N=  8  mice  per  group  from 2  independent  experiments)
compared to mice treated with AVN and allowed to recover without receiving the MIX5. (B) The MRKP
colonization levels 1 day post-infection in mice that received anaerobic fecal microbiota culture harvested
from Gut media (GM) did not differ from those identified in mice treated with AVN that were allowed to
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recover without receiving GM (N= 8 mice per group from 2 independent experiments). (C) Bacterial load
in samples collected from mice that received the 2 types of commensal bacterial mix quantified by qPCR
of the 16S rRNA gene.
 4.1.3.5 Partial microbiota recovery after administration of the bacterial mix
Sequencing  was  performed  in  order  to  investigate  changes  in  microbiota
produced by administration of the 5 probiotics. Yue & Clayton measure of dissimilarity
was applied in order to assess the overall microbial composition. Analysis revealed that
samples obtained from mice to which Barnesiella, Alistipes, Bacteroides, Lactobacillus
and Mucispirillum were administered differed from mice to which no bacterial mix was
given (AMOVA p<0.001, Figure R14A). The same result was obtained when comparing
samples obtained from mice to which GM was administered with the group that did not
received any bacterial mix (AMOVA p= 0.002, Figure R14A). As expected, microbiota
from mice that received the GM significantly differed from mice that received the MIX5
(AMOVA,  p<0.001),  suggesting  recovery  of  a  distinct  microbiota.  Previous  studies,
using a mix of commensal bacteria to confer protection against intestinal colonization by
other pathogens (i.e.  C. difficile) have shown that a bacterial mix could restore overall
microbial diversity which in turn may enhance the elimination of the pathogen (100). In
order to investigate if lower levels of MRKP in the group of mice treated with the mix of
5 commensal strains could be due to an increase in overall microbial diversity, Shannon
index was calculated. The obtained results indicate that there were no difference in the
Shannon diversity index between mice that did not receive any bacterial mix, mice to
which the mix of 5 bacterial strains was administered, and mice to which the anaerobic
culture  harvested  from  Gut  media  was  given  (One-way  ANOVA,  Figure  R14B).
Subsequently, analysis  was performed in order to investigate if all  5 bacterial  strains
from MIX5 could  re-colonize  the  intestine  of  antibiotic  treated  mice,  and  therefore,
reverse the microbiota alterations produced as a result of antibiotic treatment. Notably,
only  Lactobacillus  (p= 0.0045) and  Barnesiella (p= 0.0003) genera were significantly
more abundant in mice after the administration of the MIX5 compared with mice to
which no commensal bacteria was given. Moreover, the abundances of these 2 genera in
mice to which MIX5 was administered were even higher as compared with untreated
mice (Wilcoxon test,  Lactobacillus p= 0.0016,  Barnesiella p= 0.0062), suggesting that
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Lactobacillus and Barnesiella not only were able to colonize the intestine of mice after
antibiotic treatment, but also reach even higher levels than those observed in untreated
mice. On the other hand, no increase was observed in the levels of Alistipes, Bacteroides
or Mucispirillum, the other commensal bacteria administered in the MIX5. Importantly,
the abundance of Lactobacillus in mice to which MIX5 was administered was similar to
the  levels  obtained  after  administration  of  GM.  Indeed,  Barnesiella was  the  only
bacterial  genus  included  in  the  MIX5  that  was  recovered  specifically  in  mice  that
received the protective mix, and was absent from mice treated with the non-protective
GM, suggesting that  this  bacterium may be key in conferring colonization resistance
against MRKP colonization in mice.
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Figure R14. Partial microbiota recovery after the administration of the protective bacterial mix. (A)
The overall microbial composition based on Yue & Clayton measure of dissimilarity. Samples collected
from mice to which no probiotic was given (AVN_2w) differed from samples collected from animals to
which mix of 5 probiotics was administered (MIX5) and mice to which the anaerobic culture harvested
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from Gut media (GM) was administered (AMOVA, p<0.001). (B) Shannon index revealed similar diversity
between the 3 groups of mice (One-way ANOVA, ns-not significant).  (C)  Abundances of the 5 bacteria
that were administered in the protective mix (MIX5) in mice after administration of the MIX5, mice to
which  no  commensal  bacteria  was  administered  (AVN_2w),  and  mice  that  received  GM.  Only
Lactobacillus (**p=0.0045) and Barnesiella (***p=0.0003) increased after administration of the MIX5 as
compared to the group of mice that did not receive the mix.
Due to a deadline for writing and finishing this  thesis,  we were not  able  to
perform several experiments to corroborate the role of Barnesiella in resistance against
MRKP  and  identification  of  the  possible  mechanisms  of  protection.  These  future
experiments  are  discussed  in  the  Discussion  section.  We did  test  if  Barnesiella or
Lactobacillus could inhibit the growth of MRKP in vitro, however no inhibition could be
detected  suggesting  that  the  protection  against  colonization  is  not  due  to  the  direct
production  of  an  inhibitory  molecule  (e.g.  bacteriocins),  or  that  this  product  is  not
synthesized in sufficient amounts under the tested conditions.
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 4.2 Microbiota dysbiosis and MRE colonization in hospitalized patients
 4.2.1 Prevalence and characterization of MRE in acute leukemia patients
In order to investigate how microbiota promotes CR and prevents colonization
with MRE in humans, and if the same bacteria could be responsible for the inhibition of
MRE colonization in humans as observed in mice, fecal samples from patients with acute
leukemia were collected during a period of 18 months.  As previously mentioned, these
patients  are  often  colonized  with  MRE probably  due  to  low CR because  of  severe
antibiotic therapy, which makes them suitable for this study.  Sampling was performed
weekly during their hospitalization, allowing the collection of samples from the same
patient  at  different  time points.  All  fecal  samples  were  cultivated  in  ESBL selective
media in order to detect the levels of MRE intestinal colonization.  In order to confirm
that strains detected by cultivation of samples in ESBL plates correspond to MRE, 5
colonies (or the number of colonies available, in case the total number of colonies per
sample was <5) were isolated from each positive plate and subjected to determination of
sensitivity to different antibiotics and taxonomic identification. All strains isolated from
acute leukemia patients were resistant to at least 3 antibiotics that belong to different
antimicrobial categories and to which the strain does not have intrinsic resistance (MRE
definition indicated by Magiorakos et al. (80)). Thus, all strains that were identified were
indeed multidrug resistant. The prevalence of resistances to different antimicrobials in
strains isolated from acute leukemia patients during this study is represented in  Table
R1. Importantly, the majority of the isolated MRE strains are susceptible to amikacin.
Amikacin belongs to the group of aminoglycosides, and it is often used in combination
with tigecycline, showing promising efficacy both in vitro and in vivo in the critically ill
host  (81). Interestingly, the prevalence of resistance to tigecycline is low among MRE
strains  analyzed  in  this  study,  except  for  the  strains  that  belong  to  the  genus
Enterobacter, which in 48% of the cases are resistant to this antibiotic. Nevertheless, for
those infections produced by Echerichia or  Citrobacter strains isolated from this study,
the combination of amikacin and tigecycline treatment would be a good choice. On the
other hand, the prevalence of the MRE strains resistant to ciprofloxacin, an antibiotic that
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belongs to the group of fluoroquinolones and is used as prophylaxis in acute leukemia
patients, was high. Furthermore, the percentage of MRE strains isolated in this study and
resistant  to  cefuroxime  (second  generation  beta-lactam  antibiotic)  or  cefotaxime
(extended  spectrum beta-lactamase  antibiotic)  is  extremely  high,  confirming  that  the
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During the study period, fecal samples were collected from 140 acute leukemia
patients in total (Figure R15A). The number of patients positive to MRE at least once
was 84 (60%), while 56 (40%) patients never got colonized with an MRE. We collected
817 samples, out of which 227 (27.78%) were positive to MRE while 590 (72.22%) were
negative  (Figure  R15B).  The  most  frequently  isolated  MRE  belonged  to  genus
Escherichia  (31.39% of  positive  samples).  The  other  most  predominant  MRE  were
Citrobacter (28.83%), Klebsiella (25.91%), Enterobacter (6.93%), Morganella (4.74%),
Raoultella (1.09%),  Proteus (0.73%).  In addition,  Serratia was  detected in  1 sample
(0.36%) (Figure R15C).
Figure R15. Prevalence of MRE positive patients (A), samples (B) and MRE types (C) in this study.
 4.2.2 Non-microbiota variables associated with MRE intestinal levels
In the previous chapter, we have defined commensal species that may be key for
conferring protection against MRE using a mouse model. Experiments with mice allow
the control of other variables, beside the microbiota, that could impact MRE colonization
levels  (e.g.  all  mice  have  the  same immune  status,  gender,…).  However,  studies  in
patients cannot be controlled to such extent, and other variables, besides the microbiota,
that could impact MRE intestinal colonization should be also taken into account. For this
reason, we first studied how different variables (including clinical variables) could affect
MRE intestinal  colonization levels.  For this  purpose,  clinically  relevant  data  such as
immune  status  of  the  patient,  antibiotics  received,  underlying  diseases,  etc.  were
collected  for  each  analyzed  patient.  In  addition,  other  data  that  could  impact  MRE
intestinal  colonization  (i.e.  gender,  age)  were  also  taken  into  account.  All  variables
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analyzed could be divided in 2 groups. The first group is composed of those variables
that do not vary with time (gender, type of leukemia patient suffered, age, type of MRE
detected in the sample, type of admission- if the sample was collected during admission
during  which  chemotherapy  or  transplant  were  performed).  Temporal  variables  were
included in the second group of clinical factors (antibiotic treatment, neutropenia: low
number of neutrophils, parenteral nutrition: intravenous nutrition in which the normal
process of digestion is bypassed, mucositis: inflammation of the oral and gastrointestinal
mucosa,  antifungal  treatment).  Due  to  the  different  nature  of  the  studied  variables,
analysis of their effect on MRE intestinal colonization levels was performed differently
for temporal and non-temporal variables, as will be explained below.
 4.2.2.1 Impact of non-temporal variables on MRE intestinal levels
For  the  analysis  of  the  effect  of  non-temporal  variables  all  MRE  positive
samples (N= 227) were grouped into categories defined by a particular variable (e.g.
gender: samples were divided in those collected from male or female) (Figure R16).
Wilcoxon test revealed that there were no significant differences in the levels of MRE
colonization in males compared to females (Figure R16A). In order to investigate if the
age of the patient at the moment of sampling could be associated with MRE colonization
levels, linear regression analysis was performed. There was no significant association
between the  MRE levels  and  the  age  of  the  patients  (Figure R16B).  As  previously
described  in  Methods,  patients  included  in  this  study  were  diagnosed  with  acute
leukemia, which could be divided in 2 groups depending on the immune cells affected by
the  disease:  lymphoblastic  or  myeloid.  Patients  with  myeloid  leukemia  had  slightly
higher intestinal levels of MRE, although the observed difference was not statistically
significant (Wilcoxon test p= 0.08,  Figure R16C). Since it was possible that not every
MRE taxonomic type was able to colonize the intestine at same level, Kruskal-Wallis test
was performed on the levels of colonization of different taxonomic types of MRE. Only
MRE  that  were  detected  in  at  least  5  samples  were  included  in  this  analysis  (i.e.
Escherichia, Citrobacter, Klebsiella,  Enterobacter, Morganella).  The analysis revealed
no differences  in  the  intestinal  colonization  levels  between the  different  MRE types
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identified, suggesting that all MRE types are equally capable of colonizing the intestinal
tract (Figure R16D).
Figure R16. Effect of gender, age, type of leukemia and type of MRE on MRE colonization levels.  (A)
The levels of MRE in males (M) and females (F) was not statistically different (Wilcoxon test, ns-not
significant). (B) Linear regression on MRE levels depending on age (years) of the patient at the moment of
sampling  revealed  no  association  between MRE levels  and  patient’s age.  (C) The  levels  of  MRE in
samples collected from patients with lymphoblastic leukemia (ALL) are slightly lower but not significantly
different (Wilcoxon, ns) from those measured in samples collected from patients with myeloid leukemia
(AML). (D) MRE levels depending on taxonomic type of MRE detected in the sample (Escherichia- Esch.,
Citrobacter-  Citro.,  Enterobacter-  Entero.,  Klebsiella-  Kleb.,  Morganella-  Morg.).  Only  MRE  types
detected in more than 5 samples are represented. Kruskal-Wallis revealed no differences between different
groups (ns). Levels of colonization are represented in logarithmic scale per gram of fecal material. Mean
and +/- SEM are plotted. Numbers above each bar stand for number of samples (n) and number of patients
from which samples were collected (m).
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As mentioned before, due to their health status, patients are spending long time
intervals in the hospital where they undergo 1 or more rounds of chemotherapy and some
of them also receive a transplant. The chemotherapy is initiated immediately after the
admission to the hospital, which is why all samples collected during this admission are
grouped together and analyzed as a non-temporal  variable.  For this  reason,  levels of
MRE in samples  collected  during chemotherapy were compared to  those in  samples
collected during the transplant period. Interestingly, Wilcoxon test revealed significantly
different MRE colonization levels between these 2 groups of samples (Figure R17A).
Since patients received different types of chemotherapy, which could have an effect on
the levels of MRE colonization,  we analyzed separately those samples obtained from
patients receiving an intensive chemotherapy (results in a neutropenic state of the patient
that  is  expected  to  last  for  more  than  2  weeks)  or  non-intensive  chemotherapy.
Interestingly, levels of MRE collected during intensive chemotherapy were similar to the
levels  of  MRE  collected  during  the  non-intensive  one,  suggesting  that  the  type  of
chemotherapy that the patient received does not affect MRE colonization levels (Figure
R17B).  On  the  other  hand,  transplant  treatment  could  be  allogeneic  or  autologous
depending on the source of the transplanted cells (the donor and recipient of the cells are
the same person- autologous, or a different person- allogeneic). Man-Whitney revealed
that the type of transplant did not influence the MRE intestinal levels (Figure R17C).
Figure R17. Effect of chemotherapy and transplant on MRE intestinal colonization levels. (A) MRE
fecal levels in samples collected during an admission in which the patient received chemotherapy (Chemo)
differed significantly from MRE levels in samples collected during an admission in which the patient
received a transplant (Transplant), (Wilcoxon test, **p<0.01). (B) Wilcoxon test revealed no differences
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(ns-not significant) in MRE levels due to the intensity of the chemotherapy received.  (C) The type of
transplant (allogeneic or autologous) does not impact MRE intestinal levels (Wilcoxon test, ns). Levels of
colonization are  represented  in  logarithmic  scale  per  gram of fecal  material.  Mean and +/-  SEM are
plotted. Numbers above each bar stand for number of samples  (n)  or  number of  patients from which
samples were collected (m).
 4.2.2.2 Impact of temporal variables on MRE intestinal levels
As previously mentioned, variables such as neutropenia or antibiotic treatment
are initiated at some point of patient’s admission and last for different periods of time.
For this reason, these variables were considered as temporal. In order to investigate the
effect of these variables on MRE colonization levels, paired analysis was performed. For
this purpose, levels of MRE in the sample previous to the initiation of the treatment or
complication  (i.e.  mucositis)  were  compared  to  the  levels  of  MRE in  the  following
sample collected after the initiation of the treatment/complication, both samples being
collected during the same admission. This analysis allowed us to investigate if certain
treatments  or  conditions  could  be  associated  with  increase  or  decrease  in  MRE
colonization levels once the patient has been colonized. Clinical variables whose effects
on MRE colonization levels were tested through Wilcoxon matched-pairs signed rank
test are neutropenia, parenteral nutrition, mucositis, antifungal treatment and antibiotic
treatment. Interestingly, analysis revealed that decrease in the number of neutrophils was
associated with significant decrease in MRE levels (Wilcoxon matched-pairs signed rank
test  p<0.05,  Figure R18A),  while parenteral  nutrition,  mucositis  or any of the tested
antifungal treatments seem not to affect MRE levels, once the MRE has colonized the
intestinal tract (Wilcoxon matched-pairs signed rank test, Figure R18B-E).
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Figure  R18.  Levels  of  MRE in  samples  collected  before  and  after  the  initiation  of  the  clinical
variables. (A) Wilcoxon matched-pairs signed rank test revealed significant (*p<0.05) decrease in MRE
levels  upon  initiation  of  the  neutropenic  state  in  patients.  Other  clinical  variables  such  as  parenteral
nutrition (B), mucositis (C), amphotericin treatment (D), and caspofungin treatment (E) do not affect MRE
levels (ns-not significant), although in case of parenteral nutrition and caspofungin treatment, p value of
Wilcoxon matched-pairs signed rank test was lower than 0.1, and is stated next to the graph. Levels of
colonization are represented in logarithmic scale per gram of fecal material. Numbers next to each graph
stand for number of pairs of samples (n) or number of patients from which samples were collected (m).
A similar analysis was performed to investigate the effect of different antibiotic
treatments on MRE intestinal levels. For this purpose, antibiotic treatments for which
more than 5 pairs of samples existed (aminoglycosides, beta-lactams and glycopeptides)
were considered for the analysis. Antibiotics were arranged into different classes in order
to  obtain  more  strength  for  the  statistic  analysis.  The class  of  beta-lactams included
aztreonam, meropenem and piperacillin/tazobactam, while teicoplanin and vancomycin
composed  the  class  of  glycopeptides.  Aminoglycosides  included  amikacin  treatment.
Interestingly,  analysis  of  the  effect  of  different  antibiotic  treatments  on  MRE
colonization levels revealed that beta-lactams (Wilcoxon matched-pairs signed rank test,
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p<0.05)  and  glycopeptides  (p<0.01)  decrease  MRE  levels  (Figure  R19),  while
aminoglycosides do not have an effect on the MRE colonization levels.
Figure R19. Levels of MRE in samples collected before and after the initiation of different antibiotic
treatments. (A)  Wilcoxon matched-pairs signed rank test revealed significantly lower levels of MRE in
samples collected after the introduction of beta-lactams to patients (*p<0.05). (B) No significant changes
were  observed  in  MRE  levels  upon  administration  of  aminoglycosides  (ns–not  significant).  (C)
Glycopeptide  treatment  decreased  MRE  levels  significantly  (**p<0.01).  Levels  of  colonization  are
represented in logarithmic scale per gram of fecal material. Numbers next to each graph stand for number
of pairs of samples (n) or number of patients from which samples were collected (m).
Results represented in  Figure R19 suggest that antibiotic treatment, although
given intravenously, which is the case for these antibiotics, could reach the intestine and
have effect on MRE directly or through changes in the intestinal microbiota. Importantly,
some  of  the  strains  detected  in  the  samples  that  were  included  in  this  analysis  are
susceptible to some of the analyzed antibiotics, while others are resistant. For this reason,
paired analysis for each antibiotic treatment was repeated, taking into account the data
about sensitivity of the MRE strain to the given antibiotic. Analysis of the effect of beta-
lactams on MRE levels in a group of samples in which the MRE detected strains were
sensitive to the beta-lactams revealed that this antibiotic decreased significantly MRE
colonization levels (Wilcoxon matched-pairs signed rank test p<0.001;  Figure R20A).
The observed reduction was more clear compared to when all pairs of samples were
analyzed,  independently  if  MRE was  sensitive  or  resistant  to  this  antibiotic  (Figure
R19A).  Since  MRE  strains  besides  sensitivity  to  beta-lactams,  could  also  display
susceptibility to other antibiotics that were given to the patient during the same time
period, the analysis was repeated, but in this case only samples in which MRE strains
were sensitive to beta-lactams, and not to any other antibiotic given during the time of
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sampling were included in the Wilcoxon matched-pairs signed rank test (Figure R20B).
Since there were only 3 pairs of samples that fulfilled the criteria, it was not possible to
obtain  a  significant  p  value  using  the  Wilcoxon test.  Nevertheless,  in  all  3  pairs  of
samples,  administration  of  beta-lactam  resulted  in  a  complete  clearance  of  MRE,
suggesting that beta-lactams produce a reduction in MRE colonization levels when the
MRE is exclusively susceptible to this antibiotic and not to other antibiotics that were
received by the patients during the sampling period. On the other hand, it is possible that
the  antibiotic  treatment  could  promote  MRE  colonization  levels,  when  MRE is  not
sensitive to the given antibiotic. For this reason, an analysis was performed to determine
if beta-lactams could increase MRE colonization levels when they were given to patients
colonized with an MRE strain resistant  to  the beta-lactams received (Figure R20C).
Interestingly, there were no significant changes in MRE colonization levels in these pairs
of  samples.  Thus,  beta-lactams  does  not  seem to  promote  intestinal  colonization  by
MRE. Although the MRE detected in samples from this last analysis were resistant to
beta-lactams, they could be sensitive to other antibiotics given at the same time, which
would mask the effect of beta-lactams. For this reason, pairs of samples containing MRE
sensitive  to  other  antibiotics  given  during  the  same  period  as  beta-lactams  were
eliminated  for  the  subsequent  analysis  (Figure  R20D).  Interestingly,  the  result  was
similar  to  the  one  obtained  before:  beta-lactams  do  not  seem  to  increase  MRE
colonization levels when they are given to patients who are colonized with MRE strains
resistant to the received beta-lactams.
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Figure R20. Levels of MRE in fecal samples collected before and after the administration of beta-
lactams. (A) When only those pairs of samples in which the identified MRE is sensitive to beta-lactams
are  included  in  analysis,  the  reduction  in  MRE  levels  upon  beta-lactam  treatment  was  even  higher
compared to analysis when all pairs of samples, independently if MRE strain was sensitive to the beta-
lactams, were included in analysis (**p<0.001). (B) When only are included those pairs of samples with
MRE sensitive to beta-lactams but resistant to all other antibiotics given during that period of time, the
decrease in MRE colonization levels was not significant,  probably due to the low number of pairs of
samples (N= 3), although the trend in MRE reduction was clear. (C)  Analysis did not reveal change in
MRE levels when beta-lactams were given to patients who were colonized with MRE strains resistant to
this antibiotic (ns-not significant).  (D)  The same result was obtained when from the group of samples
shown in C, were eliminated those samples that contained an MRE sensitive to other antibiotics received
during the period of sampling. Levels of colonization are represented in logarithmic scale per gram of fecal
material. Numbers next to each graph stand for number of samples (n) or number of patients from which
samples were collected (m).
A similar analysis was performed to identify the effect of aminoglycosides on
MRE colonization levels. Although there was no overall change in MRE levels when
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aminoglycosides were administered to patients (Figure R19B), it was of interest to test
the  effect  of  this  treatment  on samples  with  MRE strains  sensitive  to  this  antibiotic
(Figure R21A). The analysis revealed there was significant reduction in MRE levels in
these pairs of samples (Wilcoxon matched-pairs test, p= 0.043), suggesting that systemic
aminoglycosides also have an inhibitory effect against intestinal MRE that are sensitive
to this antibiotic. As in the analysis with the beta-lactams, and in order to investigate the
effect of exclusively aminoglycosides on MRE, those pairs of samples, in which MRE is
sensitive to other antibiotics also received by the patient during the sampling period,
were  excluded  from  the  analysis  (Figure  R21B).  This  last  analysis  shown  that
intravenous  aminoglycosides  alone  also  have  an  inhibitory  effect  on  MRE intestinal
levels when they are given to patients colonized with strains sensitive to these antibiotics,
since in all 5 cases the MRE was completely cleared after aminoglycoside administration
(Wilcoxon matched-pairs test, p= 0.031). Due to the low number of samples (n= 2), it
was not  possible  to  analyze  the  effect  of  aminoglycosides  when they were  given to
patients colonized with aminoglycosides-resistant MRE strains.
Figure  R21.  Levels  of  MRE  in  samples  collected  before  and  after  the  administration  of
aminoglycosides. (A) Wilcoxon matched-pairs signed rank test revealed that when only are included those
pairs  of  samples  in  which  the  detected  MRE  was  sensitive  to  aminoglycosides,  the  reduction  was
significant  (p=  0.043). (B)  When  only  are  included  those  pairs  of  samples  with  MRE  sensitive  to
aminoglycosides but resistant to all other antibiotics given during the sampling period, the decrease in
MRE colonization levels was even more pronounced (p= 0.031). Levels of colonization are represented in
logarithmic scale per gram of fecal material. Numbers next to each graph stand for number of pairs of
samples (n) or number of patients from which samples were collected (m).
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Analysis performed in order to investigate the effect of glycopeptides treatment
on MRE levels revealed that these antibiotics decreased MRE levels (Wilcoxon matched-
pairs signed rank test p<0.01; Figure R19C). These results were somewhat unexpected
since glycopeptides have no effect on Gram-negative bacteria such as MRE. In order to
investigate if this was due to the effect of another antibiotic given at the time, additional
analysis were performed. As in case with other antibiotic treatments, Wilcoxon matched-
pairs  signed rank test  was applied on pairs  of samples collected before and after the
initiation of glycopeptide treatment, in which MRE was resistant to all other antibiotics
given during the sampling period (Figure R22). In this case, only 3 pairs of samples
fulfilled the conditions.  Although glycopeptide administration seem to decrease MRE
levels,  due to  the low number  of  samples,  the  observed change was not  statistically
significant.
Figure  R22.  Levels  of  MRE  in  samples  collected  before  and  after  the  administration  of
glycopeptides. When only those pairs of samples in which the detected MRE was resistant to all other
antibiotics given during the sampling period were included in analysis, the detected changes were not
significant (ns-not significant), although the trend towards MRE reduction could be observed (p= 0.125).
Levels of colonization are represented in logarithmic scale per gram of fecal material. Numbers next to
each graph stand for number of pairs of samples (n) or number of patients from which samples were
collected (m).
Results of the analysis performed in order to investigate association between
antibiotic  treatment  and  MRE  colonization  levels  revealed  that  antibiotics  given
intravenously to which MRE strains are sensitive could reach the intestine and decrease
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MRE levels.  Moreover, it  seems that these antibiotics,  when administered to patients
colonized with resistant MRE strains do not promote MRE colonization levels. Due to
the effect of antibiotics on sensitive strains, analysis performed on other temporal clinical
variables  (neutropenia,  mucositis,  parenteral  nutrition  and  antifungal  treatment)  were
repeated, this time eliminating those pairs of samples in which the MRE strains were
sensitive to antibiotics  given during the sampling period.  Due to  the low number of
samples,  analysis  was  performed  only  for  parenteral  nutrition  and  neutropenia.
Importantly, also in this new analysis, initiation of neutropenia seems to reduce the levels
of MRE (p= 0.034, Figure R23A). These results indicate that, unexpectedly, neutropenia
may have an inhibitory effect on MRE intestinal levels. On the other hand, parenteral
nutrition does not seem to affect MRE intestinal levels (p= 0.25, Figure R23B).
Figure R23. Levels of MRE in samples collected before and after the initiation of neutropenia and
parenteral nutrition.  (A)  Analysis performed exclusively on those pairs of samples with MRE strains
resistant to all antibiotics received during the sampling period revealed a reduction of MRE levels upon
initiation of the neutropenic state (p= 0.034).  (B) When analyzed only those pairs of samples with MRE
strains resistant to all antibiotics received during the sampling period, parenteral nutrition does not seem to
affect MRE intestinal levels (p= 0.25). Levels of colonization are represented in logarithmic scale per gram
of fecal material. Numbers next to each graph stand for number of samples (n) or number of patients from
which samples were collected (m).
In  order  to  study  the  independent  effect  of  clinical  variables  on  MRE
colonization levels, all clinical variables were included in a multivariate analysis. For this
purpose,  Lasso  regression  with  positive  penalty  term  λ  was  applied,  as  explained in
Methods. This approach in combination with a suitable model evaluation that included
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cross validation reduced the risk of overfitting the final model. The response variable in
the model was the change in MRE colonization levels between 2 consecutive samples.
Data about the treatment or condition that started in the period between 2 paired samples
were included as predictor variables. Besides, data about gender, type of leukemia or
type of admission were also added as predictors of the model. Lasso regression resulted
in the selection of 2 variables for the model that can explain changes in MRE levels of
colonization (p= 6.54E-05,  Figure R24). These 2 variables are administration of beta-
lactams when MRE is susceptible to the beta-lactams and colonization with Klebsiella.
Sensitivity to beta-lactams when these are administered affects negatively MRE levels,
while colonization with Klebsiella affects positively. In previous analysis, Kruskal-Wallis
showed  no  differences  in  MRE  intestinal  levels  between  different  taxonomic  types
(Figure R16D). However, a trend towards higher MRE levels in case taxonomic type
was  Klebsiella could  be  actually  observed.  Moreover,  Wilcoxon  test  revealed
significantly higher MRE levels between group of samples in which the identified MRE
was  Klebsiella as  compared  to  those  in  which  the  detected  MRE  was  Citrobacter
(p<0.05).  Importantly,  with  only  these  2  variables,  sensitivity  to  beta-lactams  and
colonization with Klebsiella, the model generated by Lasso regression is able to predict
12.5% of the variability in the MRE levels data from this study (R2 adjusted for the
model is 0.125).
Figure R24. Clinical variables selected with multivariate analysis as predictors for change in MRE
levels. Sensitivity to beta-lactams in MRE strains when these antibiotics are given to patients correlates
negatively with MRE levels, while colonization with Klebsiella correlates positively to MRE colonization
levels. The x axis represents coefficients of interaction (β) for these 2 clinical variables.
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 4.2.2.3 Clinical parameters associated with the intestinal colonization levels in the
first MRE positive sample
Previous analysis revealed clinical variables associated with changes in MRE
levels  once  the  patient  is  colonized.  Additional  analysis  were  performed in  order  to
investigate  if  any  clinical  variable,  previous  to  the  colonization  with  MRE,  could
influence MRE intestinal colonization levels. For this purpose, colonization levels in the
first MRE positive sample from each admission were analyzed. In order to assure that the
patient got colonized in the hospital, samples included in the analysis had to be preceded
with an MRE negative sample. Due to the results obtained from previous analysis in
which  administration  of  antibiotics  to  which  MRE strains  were  sensitive  resulted  in
reduction of colonization levels, all samples that were susceptible to antibiotics that were
given to the patient at the moment of sampling were discarded from the analysis. Only
those clinical variables that had more than 5 samples per group were analyzed. Analysis
revealed that the occurrence of mucositis previous to the first MRE colonization resulted
in trend towards higher levels of MRE. Although the comparison was not statistically
significant, p value was low (Wilcoxon test p= 0.057; Figure R25A). It was possible that
the effect of mucositis on MRE colonization levels could depend on the time that passed
since mucositis until MRE colonization (probably mucositis has a greater effect on MRE
levels if it has occurred close to the time-point when MRE was detected). For this reason,
linear  regression  was  applied  in  order  to  take  into  consideration  the  time  from the
initiation of mucositis to the moment in which MRE was detected. Linear regression
analysis  confirmed  our  hypotheses:  levels  of  colonization  in  the  first  MRE positive
sample  were  higher  when  mucositis  occurred  shortly  before  the  sampling  (Figure
R25B). Moreover when the comparison represented in Figure R25A was repeated with
only those cases in which mucositis occurred no more than 2 weeks previous to MRE
detection, the difference in MRE levels between samples collected after the occurrence
of mucositis and MRE levels in samples from patients that did not develop mucositis was
statistically significant (Wilcoxon test p<0.05; Figure R25C).
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Figure R25. Effect of mucositis on MRE intestinal levels in the first MRE positive sample identified
during the patient’s hospitalization period. (A) Levels of MRE intestinal colonization in the first MRE
positive sample from each hospital admission when patients developed mucositis previously (Yes) or when
mucositis did not occur before sampling during the same admission period (No). Wilcoxon test revealed no
significant differences between these 2 groups, although the p value was close to significant (p= 0.057).
(B) MRE levels in the first positive sample in relation with the days that passed since mucositis (x axis).
All  samples  collected  more  than  1  month  after  mucositis  are  grouped  together  (>30).  Samples  from
patients that never developed mucositis previous to colonization are also grouped together (N).  Linear
regression revealed significant trend toward higher MRE levels in samples collected shortly after mucositis
(p<0.05). (C) Wilcoxon test revealed significant differences (*p<0.05) between MRE levels in the first
positive sample in the group of samples collected no more than 2 weeks after mucositis (Yes) compared to
MRE levels in samples collected from patients that did not develop mucositis (No). Levels of colonization
are represented in logarithmic scale per gram of fecal material.  Numbers next to each graph stand for
number of samples (n) or number of patients from which samples were collected (m).
The  same  analysis  was  repeated  with  other  clinical  variables  such  as
neutropenia,  parenteral nutrition,  antifungal and antibiotic treatment.  In none of these
comparisons  MRE  levels  were  significantly  affected  by  the  treatment  or  condition
previous to the sampling (Figure R26).
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Figure R26.  MRE levels  in  the  first  positive  sample  from each admission  for all  tested  clinical
variables. The bargraphs represent the comparison of (i) MRE levels between samples collected after the
occurrence of the variable under study (condition or treatment) (Yes) with (ii) the MRE levels in samples
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collected  from patients  that  did  not  have  that  particular  treatment  or  condition  (No).  For  all  clinical
variables shown in this figure,  Wilcoxon showed no significant differences (ns-not significant).  Linear
regression was applied in order to investigate if MRE colonization levels could be associated with time
that passed since the treatment or complication until the moment of sampling (figures on the right for each
variable analyzed).  None of  the clinical  variables  shown association with MRE intestinal  levels using
linear regression analysis.  Levels of colonization are represented in logarithmic scale per gram of fecal
material. Numbers next to each graph stand for number of samples (n) or number of patients from which
samples were collected (m).
 4.2.3 Identification  of  bacteria  associated  with  protection  against  MRE
colonization in hospitalized patients
In the previous chapter, we have defined the effect of clinical variables on MRE
intestinal levels. Here, we wanted to study how changes in the microbiota composition
may impact the ability of MRE to colonize the intestine. Results from this analysis could
identify those commensal bacteria associated with protection against MRE (when they
are present MRE levels decrease, while MRE can efficiently colonize the intestine when
they are absent). In order to perform this analysis, we analyzed the composition of the
microbiota of all samples obtained from every patient. An example of the data obtained
from 1 patient is presented in Figure R27. As it can be observed in Figure R27, a patient
can  be  admitted  into  the  hospital  in  several  occasions  for  several  reasons  (e.g
chemotherapy  or  transplant).  This  particular  patient  got  colonized  with  MRE in  the
second admission period and the MRE intestinal levels varied in time until MRE was
completely  eliminated  in  the  third  admission  period.  Different  antibiotic  treatments,
which can have an effect on MRE levels and on the microbiota composition, are being
introduced to the patient alone or in the combination with other treatments during the
admission  period.  Moreover,  although  not  shown  in  this  particular  example,  as
mentioned in the previous chapter, patient could suffer complications such as neutropenia
or/and mucositis that could also affect MRE colonization levels.
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Figure R27. Microbiota composition and clinical variables collected for a particular patient.  In the
middle rectangle, microbiota composition of all samples collected from this patient is represented: each bar
represents 1 sample. The most abundant bacterial OTUs (49 together with the group “Other” containing the
remaining lower abundance OTUs) are shown and labeled with different colors as indicated. Red line
represents MRE levels identified by plate counting technique. Lower rectangle represents 3 admissions
during which all samples were collected. Patient went through 2 rounds of chemotherapy and subsequently
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received  a  transplant.  Upper  rectangle  represents  the  antibiotic  treatment  the  patient  received.  Other
variables included in the analysis are not represented in order to simplify the graph.
Due  to  the  complexity  of  the  data,  it  would  not  be  possible  to  identify
commensal  bacteria  associated  with  protection  against  MRE  colonization  in  acute
leukemia patients with classic statistical analysis. For this reason LV mathematical model
was applied (127) This model analyzes the dynamics of the microbiota composition and
accounts for external perturbations such as antibiotic treatment, allowing to identify key
commensals associated with pathogen colonization levels. The theory behind the model
and  detailed  methodology  are  explained  in  section  3.10.3  of  Material  and  Methods.
Briefly, the rate of change in MRE levels between 2 consecutive samples collected from
the same admission period, normalized by the number of days that passed between both
samples, was used as response variable for the model. As explained in the methodology
section, since the absence of MRE in negative samples could be explained by resistance
to colonization or by the absence of exposure to MRE, the rate of MRE change was
calculated only for those pairs of samples in which the first one had MRE levels. At the
beginning of the study, we tried to perform the analysis including all pairs of samples,
independently if the first sample of the pair had MRE levels, but the solution for this
model was not reliable, probably due to the problem that we have pointed out. When
pairs  of  samples  in  which  the  first  one  was  negative  were  eliminated  from  further
analysis, the solution for the model became reliable, indicating that probably the data
about pairs of samples in which the first sample was negative was introducing noise into
the  model.  The genus abundances,  representing the commensal  bacteria  identified  in
acute leukemia patients, normalized by the total bacterial density of each sample were
used  as  predictor  variables  for  the  model.  For  the  analysis  we  considered  25  most
abundant genera identified in all  patients, including the group “Other” containing the
remaining  lower  abundance  genera.  This  number  of  genera  was  chosen  since
introduction of more than 25 genera would not allow us generation of a reliable model,
due to the high number of variables included into the model. For pairs of samples of
interest,  geometric  mean  abundances  were  calculated  from  logarithmic  values  of
normalized genus abundances.  Besides bacterial  abundance data,  all clinical variables
that were found to be statistically significant in univariate analysis explained in sections
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4.2.2.1 and 4.2.2.2 were included into the model. Also, data about the sensitivity of MRE
detected in each sample to the antibiotics given at the moment of sampling were also
included into the model. In total, 132 pairs of samples entered the model. As in case of
multivariate analysis of clinical variables, Lasso regression was used to solve the model.
Importantly, the  model  selected  7  variables  that  were  associated  with  MRE
levels  (p=  6.42E-07;  Figure R28).  Among clinical  variables,  administration  of  beta-
lactams, when the identified MRE strain is sensitive to these antibiotics, is negatively
associated with MRE levels, confirming the result obtained by multivariate analysis on
clinical  variables,  explained in  section 4.2.2.  Moreover, transplant  and chemotherapy
were also correlated with MRE levels.  Among genera,  Coprobacillus was negatively
associated with MRE levels, indicating that it could be a potential protector commensal
against  MRE  colonization.  On  the  other  hand,  Paraprevotella and  Klebsiella were
positively correlated with the MRE intestinal levels.
Figure R28. Genera and clinical variables selected by LV as associated with MRE colonization levels.
In blue are represented negatively correlated variables, while in red are those that are positively correlated
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with MRE levels. The coefficient of correlation is represented on x axis. Coprobacillus, administration of
beta-lactams when the identified MRE strain is sensitive to beta-lactams, and transplant are negatively
correlated with MRE intestinal levels. On the other hand, Paraprevotella, Klebsiella and chemotherapy are
positively associated with MRE intestinal levels.
In order to visualize better the association of the genera selected by the model
with MRE intestinal levels, the mean abundance of the commensal bacteria identified by
the model were plotted in relation with the MRE rate (Figure R29). As shown on this
figure,  the  abundance  of  Coprobacillus,  the  genus  negatively  associated  with  MRE
levels,  is higher in pairs  of samples where MRE decreases,  and lower in samples in
which MRE increases. On the other hand, negatively associated genera (Klebsiella and
Paraprevotella) are more abundant in samples in which MRE increases than in those
where MRE decreases.
Figure R29. LV model identifies commensal bacterial genera that are associated with MRE levels in
patients. Geometric mean abundance (Mean abunddance) of bacterial genera in pairs of samples in which
it was observed a reduction (blue) or increase (red) of MRE. Only those bacterial genera identified by LV
model to be associated with MRE intestinal levels are shown.
Since bacterial genus can be divided into different OTUs, some of which may
have an effect on MRE levels and other not, and different patients may contain different
OTUs belonging to the same genus, we decided to repeat the analysis, this time at the
OTU level, which may allow us to identify with more precision bacteria that could have
a protective role against MRE intestinal colonization. For this purpose, 25 most abundant
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OTUs (which coincide with those OTUs with the  mean abundance higher than 0.1%)
were  considered  for  analysis,  including  the  group  “Other”  containing  the  remaining
lower abundance OTUs. Importantly, the model selected 12 variables that could explain
change  in  MRE  colonization  levels  (p=  7.51E-06;  Figure  R30).  Out  of  6  bacteria
selected  by the model,  3  were negatively correlated  with MRE levels  (could have  a
protective  effect):  1  OTU  classified  as  Lactobacillus and  other  2  as  Bacteroides.
Positively correlated bacteria were 3 OTUs within the genera Bacteroides, Klebsiella and
Alistipes. Administration of beta-lactams in general, as well as administration when the
identified MRE strain was sensitive to the beta-lactams, was negatively associated with
MRE levels, which confirms the results obtained from multivariate analysis explained in
section 4.2.2.  Moreover, transplant  (negative correlation)  and chemotherapy (positive
correlation) were confirmed as clinical variables that could affect MRE levels.
Figure R30. OTUs and clinical variables selected by LV to be associated with MRE colonization
levels.  In blue are represented negatively correlated variables; while in red are those that are positively
correlated  with  MRE  levels.  The  coefficient  of  correlation  is  represented  on  x  axis.  Among  clinical
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variables, transplant, administration of beta-lactams in general, as well as administration of beta-lactams
when the detected MRE is sensitive to beta-lactams (SensiBeta) are negatively correlated to MRE. On the
other hand, chemotherapy is positively associated with MRE colonization levels.
Finally, we plotted the levels of the OTUs identified by LV to be associated with
MRE levels. As shown in  Figure R31, all 3 OTUs that are negatively correlated with
MRE  levels  were  present  in  higher  abundances  in  pairs  of  samples  where  MRE
decreases, as compared to pairs of samples in which MRE levels increase, indicating that
these OTUs may have a  protective role  against  MRE. On the other  hand,  positively
correlated bacteria were more abundant in those pairs of samples in which MRE levels
increase than in those where MRE levels decrease.
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Figure R31. LV model identifies commensal bacterial OTUs that are associated with MRE levels in
patients. Geometric mean abundance (Mean abundance) of bacterial genera in pairs of samples in which it
was observed a reduction (blue) or increase (red) of MRE. Only those bacterial OTUs identified by the LV
model to be associated with MRE intestinal levels are shown.
In order to confirm the accuracy of the model, factors selected by the models
that could influence MRE levels (genera and clinical variables or OTUs and clinical
variables) were used as predictors of MRE levels. Abundances of predictor genera or
OTUs and presence or absence of clinical variables such as beta-lactam treatment and
their coefficients of interaction with MRE served to calculate expected MRE rates for
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each pair of samples. The relation between the real MRE rates for each pair of samples
and those predicted by each of the models (performed on genera or OTUs) are plotted in
Figure R32. Linear regression of real against predicted MRE rates revealed that 24% of
variability in MRE rates could be explained by the model that included OTU abundances
as  predictors  (R2  adjusted=  0.24,  Figure R32B).  On the  other  hand,  the  model  that
included 25 most abundant genera as predictors of the MRE rates was able to explain
23.9% of the variability in MRE rates (R2 adjusted= 0.239, Figure R32A).
Figure R32. Real MRE rates plotted against MRE rates predicted by the models. Predicted MRE rates
for pairs of samples were calculated using the variables selected by LV as correlated with MRE rates and
coefficients of interaction for these variables. (A) 23.9% of variability in MRE rates could be explained by
the model that included abundances of the genera and clinical variables as predictors (linear regression, R2
adjusted=  23.9%).  (B) The  model  that  included  abundances  of  the  OTUs  and  clinical  variables  as
predictors was able to explain 24% of variability in MRE rates (linear regression, R2 adjusted= 24%).
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 4.3 The role of the microbiota dysbiosis in ERE
Epizootic rabbit  enteropathy is  a  severe gastrointestinal disease that  occurs in
young rabbits in the first weeks post-weaning  (89), a period during which changes in
microbiota  composition  are  known  to  occur.  In  a  recent  study,  Bauerl  et  al.
(89) described remarkable dysbiosis and reduced taxonomic diversity in cecal microbiota
of animals with ERE, although it remains unclear if the observed changes are the cause
or the consequence of the disease. On the other hand, Licois et al. (92) reproduced the
disease in healthy animals by administrating intestinal contents obtained from rabbits
affected  by  ERE,  indicating  that  the  disease  is  transmissible  among  rabbits  and
suggesting  that  an  infectious  agent  may  be  involved  in  the  development  of  this
pathology. However, no causative agent has been identified for the moment. In order to
investigate  the  role  of  the  dysbiosis  in  ERE  development  several  objectives  were
proposed,  as  previously  mentioned:  (i)  to  investigate  if  dysbiosis  observed  in  ERE
rabbits could be detected before the disease onset and thus could be the cause of the
disease;  (ii)  to  investigate  the  microbiota  dynamics  after  the  weaning  and  identify
changes in microbiota that could lead to ERE development;  (iii)  to investigate if  the
cause of ERE could be due to an infectious agent.
 4.3.1 ERE is characterized by dysbiosis of the intestinal microbiota
To evaluate the role of dysbiosis in ERE development, caecotroph samples were
prospectively collected from littermate rabbits during 3 consecutive weeks, starting the
day  of  weaning.  Caecotrophs,  soft  feces  made  up  of  essentially  cecal  contents  and
secreted by rabbits at dawn, were collected instead of regular fecal samples, since the
microbiota of caecotrophs is equivalent to that one from the cecum (Figure R33) and
oral  inoculation  of  cecal  contents  has  been  shown to  reproduce  the  disease  in  SPF
healthy rabbits (130).
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Figure R33. cecal and caecotrophs microbiota of rabbits.  Phylogenetic  classification of  16S rDNA
frequencies in the cecum or caecotrophs samples from healthy rabbits, 21 days after weaning. Each bar
represents the microbiota of an individual rabbit whose ID number is indicated above the bar. The most
predominant bacterial taxa are shown and labeled with different colors as indicated. Bacterial taxa were
obtained by classification of 16S rDNA sequences to the genus level using Mothur. In case a sequence
could not be classified to the genus level, the closest level of classification to the genus level was given,
preceded by “unclassified_”.
In addition to collecting caecotrophs,  food consumption was measured daily
after weaning and careful visualization of appearance of ERE compatible signs (Table
R2) was performed in order to detect those rabbits that develop ERE.
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R4 Pb P P P P
R17 P P P P
R11 P P P P
R15 P P P P
R16 P P P P
R18 P P P P P P
R8 P P P P
R24 P P P P P P
R25 P P P P
R27 P P P P P
R31 P P P P P
a Rabbits are sorted in the same order as ERE rabbits shown in  Figure R34.  Only those rabbits that
developed ERE are indicated in the table. Healthy rabbits did not develop any of the symptoms, signs and
lesions shown in the table.
b P=presence of a particular lesion, symptom or sign.
While most rabbits (62%) increased their food intake during the 3 weeks period
and did not develop any ERE compatible sign, a total of 11 rabbits developed a sharp
decrease in food intake (>50% reduction) during days 7 to 12 after weaning (Figure
R34). None of these 11 rabbits increased their food intake afterwards (Figure R34) and
all  rabbits  developed  clinical  signs  compatible  with  ERE  including  diarrhea  and
prostration (Table R2). A necropsy was performed to corroborate ERE development in
these 11 rabbits. Gross lesions compatible with ERE were observed in all rabbits that
developed a sharp decrease in food intake (Table R2). However, consistent with ERE, no
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macroscopic signs of inflammation or congestion were observed in the intestinal tract of
none of these rabbits. As expected, no gross lesions compatible with ERE were observed
in those rabbits that did not develop a sharp decrease in food intake, neither signs of
disease. In summary, 38% of the rabbits under study spontaneously developed ERE.
Figure R34. Food intake by rabbits after weaning: the amount of food (g) consumed by rabbits at
different days after weaning is shown as a color-coded heatmap. Day 0= Day of weaning. NA: not
analyzed due to death or euthanasia of that particular rabbit. The day of ERE onset as revealed by a sharp
drop in food intake (>50% reduction compared to the previous day) is indicated with an asterisk. Healthy
rabbits  were  followed for  another  week.  No decrease  in  food  consumption  was  observed  during  this
additional week neither signs of disease in healthy rabbits.
As previously mentioned, microbiota dysbiosis has been associated with ERE
(89). Nevertheless, the study published by Bauerl et al. (89) is the only one that describes
the microbiota dysbiosis in ERE rabbits using high-throughput sequencing techniques. In
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order to confirm these results in rabbits from this study, the microbiota composition of
samples collected after ERE onset was studied. The ERE onset was defined as the day in
which a sharp drop in food consumption was detected (see Methods and Figure R34).
For identifying bacteria that characterize ERE, 16S rRNA high-throughput sequencing
using  the  454  Roche  platform  was  performed.  The  overall  microbial  diversity  was
analyzed by calculating the Shannon index, which takes into account the number and
relative abundance of OTUs found in a given sample. OTUs analysis showed that the
microbiota from rabbits with ERE was less diverse than the one from healthy controls
(lower Shannon index, P<0.05, Figure R35A). Subsequently, the overall structure of the
microbiota  of  healthy  and  ERE  rabbits  was  analyzed  in  order  to  detect  potential
differences. The microbiota similarity was quantified by applying the Yue & Clayton
measure of dissimilarity  that  compares  the relative abundance of OTUs present  in  2
given  pair  of  samples.  PCoA was  used  to  cluster  samples  along orthogonal  axes  of
maximal variance. The first principal coordinate of analysis (PC1) separated samples by
health status indicating that the microbiota structure from rabbits with ERE differ from
that of healthy controls (Figure F35B). Analysis of the molecular variance of the Yue &
Clayton dissimilarity values confirmed that this difference was statistically significant
(AMOVA,  P<0.001).  The  non-parametric  Wilcoxon  test  was  performed  in  order  to
identify specific microbial changes in ERE rabbits. To avoid false positives, the FDR was
applied.  At  the  genus  level,  the  relative  abundance  of  12  bacterial  genera  were
significantly  different  (FDR<0.05)  between  rabbits  with  ERE  and  healthy  controls
(Figure F35C). Specifically, the microbiota of rabbits with ERE had higher levels of the
genera Clostridium, Turicibacter, Robinsoniella, Coprobacillus, Roseburia, Bacteroides,
Alistipes, Akkermansia, Campylobacter and  Anaerovax and lower levels of  Fusibacter
and Adlercreutzia. When using a less stringent FDR threshold (FDR<0.1), the abundance
of 21 out of 32 analyzed genera differed between rabbits with ERE and healthy controls.
On  the  other  hand,  the  relative  abundance  of  11  OTUs  (FDR<0.05)  and  34  OTUs
(FDR<0.1) was found to be significantly different between both groups. Altogether these
data  indicate  that  ERE,  also in  rabbits  from this  study, is  associated  with  a  marked
intestinal microbial dysbiosis.
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Figure R35. Epizootic rabbit enteropathy is characterized by dysbiosis of the intestinal microbiota.
Microbiota composition was analyzed in caecotrophs samples from rabbits with ERE (1 to 3 days after
ERE initiation) and compared with a similar time point (day 11 post-weaning) of healthy (HLT) littermate
controls. (A) The Shannon index of the identified OTUs for each sample and mean +/- SEM for each group
was calculated and plotted (*P<0.05, Wilcoxon test). (B) PCoA from the Yue & Clayton values calculated
between all the samples. (C)  Heatmap representing the standard deviation from the mean of the relative
abundance  of  statistically  significantly different  genera  between rabbits  with ERE and HLT littermate
controls  (Wilcoxon  test,  FDR<0.05).  Red  colors  represent  values  above  the  mean  and  green  colors
represent values below the mean. N= 10 for the HLT group and 7 for the ERE group.
 4.3.2 Microbiota dynamics after the weaning and before the ERE onset in healthy
and ERE rabbits
In order to elucidate if the observed changes were consequence of the disease
state or could be responsible for triggering ERE, the composition of the microbiota of
rabbits  before  ERE onset  was  analyzed.  The  Yue  & Clayton  index  and PCoA were
applied to analyze overall changes in the microbiota after weaning and before ERE onset.
Changes  of  the  microbiota  over  time  could  be  identified  in  PC1  (Figure  R36A).
Interestingly, the day of weaning, samples from healthy rabbits are scattered distributed
along  the  axis  defined by PC1,  suggesting  variability  of  the  microbiota  at  weaning.
However, from day 7, samples move towards the positive values of the axis and cluster
tightly at day 9 after weaning. From this day, samples keep clustering tightly between
similar  values  of  the  PC1  axis.  Importantly,  samples  obtained  from mothers  cluster
tightly and are located within the same values as samples of days 9 to 21 after weaning.
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Remarkably, samples from ERE rabbits before disease onset (days 0 to 9 after weaning),
move across the PCoA axis towards the positive values in a similar manner as healthy
rabbit samples. This observation was supported by a linear regression analysis including
interaction between disease state and time factors. Both groups fit a regression line with
a similar  slope over time given that the P value associated with the time factor  was
significant (P<0.0001) while no significance (P>0.05) was obtained for the disease factor
or the interaction between time and disease. Moreover, when different time points were
analyzed  separately  (Figure  R36B),  no  separation  was  observed  by  disease  state
(AMOVA,  P>0.05).  Altogether  these  results  suggest  that  the  microbiota  structure  of
rabbits that will develop ERE, before ERE onset, is similar to that of healthy rabbits and
evolve in a similar manner after weaning towards an adult microbiota state.
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Figure R36. Evolution of the microbiota after weaning and before ERE onset.  (A)  First principal
coordinate of analysis of the PCoA from the Yue & Clayton values obtained between all samples plot over
time.  (B) PCoA at  different  days  after  weaning  from the distance  matrix  generated  using  the  Yue &
Clayton index between samples from a specific day. D0= day of weaning. Both in (A) and (B), samples
from rabbits with ERE after disease initiation are not included in the analysis. Most of the rabbits (9 out of
11) initiate ERE before day 11 after weaning, thus samples from rabbits with ERE from this or subsequent
days are not included. N= 8-11 per group except for day 21 where N= 4. Two consecutive samples from 4
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mothers, obtained the day of weaning and 7 days afterwards were also included in the analysis shown in
(A).
Although the structure of the microbiota from healthy rabbits and those that will
develop ERE does not differ before ERE onset, both groups could still differ in specific
bacterial taxa. Thus, analysis were performed in order to confirm if any of the changes
observed  in  rabbits  with  ERE (Figure  R35C)  could  be  detected  before  ERE onset
(Figure R37).  Remarkably, no significant differences in the abundance of any of the
bacterial genera analyzed (Figure R37) were detected between healthy rabbits and those
that will develop ERE, at any time point before ERE onset, even using a less stringent
threshold of  FDR<0.1.  On the other  hand,  the rest  of  bacterial  genera that  were not
significantly different after disease onset, did also not differ between both groups before
the  beginning  of  the  disease.  Similarly,  no  differences  between  both  groups  were
identified at the OTU level or other phylogenetic levels. Besides, no differences in the
Shannon diversity index were observed before ERE onset. These results suggest that the
dysbiosis observed in rabbits with ERE is a consequence of the disease rather than its
initial cause.
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Figure  R37.  Bacterial  genera  abundance  in  healthy  and  ERE  rabbits  before  onset. Relative
abundance at different days after weaning of bacterial genera that were found to be significantly different
in rabbits with ERE (Figure R35C). Horizontal lines represent the mean for each group. D0 = day of
weaning. Samples from rabbits with ERE after disease initiation are not included in the analysis. Most of
the rabbits (9 out of 11) initiate ERE before day 11 after weaning, thus samples from rabbits with ERE
from this or subsequent days are not included. N= 8-11 per group and time point.
 4.3.3 Comparison of the microbiota composition of ERE rabbits on the day of
disease onset with age-matched healthy littermate controls
Different rabbits start developing ERE at different days after weaning (Figure
R34).  If the observed microbiota dysbiosis was responsible for triggering the disease
state, it  could be possible that microbiota changes would have developed in different
rabbits at different time points, resulting on different days of ERE onset. For this reason
and in order to elucidate if the identified dysbiosis occurred exclusively after ERE onset,
samples obtained the day of ERE onset were analyzed and compared to age matched
healthy controls. For 8 out of 11 rabbits, a caecotroph sample was obtained the day of
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onset.  Yue & Clayton measure of dissimilarity  and PCoA were used to compare the
microbiota structure of these samples with that one from samples obtained after ERE
onset and from samples of healthy controls collected at similar days after weaning. The
microbiota from samples obtained after onset differ from that one of samples collected
the  day  of  onset  and  from samples  of  healthy  controls  (AMOVA,  P<0.001;  Figure
R38A).  However,  no  significant  difference  in  the  microbiota  structure  was  observed
between  samples  collected  the  day  of  onset  with  those  from  age-matched  healthy
controls (AMOVA, P>0.05; Figure R38A). Similar results were obtained using UPGMA
hierarchical clustering (Figure R38B). Moreover, no statistically significant differences
were detected between healthy controls and samples collected the day of ERE onset in
any bacterial genera whose abundance was found to be altered after ERE onset (Figure
R38C),  neither  in  any  other  bacterial  taxa  or  OTU  (see  Methods  for  the  different
comparisons performed using different healthy control groups). Besides, no differences
in the Shannon diversity index were observed between samples from ERE rabbits the day
of onset and age-matched healthy littermate controls. Altogether these results confirm
that  the  dysbiosis  observed  in  the  intestinal  microbiota  of  rabbits  with  ERE  is  a
consequence rather than the initial cause of the disease.
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Figure R38. Microbiota dysbiosis occurs after ERE onset. (A) PCoA or (B) UPGMA hierarchical tree
obtained from the Yue & Clayton values calculated between samples from rabbits with ERE collected the
day of onset or after onset and samples from healthy rabbits at similar time points (Days 9 and 11 after
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weaning).  (C) Relative abundance  of  bacterial  genera that  were  found to be  significantly different  in
rabbits with ERE (Figure R35C) from samples obtained from sick rabbits the day of onset or after onset,
compare with samples from healthy littermate controls at similar time points. N= 7-10 per group and time
point. The mean for each group is shown.
 4.3.4 Higher  sequencing  coverage  using  Illumina  platform  identifies  a  unique
microbiota change the day of ERE onset
Although  previous  results  did  not  identify  any  change  that  precedes  ERE
development,  there  was  still  the  possibility  that  changes  in  low  abundant  bacteria
between healthy and ERE rabbits before the disease onset have not been identified due to
the low number of sequences (2849 ± 779) obtained by 454 sequencing technology. For
this  reason,  all  samples  were  re-sequenced  using  the  newer  Illumina  platform  (not
available at the beginning of the study), which now allows obtaining higher sequencing
coverage per sample at a similar cost. Analysis performed on sequences obtained using
this new platform revealed results similar to those represented in  Figure R35B when
comparing the microbiota composition in samples obtained after ERE onset to that of
healthy littermates (AMOVA, p<0.001). Besides, the microbial diversity represented by
Shannon index was lower in rabbits that developed ERE compared to healthy animals
(P<0.05). In order to detect specific changes in the microbiota composition after ERE
onset,  non-parametric  Wilcoxon  test  with  FDR was  applied.  At  the  genus  level,  the
relative  abundance  of  24  bacterial  genera  were  significantly  different  (FDR<0.05)
between  rabbits  with  ERE and  healthy  controls.  Importantly,  analysis  performed  on
sequences obtained by Illumina confirmed higher abundances of the genera Clostridium,
Turicibacter, Robinsoniella, Bacteroides, Akkermansia, Campylobacter and Anaerovorax
in those rabbits that developed ERE, which was already identified with the 454 platform
(Figure  R35C).  Lower  levels  of  the  genus  Adlercreutzia in  ERE rabbits  were  also
detected  using  the  Illumina  platform.  Besides,  the  relative  abundance  of  7  OTUs
(FDR<0.1) was found to be significantly different between the groups of healthy and
ERE rabbits.
In order to confirm that there were no changes in the microbiota composition
before the disease onset in ERE rabbits, samples obtained after the weaning from the 2
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groups of rabbits were compared. No statistically significant differences (FDR<0.1) were
observed at the genus or OTU level at any day post-weaning and before ERE onset.
Since not all rabbits develop ERE on the same day post-weaning, as previously
described, comparison of samples from ERE rabbits obtained on the day of the disease
onset and samples obtained from healthy rabbits on day 9 post-weaning was performed.
Interestingly, analysis revealed significantly higher abundance (FDR<0.1) of the genus
Clostridium in ERE rabbits (Figure R39A). Moreover, this difference was basically due
to the presence of a single Clostridium OTU (OTU31) in ERE rabbits, which was absent
in the healthy animals (Figure R39B). This result suggests that the OTU31 may have a
key role in the initiation of ERE.
Figure  R39.  The  relative  abundances  of  taxa  differently  abundant  between  samples  of  healthy
rabbits collected on day 9 post weaning (HLT_D9) and samples from ERE rabbits on the day of
onset (ERE_onset). (A) Clostridium is present in higher abundance (**p<0.01; FDR<0.1) in rabbits that
develop ERE, and this difference in relative abundance is due to only 1 single OTU (**p<0.01) (B). Means
and +/- SEM values are represented. 
To confirm the association of the Clostridium OTU31 with the development of
ERE, all sequences obtained by Illumina from all healthy rabbits’ samples (1 392 113
sequences,  74  samples  in  total)  were  aligned  against  the  representative  sequence  of
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OTU31. Blast  analysis  revealed that none of 1 392 113 sequences correspond to the
OTU31 (none  of  the  sequences  shown  more  than  95% of  similarity  to  Clostridium
OTU31). In contrast, OTU31 was found to be present in samples collected before the
disease onset in all but 1 ERE rabbit, in which indeed it was possible to detect this OTU
after the disease onset. Altogether, these results suggest that this OTU is characteristic of
ERE rabbits and may be involved in the initiation of the disease.
 4.3.5 The  effect  of  decreasing  food  consumption  on  ERE  development  and
microbiota dysbiosis
As previously described, a drastic decrease in food consumption is considered
the first  sign of ERE, which occurs in all  rabbits  that develop the disease.  Although
unlikely, it  could be possible that  food restriction could be the trigger  that promotes
dysbiosis and ERE development. For this reason an experiment was performed in which
food consumption was restricted in a group of rabbits, as described in Methods. Since the
majority of the rabbits develop ERE between the first and second week after weaning,
food deprivation was performed in 2 groups of rabbits, initiating the food restriction on
the first or the second week post-weaning. In order to assess the effect of exclusively
food restriction on the  microbiota  composition,  all  rabbits  that  developed ERE were
excluded from analysis, since ERE rabbits have marked microbiota dysbiosis and this
could  mask  the  changes  in  the  microbiota  produced  as  a  result  of  food  restriction.
Importantly,  there  was  no  difference  in  the  number  of  rabbits  that  developed  ERE
between  the  group  of  rabbits  subjected  to  food  restriction  and  the  control  group,
suggesting  that  food  restriction  does  not  promote  ERE.  Subsequently,  microbiota
analysis was performed from cecal contents collected from the control group of rabbits
with unlimited access to food and from the group of rabbits in which food was restricted.
As a control, the cecal content from another group of rabbits with unlimited access to
food and which have developed ERE was also analyzed. Yue & Clayton measure of
dissimilarity  and PCoA were used to  compare  the microbiota  structure  from these  3
groups of rabbits. As shown in Figure R40, the microbiota from samples obtained after
ERE onset differ from those samples collected after 2 days of food restriction and from
samples of healthy controls (AMOVA, P<0.001), independently whether restriction was
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performed at 1 or 2 weeks post-weaning (Figure R40A and Figure R40B, respectively).
Interestingly, the  microbiota  from samples  obtained  after  2  days  of  food  restriction,
independently whether  restriction was performed at  1  or 2  weeks post-weaning,  was
significantly different from the microbiota of healthy rabbits with unlimited access to
food (AMOVA, P= 0.002;  Figure R40), suggesting that the food deprivation produced
changes  in  the  microbiota.  Altogether,  these  results  suggest  that  the  overall  changes
observed after  ERE onset  could not  be explained by reduction in food consumption,
although reduction in food consumption does change the microbiota.
Figure R40. Food restriction does not reproduce the microbiota dysbiosis observed after ERE onset.
The overall microbial composition in samples from healthy rabbits subjected to food deprivation for 2
consecutive days (HLT restricted),  starting 7 days after weaning  (A) or 14 days post-weaning  (B).  As
control, samples collected from age-matched healthy control groups (HLT control) and from rabbits that
develop ERE (ERE after), were also analyzed.
Subsequently, the non-parametric Wilcoxon test with FDR was applied in order
to  identify  specific  changes  in  the  microbiota  induced  by  food  restriction.  When
compared to control, samples obtained after food restriction performed on the second
week post-weaning revealed  a  higher  relative  abundances  (p<0.01;  FDR<0.1)  of  the
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genera  Anaerovorax and  Olsenella,  and  lower  abundance  (p<0.01;  FDR<0.1)  of
Anaeroplasma. Similarly, Anaerovorax was detected as a genus with significantly higher
abundance (p<0.01)  in  the  group of  food restriction on the  first  week post-weaning.
These results suggest that the higher abundance of Anaerovorax in ERE rabbits could be
explained, by the decrease in the food consumption (Figure R41).
Figure  R41.  Higher  abundance  of  the  genus  Anaerovorax in  ERE  rabbits  could  be  due  to  the
decrease  in  the  food  consumption  in  this  group  of  rabbits.  Relative  abundance  of  the  genus
Anaerovorax in samples collected from healthy control group (HLT_C), samples collected after 2 days of
food deprivation (HLT_R) and samples from ERE rabbits.
 4.3.6 Analysis of the genome of the OTU31 classified as Clostridium and associated
with ERE onset
Having discarded the role of food restriction in ERE development and major
dysbiosis,  the  investigation  was  focused  on  the  Clostridium OTU31,  identified  as  a
possible  etiological  agent  of  ERE.  Indeed,  several  species  of  Clostridium (e.g.  C.
botulinum, C. tetani, C. difficile) are known etiological agents of infectious diseases both
in  humans  and  animals.  Moreover,  for  over  a  decade,  it  has  been  suggested  that
Clostridium spp. could be a possible etiological agent of ERE (94).
In  order  to  study  in  more  detail  the  Clostridium OTU31 and  determine  its
potential virulence capabilities and role in ERE, an attempt to isolate this OTU from
139
Role of intestinal dysbiosis on gut colonization by bacterial pathogens
fecal samples of ERE rabbits was performed. After analysis of more that 1,000 colonies,
we were able to isolate 1 bacterial colony whose 16S RNA gene sequence had 100%
similarity to the representative sequence of OTU31. Subsequently, the genome of this
strain was sequenced as described in Methods. Based on phylogenomic analysis of 92
genomes  of  members  of  the  Clostridiales  order,  the  OTU  identified  as  a  putative
etiological  agent  of  ERE  was  demonstrated  to  be  a  novel  species  of  the  genus
Clostridium, which we named Clostridium cuniculi (Figure R42). Moreover, the closest
neighbors of C. cuniculi are C. botulinum and C. perfringens, 2 well-known pathogens.
Interestingly, both C. botulinum and C. perfringens produce potent toxins, which induce
muscle paralysis, a major cause of the disease symptoms observed during the course of
the  disease  induced  by  these  pathogens.  Interestingly,  as  mentioned  in  Introduction
section 1.2.3.3, intestinal paralysis has been suggested to be the cause of some of the
signs observed in ERE (e.g. cecum impaction) (92). For these reasons, all genes that




Figure R42.  The OTU31 is  a  new species  of  the genus  Clostridium.  The tree represents  the best
phylogenetic location of the OTU31 and species belonging to the genus  Clostridium. The bootstrap
value is stated when it was lower than 95%. The heatmap represents percentage of identity of the OTU31
with  other  species  of  the  genus  Clositridum  calculated  by  implementation  of  ANI  and  MASH  (see
Methods). 
The analysis of the genome revealed the presence of 2 virulence factors: exoU,
a type III effector protein with cytotoxic properties, and a gene encoding for a hemolysin.
Moreover, an operon strikingly similar to  the operon present in  C. botulinum,  which
encodes the type A neurotoxin complex, was also identified (Figure R43). This complex
in  C.  botulinum is  composed  by  the  botulinum  neurotoxin  (BoNT),  several  toxin
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associated proteins known as the hemagglutinins (HAs), the transcription factor botR,
and the non-toxic non-hemagglutinin protein (NTNH)  (131). BoNT functions as Zinc-
dependent  metalloprotease  that  inhibits  the  release  of  neurotransmitter  acetylcholine
from peripheral cholinergic synapses, resulting in muscle relaxation. As shown in Figure
R43, the operon detected in the genome of C. cuniculi contains all the HAs genes and a
transcriptional factor similar to that one present in an operon encoded by C. botulinum.
In contrast,  C. cuniculi is lacking the gene that encodes BoNT, and instead encodes a
protein with domains similar to those present in hemagglutinins (ricin domain) and in
serine  protease  inhibitors.  Interestingly,  the  inhibition  of  a  serine  protease
(acetylcholinesterase) is known to cause paralysis  (132), an event that is thought to be
the cause of some of the signs observed in ERE.
Figure R43. The operon detected in the genome of C. cuniculi and corresponding operons in genomes
of  C. botulinum and  C.  perfringens.  The names above genes encoded by the operon detected in the
genome of  C. cuniculi correspond to the best match obtained by aligning the sequence of the proteins
encoded by the genes of the operon against the NCBI database. The asterisk marks genes that are only
partially similar to the indicated genes. The names bellow genes encoded by the operon correspond to the
protein domains identified in amino-acid sequences encoded by these genes using InterPro and considering
the most significant hit. In yellow are marked transcription regulators, in red effector proteins, in blue
hemagglutinins,  and  in  brown  holins.  BotA-  botulinum toxin  A;  NTNH-  nontoxic,  nonhemagglutinin
protein; HA- hemagglutinins; IR- inverse repeats.
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 4.3.7 Attempt to reproduce ERE by administration of the  C.  cuniculi to healthy
SPF rabbits
In  order  to  test  the  role  of  C.  cuniculi in  ERE development,  an  attempt  to
reproduce the disease was performed, as described in Methods. Since some authors were
able to reproduce ERE in healthy rabbits by administration of the inoculum obtained
from cecal content of animals that developed the disease (93,94), a group of rabbits was
orally inoculated with cecal content of animal that developed ERE as a positive control.
The second group was orally inoculated with 108 CFUs of the C. cuniculi isolated strain,
while  the  third group served as  a  negative control  and was not  inoculated  with  any
bacteria. All 3 groups of rabbits were observed for appearance of ERE signs, and their
food consumption was measured daily. No specific reduction in food consumption was
observed in the groups of rabbits that received  C. cuniculi strain. On the other hand,
although a slight reduction in food consumption was observed in the group of rabbits that
were inoculated with the cecal contents from ERE rabbits  (Figure R44),  no specific
signs  such  as  mucus,  diarrhea,  or  cecal  impaction  could  be  observed  in  any  of  the
analyzed  groups.  These  results  suggest  that  our  experimental  setup  was  not  able  to
reproduce the disease even with the inoculum obtained from ERE rabbits and therefore
further attempts should be performed in order to fully elucidate the role of C. cuniculi in
the initiation of ERE.
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Figure R44. Food consumption changes during the attempt to experimentally reproduce ERE. Food
consumption  (in  grams)  measured  during  2  weeks  in  a  control  group  of  rabbits  that  received  PBS
(Control), a group of rabbits to which C. cuniculi strain was administered, and a group of rabbits to which
cecal contents of ERE rabbits was administered (cecal content). One-way ANOVA revealed significantly
different means between the control group and the cecal content group (p<0.01), while no difference was






 5.1 Microbiota dysbiosis and MRE colonization and persistence in mice
The intestinal microbiota provides the protection against the colonization with
intestinal pathogens, a phenomenon known as “colonization resistance”  (133). On the
other hand, microbiota dysbiosis as a result of antibiotic treatment is associated with the
loss  of  colonization  resistance  and,  consequently,  intestinal  tract  colonization  by
antibiotic-resistant  pathogens,  such  as  MRE.  In  a  study  published  by  Hoyen  et  al.
(87) authors demonstrated that not all antibiotic treatments affect equally the capability
of K. pneumonieae to colonize the intestine of the mice, suggesting that some members
of the intestinal microbiota participate in CR, while others are dispensable. However, the
effects  of  different  antibiotic  treatments  on the  microbiota  composition  and bacterial
species that are necessary for the maintenance of the CR against MRE are not completely
understood. In the first chapter of this thesis, we have investigated the effects of different
antibiotic  treatments  on  the  microbiota,  and subsequently, on  MRE colonization  and
persistence using a mouse model. We specifically investigated the effect of 3 antibiotics
(ampicillin, vancomycin and neomycin). Vancomycin is a glycopeptide antibiotic with
activity  mainly  against  Gram-positive  bacteria,  although  a  previous  study  that  we
performed in mice demonstrated that administration of this antibiotic could also result in
alteration of Gram-negative bacteria (66). Consistent with the results from our previous
study, mice treated with vancomycin had lower abundances of genera belonging to the
phylum  Bacteroidetes  (Gram-negative)  and  Firmicutes  (Gram-positive),  while  the
phylum Proteobacteria underwent a drastic expansion. The depletion of the bacteria from
the phylum Bacteroidetes is somehow paradoxical because this phylum contains bacterial
species, which are resistant to vancomycin. Nevertheless, the resistance to vancomycin
of Bacteroidetes species is frequently lower  (MIC50= 4- 128μg/ml)  than the resistance
observed in  Proteobacteria  species such as  K. pneumonie  (MIC50= 128- 1024μg/ml)
(134–137). Taking into account the high concentrations that vancomycin can reach in the
gut  after  oral  administration  (500  g/g)  (138),  it  is  possible  that  while  some of  the
Proteobacteria strains can survive in the gut after  vancomycin treatment, most of the
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Bacteroidetes strains are depleted by the action of the antibiotic. Nevertheless, we cannot
discard the possibility that some Firmicutes species that are depleted after vancomycin
therapy could be important for the growth of Bacteroidetes species. Futures studies will
be necessary to elucidate the mechanism by which basically all Bacteroidetes species are
depleted  after  vancomycin  treatment.  On  the  other  hand,  mice  were  treated  with
ampicillin,  a broad-spectrum antibiotic active against  Gram-positive and some Gram-
negative bacteria. In a study published by Ubeda et al. (65) ampicillin treatment resulted
in the increase of the family Streptococcaceae in the mouse cecum, while the abundance
of  the  family  Erysipelotrichaceae  and  Lachnospiraceae  decreased.  In  this  study  we
confirmed that families Erysispelotrichaceae and Lachnospiraceae were decreased as a
result of the ampicillin treatment. However, the increase in the abundance of the family
Streptococcaceae could not be detected in mice treated with ampicillin as a part of this
thesis, which could be explained by the fact that this family was not present in the fecal
samples of most of the analyzed mice before treatment. In addition, our results indicate
that  mice  treated  with  ampicillin  had  significantly  higher  levels  of  Proteobacteria,
specifically the genus Parasutterella. On the other hand, neomycin is an antibiotic with a
relatively  narrow  spectrum  (mainly  against  Gram-negative  bacilli  but  not  against
anaerobes,  which  account  for  most  of  the commensal  bacteria  identified  in  the  gut).
Thus,  it  was  not  surprising  that  the  overall  effect  of  neomycin  on  the  microbiota
composition was mild as compared to the effect of vancomycin or ampicillin. Overall,
these results indicated that each of the tested treatments produced distinct changes in the
microbiota composition.
Previous studies have shown that antibiotic treatment renders mice susceptible
to colonization with antibiotic-resistant Enterobacteriaceae. In a recent study, Lewis  et
al. (139) demonstrated that the administration of vancomycin to mice results  in high
levels of intestinal colonization with carbapenem-resistant  K. pneumoniae. In order to
investigate the role of microbiota dysbiosis,  as a result  of ampicillin,  vancomycin or
neomycin treatments,  on colonization with  MRE,  mice  were infected with  multidrug
resistant Klebsiella pneumoniae (MRKP). We found that MRKP was unable to colonize
the intestine of the untreated mice, as shown before by Donskey et al. (140). On the other
hand, consistently with the different effect of the tested antibiotics on the microbiota
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composition,  MRKP colonized at  high levels the intestine of those mice treated with
ampicillin or vancomycin, but not after neomycin treatment. Consistent with our results,
other authors also reported the ability of K. pneumoniae to colonize the murine intestine
after the ampicillin treatment (85). These results suggest that vancomycin and ampicillin
treatment  depleted  bacteria  that  are  necessary  for  the  maintenance  of  the  CR,  while
neomycin treatment, although produced changes in the microbiota composition, did not
affect the key bacteria necessary for the protection against MRKP intestinal colonization.
Importantly, we  observed  that  once  established,  MRKP could  persist  in  the
intestine of the vancomycin and ampicillin treated mice for up to 1 month. These results
were even more pronounced when the 3 antibiotics were given together. This last result
is  worrying since frequently, as described in the project 2 of this  thesis,  hospitalized
patients received more than one antibiotic at the same time, which could render them
more susceptible for colonization with the multidrug resistant pathogens. Moreover, our
results are consistent with the ones obtained by Caballero et al. (85) in which the authors
demonstrated the capability of MRKP to persist in the intestinal tract after ampicillin
treatment. Nevertheless in their study  (85), mice were infected concurrently with VRE
and MRKP, thus  it  was  possible  that  somehow VRE could  be  necessary  for  MRKP
persistence, which was ruled out in our study. Subsequent analysis of the microbiota of
treated mice and infected with MRKP revealed that mice did not recover their baseline
microbiota  after  1  month  since  the  cessation  of  the  antibiotic  treatment.  This  result
suggested,  as  previously  was  demonstrated  for  VRE  (65) or  C.  difficile (24),  that
permanent changes in the microbiota could allow persistence of MRE in the intestinal
tract. Both for VRE and C. difficile it was demonstrated that ampicillin or clindamycin
promote permanent changes in the murine microbiota that render mice susceptible to
colonization by these pathogens even 4 weeks after antibiotic withdrawal. 
In  order  to  investigate  if  antibiotics  promote  persistent  changes  in  the
microbiota that could promote MRKP colonization and persistence, mice were treated
with AVN and allowed to recover for 2 or 4 weeks before inoculation of MRKP. Our
results  demonstrated  that  AVN  produced  profound  changes  in  the  microbiota  that
persisted  up  to  1  month  post-treatment,  which  rendered  mice  susceptible  to  MRKP
colonization. These results are consistent with those of Lewis et al. (139), in which it was
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demonstrated that mice treated with vancomycin or metronidazole remained susceptible
to colonization with carbapenem-resistant K. pneumoniae during 2 weeks after the end of
the treatment.
Although our  results  and those obtained by Lewis  et  al. (139) indicate  that
antibiotics  per se can promote permanent changes in the microbiota, which permit gut
colonization by MRKP and therefore could contribute to the ability of MRKP to persist
for long time in the intestinal tract after antibiotic withdrawal, we cannot rule out the
possibility that MRKP colonization could prevent the recovery of the microbiota, which
would enhance persistence of the pathogen in the intestinal tract.  Indeed, it  has been
shown in mice that infections with another member of the family Enterobacteriaceae
(Salmonella) induced intestinal inflammation, which promotes microbiota dysbiosis, and
enhances intestinal colonization by this pathogen  (63). Thus, it would be important to
investigate if MRKP, once colonizes the intestine, prevents the microbiota recovery and
also enhances its own persistence in the murine gut. 
Several studies have shown that the fecal transplant restores the microbiota and
CR against  intestinal  pathogens.  In  a  study  published  by  Ubeda  et  al. (23) authors
demonstrated that administration of fecal suspension from untreated mice to those that
were previously treated with vancomycin and infected with VRE resulted in the recovery
of the microbiota and clearance of VRE. We obtained similar results with MRKP. Indeed,
mice  treated  with  antibiotics  that  received  a  fecal  transplant  recovered  a  microbiota
similar to that of untreated mice and were no longer susceptible to MRKP colonization.
These  results  demonstrate  that  the  incomplete  microbiota  recovery  allowed  MRKP
colonization and that  restoration of  the  microbiota  with a  fecal  transplant  allows re-
establishment of CR against this pathogen. This last result shows the efficacy of the fecal
transplant as a prophylactic therapy against MRKP colonization. Although, we did not
investigate the therapeutic effect of fecal transplant on MRKP colonization by giving a
fecal transplant to mice that were already colonized with MRKP, the therapeutic effect of
fecal transplants against MRKP was already demonstrated by Caballero et al. (85). The
authors demonstrated that fecal transplant could completely eliminate MRKP and VRE
in mice that were already concurrently colonized with these 2 pathogens. Although our
experimental set up was slightly different (treatment with a cocktail of antibiotics instead
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of treating with ampicillin; and mono-colonization with MRKP instead of MRKP+VRE),
it is likely that similar results would have been obtained. However, this remains to be
demonstrated.
In  a  study  published  by  Ubeda  et  al. (23) the  authors  demonstrated  that
administration of an anaerobic fecal culture, besides fecal transplant, could clear VRE
from the murine intestine. This experiment, in addition to next-generation sequencing
analysis, allowed the identification of key commensal bacteria that provide CR against
VRE.  We decided to  apply  the  same approach in  order  to  determine  those  bacterial
strains  that  could  protect  against  MRKP  colonization  in  mice.  For  this  purpose,  4
different  anaerobic  fecal  cultures  (grown  in  Gut,  Schaedler,  Wilkinson  and  Sellers
cultivation media) were administered to mice after the cessation of the AVN treatment.
Notably, none of the tested anaerobic fecal cultures was able to prevent colonization with
MRKP. This result was somewhat unexpected, since at least one of these media (Gut
media), supposedly allows the growth of a remarkable proportion of the fecal microbiota,
as described in a study published by Goodman et al. (141). However, it was possible that
the Gut media, although could support the growth of a large group of intestinal bacteria,
does  not  support  the  growth  of  key  members  of  the  microbiota  necessary  for  the
maintenance  of  the  CR  against  MRKP.  Indeed,  subsequent  sequencing  analysis
demonstrated that the levels of  Barnesiella,  one of the most abundant genera found in
untreated mice, could not be restored in treated mice after administration of Gut media.
Since none of the anaerobic fecal cultures had a protective effect against MRKP,
we decided to change the strategy in order to identify commensal bacteria that could
confer  protection against  MRKP. We compared the microbiota  compositions  of  mice
treated with AVN after 1 month of recovery and untreated mice. This comparison lead to
the identification of 5 genera that were the most affected by AVN treatment (Barnesiella,
Alistipes,  Bacteroides,  Lactobacillus  and Mucispirillum). Notably,  administration  of
bacterial isolates from these 5 genera to mice treated with AVN partially restored CR
against MRKP. Importantly, we also demonstrated that the total bacterial load in fecal
samples from mice receiving the mix containing the 5 isolates did not differ from mice
that received the fecal anaerobic cultures, which did not prevent MRKP colonization.
These results demonstrated that the reduction in MRKP colonization levels in mice to
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which the mix containing the 5 isolates was given is not simply a result of restoration of
the bacterial density. On the other hand, the effect of the protective bacterial mix was not
the result of enhancing a recovery of the overall bacterial diversity, since the Shannon
index in samples collected from mice to which the protective bacterial mix was given
was the same as in those animals that did not receive this bacterial mix. Thus in this case,
the mechanism by which the protective mix confer CR may differ from that one shown
by Lawley  et al. (100) for  C. difficile. In their study, the authors were able to confer
protection  in  mice  against  C.  difficile by  administering  a  mix  containing  6  different
commensal bacterial species. Notably, this bacterial mix was able to restore the microbial
diversity  observed  in  untreated/uninfected  mice,  which  may  inhibit  pathogen
colonization. Thus for that particular mix, restoration of the overall microbiota diversity
could be crucial for conferring protection against the pathogen, which differs from the
results we have obtained in our study. 
In order to elucidate which of the 5 bacteria that were included in the mix could
be responsible for the observed reduction in MRKP colonization levels, we analyzed the
microbiota composition of mice treated with AVN and to which MIX5 was administered.
Importantly, only the genera Barnesiella and Lactobacillus were significantly higher in
the group of mice that received the protective bacterial mix, as compared to mice that did
not receive the bacterial mix, suggesting that only these 2 genera were able to re-colonize
the  murine  gut  after  the  antibiotic  treatment.  This  is  surprising,  since  all  of  the
administered bacteria were isolated from the mice feces, and thus are adapted to grow in
the murine intestine. One possibility is that these bacterial strains need other commensal
bacteria,  absent  from the  intestine  of  the  AVN treated  mice,  for  colonizing  the  gut.
Nevertheless, our results suggest that restoration of the levels of the genera Barnesiella
and Lactobacillus is enough for conferring CR against MRKP intestinal colonization in
mice. It is important to say that the genus Lactobacillus was also re-established in mice
to which the Gut anaerobic fecal culture was given and these mice were not resistant to
MRKP colonization. These results suggest that recovery of the genus Lactobacillus alone
was not enough for suppression of the MRKP colonization. On the other hand, we cannot
discard the possibility that the Lactobacillus strain supplied by the Gut mix was different
from that one supplied by the MIX5. In addition, the Gut mix may contain other bacterial
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species that may enhance MRKP colonization. In any case, further research is needed to
elucidate if the Barnesiella and Lactobacillus strains provided by the MIX5 are sufficient
to provide protection against MRKP. In fact, we were planning to perform experiments in
which mice will be treated with AVN and will receive  Barnesiella and  Lactobacillus
strains in combination, as well as individually, but due to a deadline for thesis deposit at
the University, we have not been able to include the results from these experiments in the
thesis.
Interestingly, in  our  previous  study we have shown that  the presence of  the
genus Barnesiella in the murine intestine is associated with clearance of VRE from the
murine gut, although the mechanisms of protection is unknown (23). In another study, B.
intestihominis, together with 3 other bacterial strains, was shown to reduce the levels of
the C. difficile colonization in mice (27). Importantly, members of the genus Barnesiella
are well known as producers of the acetic acid (142), one of the most abundant SCFA in
the  intestine.  Acetate  has  been  shown  to  inhibit  the  growth  of  species  from  the
Enterobacteriaceae family such as  E. coli (143), suggesting a possible mechanism by
which acetate  produced by  Barnesiella species could be providing protection against
MRKP  colonization  in  mice.  On  the  other  hand,  many  members  of  the  genus
Lactobacillus are known as probiotic strains. In a study published by Karska-Wysocki et
al. (144) authors demonstrated that L. acidophilus and L. casei have inhibitory effects on
the growth of methicillin-resistant  Staphylococcus aureus (MRSA) in vitro. In another
study the combination of the L. acidophilus and L. plantarum was shown to effectively
reduce  the  multidrug  resistant  E.  coli levels  of  colonization  in  mice  intestine  (145)
However, the mechanism by which these probiotics confer protection in those particular
studies remains unknown. On the other hand, previous studies suggested that some of the
Lactobacillus strains could act against pathogens indirectly, through the modulation of
the immune system, as seen in case of  L.casei,  whose administration to mice infected
with S. typhimurium resulted in modulation of the inflammatory response and decreased
the severity of Salmonella infection (146). On the other hand, many Lactobacillus strains
encode for the bile salt hydrolase (BSH), enzyme that cleaves the amino acid side chain
of glyco- or tauro- conjugated bile acids to generate unconjugated bile acids (cholic and
chenodeoxycholic acids), which then are amenable to further bacterial modification to
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yield secondary bile acids (deoxycholic and lithocholic acid)  (147). The secondary bile
acids have been associated with the resistance to the C. difficile infection in mice (27),
suggesting that, beside modulation of the immune response, some of the  Lactobacillus
strains could also act directly against pathogens, through production of the secondary
bile  acids.  Moreover,  some  Lactobacillus strains  are  well  known  producers  of
bacteriocins.  In  a  study  published  by  Song  et  al. (148) authors  described  a  novel
bacteriocin produced by L. plantarum that exerted an in vitro inhibitory effect against E.
coli.  Although  there  are  several  possible  mechanisms  by  which  Barnesiella and
Lactobacillus  could exert their effect on MRKP colonization levels, further studies are
needed to elucidate which mechanism is responsible for the protection against MRKP
intestinal colonization. In fact, we performed in vitro experiments in which we tested if
Barnesiella or Lactobacillus strains used in the MIX5 could inhibit directly MRKP. For
now, we were not able to detect direct inhibition of MRKP by these protective bacterial
strains in vitro. However, this does not necessary confirm that direct inhibition is not the
mechanisms by which  Barnesiella and/or  Lactobacillus could perform their protective
effect. Indeed, the metabolism of both strains could differ  in vitro and in vivo. For this
reason we are also planning to test the inhibitory effect of cecal contents from mice that
received these two strains.  In  addition,  metabolomic and transcriptomic studies  from
mice  colonized  with  these  two strains  will  be  performed  to  investigate  proteins  and
metabolites derived from these two strains that could have an effect on MRKP growth
(either by direct inhibition or by depletion of specific nutrients).
We recognize that our study in mice has several limitations. One of them is that
we did not test the protective effect against MRKP of every single commensal bacterium
that was not recovered after AVN treatment. In any case, we were able to find at least
some important key players in CR against MRKP. On the other hand, we have focused
our studies on the bacterial fraction of the microbiota. Other studies have shown that the
growth  of  pathogenic  Enterobacteriaceae  (i.e.  enterohemorrhagic E.  coli)  could  be
inhibited by the fungi  Saccharomyces  cerevisiae  in  a  dynamic gastrointestinal  model
(149).  Thus,  it  would be interesting to analyze in  future studies  how changes  in  the
mycobiome could have  an effect  on MRKP colonization  and if  reconstitution of  the
mycobiome with specific fungi is sufficient to confer CR.
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Overall, our results indicate that persistent microbiota dysbiosis, as a result of
antibiotic treatment, promotes MRKP intestinal colonization in mice. Moreover, we were
able to define changes in the microbiota composition after antibiotic treatment associated
with the loss of the CR against MRKP. Importantly, we were able to demonstrate that the
restoration  of  2  bacterial  genera,  depleted  by  antibiotic  therapy,  was  sufficient  to
significantly diminish the ability of MRKP to colonize the intestinal tract.
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 5.2 Microbiota dysbiosis and MRE colonization in hospitalized patients
Infections  caused by MRE represent  a  great  threat  worldwide,  especially  in
hospitalized patients (81). They usually begin by the MRE colonizing the intestinal tract.
Moreover,  once  established, MRE  can  reach  high  numbers  in  the  intestine,  which
promotes their dissemination into the bloodstream (83). Woerther et al. (84) showed that
carriers with the highest levels of ESBL-producing Enterobacteriaceae were also those
with the highest risk of bacteraemia produced by these pathogens. Besides, high levels of
colonization  promote  transmission  of  the  pathogen  among  patients.  Despite  the
importance, to this date no study has investigated risk factors that could be associated
with MRE levels of gut colonization. In addition, not much is known about the members
of the microbiota that are needed for maintenance of CR against MRE. In this second
part  of  the  thesis,  we  have  investigated  risk  factors  associated  with  MRE levels  of
colonization, and we have attempted to identify commensal bacterial species associated
with resistance against MRKP intestinal colonization.  For this  study we analyzed the
MRE levels and the composition of the microbiota of 817 samples collected from 140
acute  leukemia  patients,  a  population  that  is  frequently  colonized  with  MRE.
Interestingly, our results show that more than a half of the analyzed patients (60%) got
colonized with MRE during their stay at the hospital.  A previous study in which the
authors  collected  fecal  samples  from  patients  with  haematological  and  oncological
malignancies within 72 h of their admission to a hospital revealed that 17.5% of these
patients was colonized with ESBL-producing Enterobacteriaceae (76). In another study,
authors reported 35% of prevalence of CRE in fecal swabs collected on the day 4 since
the admission in patients from the intensive care unit (78). Although our results show a
higher  percentage  of  patients  colonized  with  MRE than  the  one  reported  in  these  2
studies, it could be explained by the fact that we followed our patients through the whole
admission period, which allowed us to detect MRE in cases when patients got colonized
later during their stay in the hospital, while in previously mentioned studies screening
was performed exclusively on third or fourth day after patients’ admission.
The  analysis  of  the  susceptibility  pattern  of  the  isolated  MRE  strains  has
revealed some interesting and clinically useful data.  First,  most  of the isolated MRE
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strains identified in acute leukemia patients are resistant to ciprofloxacin. Ciprofloxacin,
a  second generation  fluoroquinolone,  is  given to  these  patients  from the  moment  of
admission to the hospital as prophylaxis, and thus, treatment with this antibiotic could
favor the expansion of the ciprofloxacin-resistant MRE strains in the intestine of the
studied  acute  leukemia  patients.  Indeed,  Jorgensen  et  al. (150) demonstrated  that
exposure of  Pseudomonas aeruginosa to ciprofloxacin rapidly selects for mutants with
high-level ciprofloxacin resistance. Moreover, in a review published by Redgrave et al.
(151),  the  authors  point  to  the  high  correlation  between  consumption  of  the
fluoroquinolones and percentage of E. coli strains resistant to these antibiotics. Thus, at
least for the acute leukemia patients of the Hospital La Fe, treatment with ciprofloxacin
will not be recommended as a therapy against infections produced by MRE. In contrast,
most of the isolated MRE strains were sensitive to amikacin and tigecyclin, 2 antibiotics
that  have  been  successfully  used  for  the  treatment  of  MRE,  including  carbapenem-
resistant strains of K. pneumoniae (81). For this reason, the combination of amikacin and
tigecycline could be a promising treatment for elimination of MRE in these particular
patients.
As previously mentioned in the Introduction, all studies to date have analyzed
the association of different clinical factors with the MRE colonization,  by looking at
prevalence of MRE positive samples (presence or absence). Here, for the first time, we
attempted to identify clinical and other factors associated with the levels of the MRE
intestinal  colonization,  since  high  MRE  intestinal  levels  are  crucial  for  subsequent
dissemination to the bloodstream, which can indeed put in serious threat the life of the
patient. Importantly, we found that gender, age, type of leukemia or parenteral nutrition
do not  affect  MRE colonization  levels.  However, the  MRE colonization  levels  were
significantly higher  in samples  collected during the chemotherapy compared to  those
samples collected during the transplant period. The major difference between these 2
admission  periods  is  that  during  the  transplant  period,  patients  receive,  beside
chemotherapy to eliminate the cancer cells, a bone marrow transplant containing immune
cells precursors. Thus, the lower levels of MRE in samples obtained during the transplant
period could be due to a faster re-establishment of a proper immune response, which
could contribute to  diminishing MRE levels  in  the gut.  The only immune parameter
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available for these patients was the level of neutrophils in blood. Surprisingly, our results
suggest  that  neutropenia  could  be associated  with  the  decrease in  MRE colonization
levels. This could be due to the more intensive antimicrobial therapy that neutropenic
patients  received.  Indeed,  as  discussed  below, we found a  clear  association  between
administration of beta-lactams with activity against MRE and decrease in MRE levels.
When we excluded samples in which the MRE was sensitive to the antibiotic that the
patient  was receiving,  the observed neutropenia was still  associated with decrease in
MRE levels, although to a lower extent, suggesting that indeed treatment of antibiotics
could  explain  in  part  the  decrease  in  MRE  levels  observed  during  neutropenia.
Nevertheless, it should be further investigated why neutropenia is still associated with
lower  MRE  levels  after  excluding  samples  in  which  the  MRE  is  sensitive  to  the
antibiotic that the patient was receiving. Besides neutrophils,  other immune cells and
effectors molecules, which are known to diminish pathogen load (e.g. IgA) could have a
role  in  MRE  intestinal  colonization  in  leukemia  patients.  This  information  was  not
available for the patients under study, but it will be interesting to investigate in future
studies  how different  immune effector  cells  and molecules  affect  MRE levels  in  the
intestinal  tract  of  patients.  Another  possible  explanation  for  the  difference  in  MRE
intestinal levels between samples collected during chemotherapy and transplant period
could  be  that  certain  patients  receiving  a  specific  type  of  transplant  would  be  more
resistant  to  MRE.  Two  main  types  of  transplants  are  received  by  these  patients,
depending on the origin of the cells infused (autologus or allogeneic, depending if the
donor  and  recipient  are  the  same  or  are  different  subjects).  Nevertheless,  patients
receiving both types of transplants have similar MRE intestinal levels, suggesting that
the  type  of  transplant  does  not  seem to  be a  key factor  involved in  MRE intestinal
colonization, neither the type of chemotherapy as we also demonstrated. Future studies,
including the analysis of other immune parameters, besides neutrophils, will be required
to clarify the differences observed during both admission periods. 
Various studies have identified different antibiotic treatments, among which are
aminoglycosides, carbapenems, quinolones and colistin, as risk factors for the presence
of antibiotic-resistant Enterobacteriaceae in the gut (76,78,86,152). These studies, as the
ones obtained in our mouse experiments, suggest that disruption of the CR by antibiotic
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treatment  opens the  way to colonization  with  MRE. However, our  analysis  of  MRE
levels  in  samples  collected  from  acute  leukemia  patients  revealed  that  beta-lactam
treatment  produces  a  reduction  in  MRE  colonization  levels.  Moreover,  when  we
analyzed only those samples in which the identified MRE strains were sensitive to beta-
lactams,  the  reduction  in  colonization  levels  was  even  more  pronounced.  More
importantly, the administration of beta-lactams, when the identified MRE strains were
resistant to these antibiotics did not produce an expansion of the pathogen. Thus from
our  analysis,  we  could  conclude  that  treatment  with  beta-lactams  does  not  promote
intestinal colonization with MRE but rather diminish the sensitive strains inhabiting the
gut. This result contradicts the result obtained in our mouse model in which mice that
were receiving ampicillin (a beta-lactam antibiotic)  were highly susceptible for MRE
colonization. In order to understand this contradictory result, it is important to notice that
all acute leukemia patients receive oral prophylactic treatment (ciprofloxacin) from the
first day of admission to the hospital. This antibiotic is known to produce alterations in
the microbiota composition, which could disrupt CR (106). Thus, it is possible that beta-
lactam treatment,  which is  given after ciprofloxacin treatment,  does not produce any
further alteration in the microbiota that could increase the level of MRE colonization. On
the other hand, it is possible that beta-lactams does produce some changes that promote
MRE colonization in some but not in all patients and therefore we are not able to detect a
significant  effect.  Interestingly,  the  beta-lactams  that  the  patients  received  were
administered through the intravenous route. Thus, our results demonstrate that, although
administered  systematically,  beta-lactams  could  reach  the  intestine  at  enough
concentration to reduce the MRE colonization levels, in case the strain is sensitive to
beta-lactams. Overall, our results suggest that the use of beta-lactams in acute leukemia
patients  could  be  beneficial  for  combating  MRE infections.  Administration  of  these
antibiotics, when the patient is colonized with an MRE susceptible to beta-lactams would
result in MRE decrease, which would reduce the probability of MRE dissemination into
the bloodstream, while the administration when patient is colonized with a beta-lactam
resistant strain would not promote MRE expansion. Nevertheless, it is important to say
that the administration of beta-lactams when patient is colonized with MRE strain that is
sensitive to these antibiotics could lead to appearance of beta-lactam resistant strains. In
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our study we detected change in beta-lactam resistance pattern in 2 cases out of 39 to
which beta-lactam was administered, while no change from sensitive to resistant MRE
strain was detected in the absence of beta-lactam treatment. This result suggest that the
administration  of  beta-lactams could  select  for  the  expansion of  low abundant  MRE
strains resistant to beta-lactams, or could result in change of the resistance in existing
MRE strains.  More importantly, we detected an increase in  MRE intestinal  levels  in
samples after the switch in resistance to beta-lactams in MRE detected strains. These
results suggest that there should be especial caution when prescribing the beta-lactam
treatment to acute leukemia patients, since it could favor the expansion of MRE strains
resistant to beta-lactams, although the change in beta-lactam resistance does not seem to
occur frequently. On the other hand, we observed that aminoglycoside treatment (i.e.
amikacin)  in  general  does  not  seem to  produce  change  in  MRE colonization  levels.
However, our results shown that intravenous aminoglycosides have an inhibitory effect
on MRE intestinal levels when given to patients colonized with strains sensitive to these
antibiotics. Due to the low number of samples in which the identified MRE was resistant
to aminoglycosides, we were not able to test the effect of administration of this antibiotic
to patients colonized with aminoglycosides-resistant MRE strains, thus we cannot rule
out  the  possibility  that  aminoglycosides  may  promote  microbiota  changes  that  may
enhance colonization of MRE aminoglycosides-resistant strains. Importantly, our results
shown that  the  glycopeptide  treatment  reduces  MRE intestinal  levels.  Glycopeptides
analyzed  in  this  study  were  vancomycin  and  teicoplanin,  antibiotics  to  which  MRE
strains are resistant. Thus, it was somewhat surprising that glycopeptides could affect
MRE colonization levels. In order to discard that this effect was due to administration of
other antibiotics at the same time as glycopeptides, to which the identified MRE strain
was sensitive,  analysis  was repeated only with those samples in which the identified
MRE strains were resistant to all antibiotics that were administered to the patient at the
moment of sampling. Although the number of analyzed pairs of samples was small (3),
the analysis did not reveal significant change in MRE levels as a result of glycopeptide
treatment.  In  summary,  the  analysis  performed  indicate  that  systemic  antibiotics,
administered  to  a  patient  colonized  with  an  MRE that  is  sensitive  to  that  particular
antibiotic, are able to reach sufficient levels in the intestinal tract to diminish intestinal
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MRE levels. On the other hand, our results show the importance of including data about
susceptibility patterns of the analyzed pathogens into the analysis and design of similar
studies.
On  the  other  hand,  we  have  shown  that  none  of  the  antifungal  treatments
analyzed in  our  study seem to  affect  MRE intestinal  levels.  However, some authors
already reported that Saccharomyces cerevisiae significantly reduced  E. coli O157:H7
growth in a dynamic multi-compartmental digestion system, possibly through a potential
inhibitory role of ethanol produced by the yeast (149). Thus, the fungal microbiota could
have a protective role against MRE. Nevertheless, as in case of beta-lactam treatment, it
is possible that the microbiota of acute leukemia patients is already perturbed as a result
of prophylactic ciprofloxacin treatment, and therefore antifungals do not promote more
expansion of MRE. Nevertheless, it would be interesting to investigate the composition
of  the  fungi  in  the  intestinal  microbiota  and determine  if  some of  them could  have
protective role against MRE intestinal colonization.
Finally, the multivariate  analysis  revealed 2 factors  independently associated
with the change in MRE colonization levels: administration of beta-lactams when the
identified  MRE  strains  are  beta-lactam-sensitive  was  independently  associated  with
decrease in MRE levels; and the taxonomy of the pathogen (the genus Klebisella)  was
associated with higher MRE levels. Since we have demonstrated that administration of
beta-lactams and aminoglycosides (piperacillin-tazobactam, carbapenems, amikacin) can
have an inhibitory effect against MRE, it was possible that the MRE strains within the
genus  Klebsiella have  a  higher  prevalence  of  resistance  to  those  beta-lactams  or
aminoglycosides, which will promote their colonization of the intestinal tract of acute
leukemia patients. For this reason, we analyzed the percentage of Klebisella MRE strains
resistant to beta-lactams and aminoglyosides and compared it to the percentage of other
MRE  resistant  strains  (e.g.  Escherichia).  There  was  no  difference  in  resistance
prevalence among the different MRE analyzed, suggesting that the higher colonization
levels  of  Klebsiella MRE are  not  due  to  a  higher  resistance  to  the  beta-lactams  or
aminoglycosides administered to patients.
Besides the inhibitory effect of antibiotics on MRE intestinal colonization, once
the MRE has colonized the gut, our results also demonstrate that mucositis in the first 2
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weeks previous MRE colonization was associated with increased MRE intestinal levels.
Mucositis  is  a  negative  consequence  of  the  chemotherapy,  characterized  by
inflammation, tissue damage and subsequent ulceration of the oral and gastrointestinal
mucosa  due  to  the  cellular  damage  of  epithelial  cells.  Importantly,  it  has  been
demonstrated in mice that intestinal inflammation can promote a dysbiotic state of the
intestinal microbiota, which would favor colonization with intestinal pathogens  (153).
Due to the low number of patients with mucositis and the variability of the microbiota
among patients, we were not able to elucidate if mucositis was associated with specific
changes in the microbiota that could promote MRE colonization. Taking into account a
recent study reporting differences in the composition of the oral microbiota depending on
the mucositis severity (154), it is likely that mucositis could also produce changes in the
gut microbiota, which may impact MRE colonization levels. Further studies including
more  samples  from  patients  developing  mucositis  should  be  necessary  in  order  to
elucidate a possible link between mucositis, microbiota and MRE colonization.
Overall, we were able to identify factors associated with the MRE colonization
levels in the intestinal tract of acute leukemia patients. As previously mentioned, high
levels  of  colonization  with  MRE is  associated  with the  increased  risk  of  bacteremia
produced by these pathogens. Thus, our results could be useful for the prevention of
dissemination  of  MRE  into  the  bloodstream.  According  to  this,  we  are  currently
collecting  data  about  the  bacteremias  that  occurred  in  the  acute  leukemia  patients
included in this study in order to confirm, in our patient’s cohort, that the high MRE
colonization levels increase the risk of subsequent bloodstream infection.
Besides identifying clinical factors associated with the MRE colonization, we
wanted to investigate how changes in the microbiota composition may impact the ability
of MRE to colonize the intestine, which would finally allow us to identify commensal
bacterial  strains  that  could  provide  protection  against  MRE colonization.  Due to  the
complexity of data we decided to apply a recently published LV mathematical model
(127). This model was successfully applied on microbiome data obtained from patients
colonized with C. difficile, identifying C. scindens as a protector commensal bacterium
against  infections  produced  by  C.  difficile (27).  This  model  takes  into  account  both
clinical factors and microbiota data in order to identify which commensal bacteria and
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clinical factors impact pathogen levels.  Interestingly, when applied on the microbiota
dynamics at the genera level, LV confirmed administration of beta-lactams, when the
detected MRE strains are sensitive to the beta-lactams that are received by the patient, as
a  factor  that  is  negatively  correlated  to  MRE  levels.  Interestingly,  LV  selected
chemotherapy (positively correlated)  and transplant  (negatively correlated)  as clinical
factors associated with MRE intestinal levels. Although these two factors did not pass the
previous multivariate analysis, it  is  possible that chemotherapy and transplant have a
strong effect over the intestinal microbiota, which affects MRE colonization levels, and
thus  are  being  selected  by  LV. Among  positively  correlated  factors,  LV selected  2
bacterial  genera:  Paraprevotella and  Klebsiella.  The positive correlation of the genus
Klebsiella is in agreement with the results obtained in the previous multivariate analysis,
where  colonization  with  MRE  strain  classified  as  Klebsiella was  also  positively
correlated with MRE levels. Further studies will be required to elucidate if this positive
association could be due to the better adaptation of this genus to the colonization of the
intestinal  tract.  On  the  other  hand,  we  found  a  negative  correlation  of  the  genus
Coprobacillus with MRE levels, which suggests that commensal bacterial species within
this  genus could have a  protective role  against  MRE colonization  in  acute leukemia
patients.  Importantly, the genus  Coprobacillus was  found to be negatively associated
with C. difficile when LV model was applied on data obtained in a study using a mouse
model (127). Moreover, in agreement with our results, in this study, Coprobacillus was
negatively correlated with bacteria from the family Enterobacteriaceae. Coprobacillus is
a  relatively novel  genus,  isolated and characterized  for  the  first  time in 2000  (155).
Coprobacillus are Gram-positive non-spore forming bacteria that reside in the intestinal
tract. Their role in colonization resistance have not been studied yet, but interestingly, a
very recent paper that analyzed metagenomic sequences searching for lantibiotics (small
peptides with bactericidal activity) reported novel lantibiotic genes which were encoded
by  2  members  of  the  Coprobacillus genus  (156).  Although  lantibiotics  are  mainly
effective  against  Gram-positive  bacteria,  recently,  a  lantibiotic  with  activity  against
Enterobacteriaceae pathogens, including Escherichia and Salmonella, has been identified
and  patented  (US  Patent  Application  20110305763).  This  lantibiotic  is  produced  by
Bifidobacterium longum, a Gram-positive natural inhabitant of the gastrointestinal tract.
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Right  now,  in  collaboration  with  the  group  of  Dr.  Jean  Marc  Rolain,  experts  in
culturomics (massive isolation of commensal bacteria), we are trying to isolate bacterial
strains  belonging  to  the  Coprobacillus genera  in  order  to  test  their  protective  effect
against MRE. 
In an attempt to identify with more precision those commensal bacteria that
could protect against MRE colonization, we decided to apply LV at the level of OTUs
(sequencing approach to identify bacterial species). As expected, all clinical variables
that  were  previously  selected  through  LV as  correlated  with  MRE levels  were  still
significant when introducing in the model the microbiota information at the OTU level.
In addition,  1 OTU within the genus  Klebsiella was positively associated with MRE
levels, confirming the results obtained when LV was applied at the genus level. This
positive  association  can  be  explained  in  several  ways:  (i)  an  expansion  of  certain
endogenous species of the genus Klebsiella promoted the colonization of MRE strains, or
more likely (ii) a particular MRE species from the genus Klebsiella is highly capable of
colonizing  the  intestinal  tract  and  its  levels  can  be  identified  both  by  16S  rRNA
sequencing and CFU counts, which actually positively correlate because they are indeed
the same bacterial species. Future genome sequencing analysis of the  Klebsiella MRE
isolated strains in comparison with metagenomic analysis  of the fecal samples could
reveal if the Klebsiella observed through culture and 16S rRNA sequencing is the same
or a different strain. If it was found that a particular Klebsiella species or strain is more
capable of colonizing the intestinal tract, subsequent studies should define the specific
colonization factors that allow this pathogen to better colonize the intestine. In addition
to the Klebsiella OTU, a higher abundance of an OTU belonging to the genera Alistipes
was  associated  with  an  increase  of  MRE  levels.  Interestingly,  Alistipes have  been
associated with the appearance of inflammation in pediatric patients with Irritable Bowel
Syndrome (157),  which,  as  indicated  above,  could  promote  the  expansion of  certain
pathogens  included  in  the  family  Enterobacteriaceae.  Moreover,  higher  levels  of
Alistipes, associated with increased levels of the family Enterobacteriaceae, have been
also observed in other  dysbiotic  conditions,  such as major depressive disorder (158).
Obviously,  additional  experiments  must  be  performed,  including  the  isolation  of
Alistipes strains in combination with mouse models of infection in order to elucidate if
164
Discussion
Alistipes has any role in the expansion of MRE strains. Several bacterial OTUs were
identified by LV model to be negatively associated with MRE. These include: 1 OTU
within the genus Lactobacillus and 2 OTUs within the genus Bacteroides. Notably, none
of these OTUs belong to the genus Coprobacillus previously selected by the LV model.
However,  it  is  possible  that  the  genus  selected  as  significant  combines  different
Coprobacillus OTUs, not very prevalent among the different patients included in the
study, that share similar mechanisms by which they exert their effect on MRE. Thus,
none of these OTUs could be identified by LV to be associated with a decrease in the
MRE levels, but combined in the same genus, they could indeed be identified by LV as
bacteria that are negatively associated with MRE levels. In contrast, we did not identify a
negative association between some genera (e.g.  Lactobacillus) and levels of MRE, but
we did identify a negative association between specific  Lactobacillus OTU and MRE
levels. In this case, some OTUs selected by LV could affect MRE colonization levels (i.e.
Lactobacillus OTU20),  however, when analyzed together  with  other  OTUs from the
same genus, this association would be weaker (not significant) if the other OTUs within
the same genus do not have a negative impact on MRE. As mentioned in the previous
chapter, bacteria belonging to the genus Lactobacillus, in combination with Barnesiella,
could  provide  CR  against  MRE  in  our  mouse  model  of  infection.  Nevertheless,  as
mentioned  above,  we  still  need  to  verify  the  contribution  of  the  isolated  murine
Lactobacillus strain on protection against MRE colonization. In the case of the identified
human Lactobacillus OTU, we are right now trying to isolate strains from this OTU in
order to test their protective effect against MRE using in vitro and mouse models. As
previously mentioned, strains within the genus  Lactobacillus (e.g.  L. plantarum) have
been identified as probiotics. Although we were able to determine more precisely, using
the  16S  rRNA  information,  which  Lactobacillus species  were  associated  with  the
decrease in MRE levels in the LV model, due to the legal questions concerning patents,
we cannot indicate to which species the Lactobacillus OTU20 belongs to. On the other
hand, LV also selected 3 OTUs within the genus Bacteroides, 2 of them being negatively
associated with MRE intestinal levels, and 1 positively. These results are in agreement
with the idea that we explained above that not all OTUs from the same genus have to be
associated in the same way with MRE colonization. Interestingly, species from the genus
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Bacteroides have been shown to have both a positive and negative effect on intestinal
colonization  by  Enterobacteriaceae  pathogens.  Huang  et  al.  (159) demonstrated  that
commensal members of the genus Bacteroides have the capacity of liberating sialic acid
from the intestinal tissue, which promotes the outgrowth of E. coli during inflammation.
On the other hand, Kamada et al. (160) demonstrated that when mice were fed with a
simple sugar diet, Bacteroides competes for nutrients with C. rodentium, which results in
elimination of this pathogenic bacteria from the murine intestine.
Overall,  we were able to identify clinical  factors associated with changes in
MRE colonization levels. More importantly, we identified several commensal bacteria
that were negatively associated with MRE colonization levels in acute leukemia patients.
However, as mentioned above, further studies are needed in order to fully elucidate the
role of these bacteria in protection against MRE colonization.  Right now, thanks to a
collaboration with Dr. Jean Marc Rolain, expert in culturomics, we are trying to isolate
the commensal bacteria identified to be associated with decrease in MRE rates in order to
validate their protective effect against MRE. The capacity of these human commensal
isolates to inhibit MRE will be tested using GF mouse models in collaboration with Dr.
Karina Xavier, principal investigator of the Gulbenkian Insitute, which harbors one of
the biggest GF mice facilities in Europe. Results from these future experiments, may
identify novel commensal bacterial strains in that could be used as probiotics to confer
protection against MRE.  Finally, we would like to mention that taking into account all
the microbiota and clinical data that we have obtained, we can indeed perform additional
studies, which due to the limitation in time to complete this thesis, could not be included
here.  Among  these  studies,  we  plan  to  analyze  how different  clinical  variables  (i.e.
antibiotics, mucositis) impact the microbiota composition. In addition, we are performing
analysis in order to evaluate how changes in the microbiota impact another disease that
frequently occur in acute leukemia patients (i.e. Graft versus Host Disease).
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 5.3 The role of the microbiota dysbiosis in ERE
Epizootic  rabbit  enteropathy  is  a  devastating  disease  that  occurs  in  young
rabbits after the weaning, and that has been associated with microbiota dysbiosis (89). In
order to investigate the role of the microbiota dysbiosis on ERE development, caecotroph
samples were collected. Caecotroph samples, type of feces made up of cecal contents and
secreted by rabbits at dawn, are believed to be microbiologicaly more similar to the cecal
content  than  normal  type  of  feces  (161),  although  no  study  to  date  confirmed  this.
Importantly, since the inoculation of the cecal contents has been shown to reproduce the
ERE in specific pathogen free healthy rabbits, it is of interest to investigate if analysis of
the microbiota present in caecotrophs could be extrapolated to the cecum. Here, for the
first  time, we used high throughput sequencing to investigate the composition of the
microbiota in caecotrophs, and to compare it to the microbiota from the cecal content of
the rabbit. Importantly, we could confirm that the microbiota composition of caecotroph
samples is representative of the microbiota of cecal contents, indicating that the sampling
of  caecotrophs  could  be  useful  for  determination  of  the  microbiota  composition  in
cecum, avoiding the sacrifice of the animals.
Once we confirmed that caecotrophs could be used for identification of changes
in  the  microbiota  composition  in  cecum,  we  proceeded  with  characterization  of  the
microbiota dysbiosis observed after the ERE onset. A study published by Bauerl  et al.
(89) described reduced diversity and alteration of the microbiota composition in rabbits
with ERE. The results from this study show that rabbits with ERE develop a pronounced
intestinal dysbiosis, characterized mainly by the expansion of several bacterial genera.
Consistent with the results from the study published by Bauerl et al., ERE rabbits from
our study harbored a microbiota with lower diversity and altered abundances of several
bacterial taxa, including increased levels of Akkermansia, Bacteroides and Clostridium.
The higher abundance of the genus Akkermansia, a mucin-degrading bacterium, could be
due to  the  presence  of  the  large  amounts  of  mucus in  the  intestine  of  ERE rabbits.
Interestingly,  the  genus  Alistipes was  found  decrease  in  ERE  rabbits  in  the  study
published by Bauerl  et al., while in our study this genus had increased abundances in
rabbits developing the disease. Although the reasons for this discrepancy are unknown, it
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is possible that different species from the genera  Alistipes, present in the rabbits from
these  2  studies,  may  behave  differently  after  ERE  initiation.  Alternatively,  different
bacterial taxa present in the different rabbits may influence  Alistipes levels after ERE
initiation.
Bauerl et al. defined 2 types of ERE, inflammatory and secretory, based on the
type of genes upregulated in each of the groups (cytokines or mucins, respectively) and
the microbiota changes that occur after ERE initiation. Interestingly, samples from ERE
rabbits obtained in our study could be separated by their different microbiota in 2 groups
along the first PCoA axis. However, since we did not analyze the genes expressed by the
host, we were not able to confirm if this separation was associated with different host
gene expression profiles.
We and others have shown that the microbiota of ERE rabbits is characterized
by dysbiosis (89). However, it remains unclear whether the microbiota changes observed
in ERE rabbits were the cause or the consequence of the disease. As mentioned in the
Introduction  section,  ERE  occurs  shortly  after  weaning,  and  the  weaning  produces
drastic changes in the microbiota composition (18). Thus it was possible that rabbits that
develop ERE could have different microbiota changes after weaning that could promote
ERE. In order to investigate how microbiota of rabbits evolves after the weaning, and if
some of the changes in the microbiota that occur during this period could result in the
development of ERE, samples were collected from littermate rabbits the day of weaning,
the day after weaning and then every other day during the next 20 days. Interestingly, our
results  show that  the microbiota  of  rabbits  the first  day of  weaning is  very  variable
among animals, and changes over time towards a microbiota that is more similar among
different rabbits. Moreover, the analysis of the overall microbiota structure revealed that
the microbiota of young rabbits reaches a composition more similar to the one of adult
rabbits (mothers) on the 11th day after weaning, suggesting that the transition to the solid
food in rabbits results in rapid adaptation of the intestinal microbiota. Importantly, the
evolution of the overall microbiota composition between healthy rabbits and those that
will  develop  ERE  did  not  differ,  indicating  that  gross  changes  in  the  microbiota
composition as a result of the weaning do not promote ERE development. Moreover,
when  samples  were  analyzed  using  the  454  platform,  no  specific  changes  in  the
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microbiota composition, observed in ERE rabbits, could be detected before the disease
onset, suggesting that the dysbiosis is rather the consequence of the disease and not the
cause.
Importantly, Licois  et  al. (92) reproduced the disease  in  healthy animals  by
administrating intestinal contents obtained from rabbits affected by ERE, suggesting that
a pathogenic agent could be involved in the development of this pathology. An infectious
process is consistent with the results that we obtained. In the first stages of the infectious
process,  the  pathogen  could  represent  a  very  small  fraction  of  the  whole  bacterial
populations residing in the intestinal tract, thus the microbiota structure of healthy and
sick rabbits could be equivalent before ERE onset. Moreover, the previous analysis was
performed on the data obtained by 454 sequencing, and the changes in low abundant
bacteria  could  have  been undetected  due  to  the  relatively  low number  of  sequences
obtained by this technology (2849 ± 779 sequences per sample). For this reason, and in
order  to  investigate  if  there  was  any  alteration  in  the  abundances  of  low  abundant
bacteria  between  ERE and  healthy  rabbits,  all  samples  were  re-sequenced  using  the
newer Illumina platform that allows obtaining a higher sequencing coverage. Analysis
performed on sequences obtained by Illumina revealed results similar to those obtained
by 454 platform.  The dysbiosis  of  the microbiota  identified  in  ERE rabbits  was not
present in these rabbits before the disease onset. However, the day of disease onset ERE
rabbits had significantly higher abundance of the genus  Clostridium.  This genus could
not be detected the day of onset in ERE rabbits using the 454 platform because of its low
abundance  at  this  particular  day  (0.022%).  Importantly,  the  increase  in  the  genus
Clostridium was due to the higher presence of a unique OTU (OTU31), defined as a
novel  species  of  Clostridium-  Clostridium  cuniculi,  phylogenetically related to  C.
botulinum and  C. perfringens, 2 well known pathogens. Importantly,  C. cuniculi could
not be detected in any of the healthy animals. On the other hand, this OTU expanded in
all ERE rabbits after the ERE onset. These results suggest that C. cuniculi could be the
trigger of the ERE, rather than the overall microbiota dysbiosis observed in ERE rabbits.
As explained previously, in some cases, microbiota dysbiosis is needed for the
colonization of the intestinal tract with pathogens. In a study published by Buffie et al.
(24) authors  demonstrated  that  the  profound  microbiota  dysbiosis  as  a  result  of
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clindamycin treatment promotes the colonization of the mice intestine with C. difficile.
However, results from our study indicate that no previous dysbiosis seems to be required
for the colonization and expansion of C. cuniculi in the intestinal tract of rabbits. Similar
result were obtained in a study published by Barman  et al. (88), in which the authors
demonstrated that a  Salmonella  strain can colonize the intestine of mice presenting an
intact  microbiota.  In  this  case,  intestinal  colonization  with  Salmonella produced
inflammation and profound changes in the microbiota of mice, which was exploited by
Salmonella for its own expansion. In the same way, the dysbiosis that occurs upon ERE
initiation may promote the expansion of C. cuniculi. Future studies are required in order
to validate this hypothesis and understand the molecular mechanisms of it. Our results
not only revealed an etiological candidate for ERE development, but also point to the
importance of the analysis of low abundant bacteria, that was provided by the higher
coverage obtained by Illumina sequencing technology. This last point should be taken
into account in the methodological design of other novel studies to investigate the role of
microbiota changes in disease development.
A recent study has shown that restriction in food consumption results in marked
microbiota dysbiosis in rats  (162). Since a decrease in food consumption was the first
sign of ERE, an experiment was performed to investigate if  the observed microbiota
dysbiosis in ERE rabbits could be in part due to the decrease in the food consumption.
The  analysis  revealed  higher  presence  of  the  genera  Anaerovorax and  Olsenella in
rabbits after 2 days of food restriction, while levels of the genus  Anaeroplasma were
lower in these animals compared to those that had  ad libitum access to food. None of
these changes were observed in a study performed on rats. Nevertheless, the difference in
the results could be due to a different baseline microbiota in rabbits and rats. Importantly,
the  microbiota  dysbiosis  observed  in  ERE rabbits  was  not  detected  in  the  group of
rabbits subjected to the food deprivation. Specifically, only the higher abundance of the
genus Anaerovorax was observed in both samples collected from ERE rabbits after the
disease onset and those samples collected after the food deprivation, indicating that only
alteration in abundance of this particular genus in ERE rabbits could be explained by the
decrease in the food consumption. On the other hand, our results shown that the decrease
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in food consumption was not the trigger of ERE development, since food restriction did
not promote to a higher extent the development of ERE signs.
Since the role of the food deprivation as a promoter of the microbiota dysbiosis
and ERE was discarded,  investigation  was centered  on  the  novel  Clostridium strain.
Importantly, various  authors  have  associated pathogens within the genus  Clostridium
with the ERE. As previously mentioned, Marlier and coworkers (94) detected high fecal
counts of C. perfringens in the digestive contents of 80% of the ERE field cases. On the
other hand, Romero et al. (95) showed that high counts of C. perfringens in the hindgut
are associated with clinical symptoms of ERE and mortality. Interestingly, Equine Grass
Sickness (EGS), another gastrointestinal disease which occurs in horses and results in
similar lesions as those observed in ERE rabbits, has been associated with the presence
of C. botulinum and C. perfringens (163). Although the etiological agent of EGS remains
unknown,  it  was  proposed  that  a  putative  toxin,  ingested  by  the  horses,  produces
neuronal damage leading to the stasis of the intestinal transport in EGS. Importantly,
some authors have suggested that the paresis in the intestinal transport could be the cause
of the pathological changes observed in ERE rabbits (92). For this reason, analysis of the
genome of  C. cuniculi was performed in order to identify potential virulence factors,
including toxins that could promote ERE. Interestingly, we detected the presence of an
operon strikingly similar to the operon encoding the type A neurotoxin complex in  C.
botulinum.  The botulinum toxin inhibits  the  release  of  neurotransmitter  acetylcholine
from peripheral cholinergic synapses, resulting in the muscle relaxation and paralysis.
However, and despite  the  presence  of  most  of  the  other  genes  characteristic  for  this
operon (e.g. hemagglutinins), the gene encoding the botulinum toxin was absent from the
operon detected in C. cuniculi. Nevertheless, in place of the botulinum toxin, the operon
encodes  for  a  protein  with  a  domain  similar  to  the  one  detected  in  serine  protease
inhibitors.  Acetylcolinesterase  is  a  serine  protease  that  catalyzes  the  breakdown  of
acetylcholine, and its inhibition could lead to paralysis, which could be compatible with
the cause of some of the signs observed during ERE. On the other hand, a recent study
has  demonstrated  that  the  non-toxic  components  of  the  botulinum  operon
(hemagglutinins) could form a complex that has in vivo toxicity on the small intestine of
the rats  (164). The authors have shown that non-toxic botulinum complex induces the
171
Role of intestinal dysbiosis on gut colonization by bacterial pathogens
formation  of  the vacuoles.  Interestingly, vacuole formation  was also observed in  the
small intestine of the ERE rabbits (165). These results suggest possible mechanisms by
which C. cuniculi could be involved in ERE development.
In order to test the role of C. cuniculi in ERE development, an experiment was
performed in which healthy SPF rabbits were infected with the putative etiological agent
of  ERE.  Since  it  has  been  demonstrated  that  ERE  can  be  reproduced  by  the
administration of the intestinal content of sick animals, cecal contents of ERE rabbits
were  administered  to  a  second group of  rabbits  as  control.  None of  these  2  groups
developed  the  ERE signs,  although  a  transitory  reduction  in  food  consumption  was
observed in rabbits that received the cecal contents from sick rabbits. Our failure in the
reproduction of ERE using cecal contents from sick animals could be due to a higher
resistance to the disease of the rabbits used in this experiment as compared to those used
by Licois and colleagues (92). In addition, our inoculum may contain lower amounts of
the  ethological  agent  required  for  the development  of  ERE as  compared to  the  well
characterized  TEC  inoculum  used  for  the  reproduction  of  ERE  in  previous  studies
(92,93). Similar reasons could explain the failure of C. cuniculi to promote ERE. Another
possible explanation is that species  C. cuniculi  includes various strains with different
levels of virulence, and that the isolated representative, used in experiment in which we
attempted to reproduce ERE, belongs to one of the low-virulent strains. However, we
cannot rule out the possibility that other bacteria, besides C. cuniculi, are required for the
development of ERE, or that  C. cuniculi is just one of the first commensal bacteria to
expand after the initiation of the disease, but not its cause. Further experiments should be
performed in order to fully elucidate the role of C. cuniculi in the ERE development.
As mentioned in the Introduction, microbiota dysbiosis has been associated with
various diseases, including IBD (69), diabetes (70), asthma (71), etc. However, for some
of  them,  it  remains  unclear  whether  the  observed  dysbiosis  is  the  cause  or  the
consequence  of  the  disease.  Our  results  demonstrate  the  importance  of  prospective
longitudinal studies for investigating the role of the microbiota dysbiosis in disease, since
the overall microbiota dysbiosis observed in ERE rabbits was not the trigger of the ERE,
but rather its consequence. Nevertheless, we cannot discard that the dysbiosis observed
after ERE onset could indeed play a role in the progression of the disease, although not
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in  its  initiation.  In  fact,  a  previous  study  showed  that  treatment  of  rabbits  with  the
antibiotic bacitracin does not prevent disease initiation but diminishes the mortality rate
associated with ERE (166), suggesting that certain intestinal bacteria could play a role in
disease  exacerbation.  Regarding  this  last  point,  an  expansion  of  the  genus
Campylobacter was observed in most of the rabbits that develop ERE. Species belonging
to this bacterial genus can produce diarrhea, a sign that is frequently observed in rabbits
that  develop  ERE.  Thus  further  experiments  should  also  elucidate  if  this  particular
bacterium could be playing a role in the progression of the disease.
In  summary,  we  have  identified  a  single  microbiota  change  preceding  the
development  of  ERE  signs  (presence  of  C.  cuniculi),  although  further  research  is




1. Oral administration of ampicillin, vancomycin and neomycin affects differently
the  intestinal  microbiota  of  mice,  which  is  then  reflected  on  the  capacity  of
multidrug resistant  Klebsiella pneumoniae  (MRKP) to colonize the gut of mice
treated  with  these  antibiotics.  Ampicillin  and  vancomycin  induce  drastic  and
persistent changes in the microbiota composition, which allowed gut colonization
and  persistence  by  MRKP.  However,  neomycin  induces  minor  microbiota
changes, which did not allow intestinal colonization by MRKP. The combination
of  the  3  antibiotics  (AVN)  promotes  intestinal  MRKP  colonization  and
persistence to a higher extent that any of 3 antibiotics alone.
2. The murine intestinal microbiota does not recover even after 1 month of AVN
withdrawal.  These  persistent  changes  render  mice  permanently  susceptible  to
MRKP colonization after AVN treatment and facilitate MRKP persistence in the
intestinal tract after antibiotic withdrawal.
3. Fecal  transplant  can  restore  the  baseline  microbiota  of  mice  after  antibiotic
withdrawal,  which  prevents  MRKP  intestinal  colonization.  In  addition,  the
administration of 5 commensal bacterial strains, belonging to genera that did not
recover  after  antibiotic  withdrawal  (Barnesiella,  Alistipes,  Bacteroides,
Lactobacillus  and Mucispirillum),  partially  restored  colonization  resistance
against MRKP in antibiotic-treated mice. The protective effect of the commensal
mixture is not due to restoration of total bacterial density or diversity.
4. Univariate  analysis  of  clinical  factors  in  relation  with  multidrug  resistant
Enterobacteriaceae (MRE) intestinal levels in hospitalized patients revealed that:
(i) acute leukemia patients admitted in the hospital for receiving chemotherapy
are colonized with higher MRE levels than those patients admitted for receiving a
transplant;  (ii)  MRE intestinal levels decrease after systemic administration of
beta-lactams and aminoglycosides when the identified MRE strain is sensitive to
these antibiotics; (iii) however, administration of beta-lactams does not promote
the expansion of MRE strains resistant to the beta-lactams received.
5. Multivariate analysis applied on all factors tested in univariate analysis identified
beta-lactam  treatment,  when  the  identified  MRE  strain  is  susceptible  to  the
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administered beta-lactams, as an independent factor associated with decrease in
MRE  intestinal  levels.  In  addition,  the  phylogeny  of  the  MRE  (i.e.  being
classified within the genus  Klebsiella) was identified as an independent factor
associated with higher MRE intestinal levels.
6. Linear regression analysis identified the development of mucositis prior to MRE
detection as a clinical factor associated with higher MRE intestinal levels.
7. Lotka-Volterra (LV) model applied to clinical and fecal microbiota sequencing
data obtained from acute leukemia patients identified higher abundances of the
genus Coprobacillus to be associated with a decrease in MRE fecal levels, while
higher abundances of the genera  Paraprevotella and  Klebsiella were associated
with  an  increase  in  MRE fecal  levels.  In  addition,  higher  abundances  of  an
operational taxonomical unit (OTU) within the genus Lactobacillus and 2 within
the genus  Bacteroides were identified to be associated with a decrease in MRE
fecal levels, while higher abundances of an  OTU from the genera  Bacteroides,
Klebsiella and  Alistipes were found to be associated with an increase in MRE
fecal levels.
8. LV model confirmed beta-lactam treatment, when the identified MRE strains are
susceptible  to  the  beta-lactams  administered,  transplant  and  chemotherapy  as
clinical factors associated with MRE intestinal levels.
9. Analysis  of  caecotroph samples  collected from rabbits  that  develop Epizootic
Rabbit Enteropathy (ERE) have confirmed the presence of microbiota dysbiosis
in  rabbits  after  the  disease  onset.  Microbiota  dysbiosis  of  ERE  rabbits  is
characterized  by  the  increase  in  abundance  of  the  genera  Clostridium,
Turicibacter,  Robinsoniella,  Coprobacillus,  Roseburia,  Bacteroides,  Alistipes,
Akkermansia, Campylobacter and Anaerovorax, and decrease in abundance of the
genera Fusibacter and Adlercreutzia.
10. The microbiota dysbiosis in ERE rabbits is not promoted by the reduction of food
consumption.  Indeed,  only  1  change  in  the  microbiota  composition  in  ERE
rabbits  can be attributed to  the decrease in  the food consumption (i.e.  higher
abundance of the genus Anaerovorax).
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11. The microbiota of weaned rabbits evolved over time until reaching a microbiota
structure similar to the one observed in adult rabbits on the day 11 post-weaning.
No differences could be detected in microbiota structure after weaning in rabbits
that develop ERE and those that remain healthy.
12. A unique microbiota change was detected in rabbits that developed ERE, before
ERE initiation. Specifically, the day of ERE onset, rabbits that developed ERE
had  higher  levels  of  a  specific  OTU  (OTU31)  belonging  to  the  genus
Clostridium. This OTU represents a novel species within the genus Clostridium,
which we named Clostridium cuniculi, and it is phylogenetically related with the
pathogens  C. perfringens and C. botulinum. The identified  C. cuniculi encodes





AGC Abundance-based greedy clustering
ANI Average nucleotide identity
AST Antimicrobial susceptibility testing
AVN Combined  antibiotic  treatment  composed  of  ampicillin,
vancomycin and neomycin
BSH Bile salt hydrolase
CD Crohn’s disease
CDI Clostridium difficile infection
CFU Colony forming unit
CLSI Clinical and Laboratory Standard Institute




EGS Equine grass sickness
ERE Epizootic Rabbit Enteropathy
ESBL Extended spectrum beta-lactamase
FDR False discovery rate
FISABIO The  Foundation  for the  Promotion  of  Health  and  Biomedical
Research of Valencia Region
FMT Fecal microbiota transplant
GF Germ-free (mice)
GIT Gastrointestinal tract
GM Fecal  anaerobic  culture  obtained by cultivation of  feces  in  Gut
modified cultivation media
IBD Inflammatory bowel disease
Ig(A, E, G, D, M) Immunoglobulin (A, E, G, D, M)
ILC Innate lymphoid cell
IL(10, 17 or 22) Interleukin (10, 17 or 22)
LB Luria-Bertani cultivation medium
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LDA Linear Discriminant Analysis
LV Lotka-Volterra mathematical model
MIX5 Mix of  5  bacterial  commensal  strains  isolated  from mice  feces
(Barnesiella, Bacteroides, Mucispirillum, Alistipes, Lactobacillus)
MRE Multidrug resistant Enterobacteriaceae
MRKP Multidrug resistant Klebsiella pneumoniae
MRSA Methicillin-resistant Staphylococcus aureus
OD Optic density
ORF Open-reading frame
OTU Operational taxonomic unit
PBS Phosphate buffer saline
PCoA Principal Coordinate of Analysis
PCR Polymerase-chain reaction
qPCR Quantitative polymerase-chain reaction
SCFA Short-chain fatty acid
SCH Schaedler cultivation media
SINA Silva Incremental Aligner
SPF Specific pathogen-free
SP1 Salmonella typhimurium pathogenicity island 1
Th (1,2 or 17) T helper cell (1,2 or 17)
Treg Regulatory subset of T cells
UC Ulcerative colitis
UPGMA Unweighted Pair Group Method with Arithmetic mean
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